WO2024157756A1 - Antibacterial filter, method for manufacturing antibacterial filter, and air purifier - Google Patents
Antibacterial filter, method for manufacturing antibacterial filter, and air purifier Download PDFInfo
- Publication number
- WO2024157756A1 WO2024157756A1 PCT/JP2024/000225 JP2024000225W WO2024157756A1 WO 2024157756 A1 WO2024157756 A1 WO 2024157756A1 JP 2024000225 W JP2024000225 W JP 2024000225W WO 2024157756 A1 WO2024157756 A1 WO 2024157756A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- antibacterial
- filter
- silver
- composition
- silicate
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 184
- 238000000034 method Methods 0.000 title claims abstract description 55
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 31
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 78
- 229910052709 silver Inorganic materials 0.000 claims abstract description 78
- 239000004332 silver Substances 0.000 claims abstract description 78
- 239000002245 particle Substances 0.000 claims abstract description 71
- 239000003242 anti bacterial agent Substances 0.000 claims abstract description 67
- 150000001875 compounds Chemical class 0.000 claims abstract description 51
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 claims abstract description 27
- 230000003068 static effect Effects 0.000 claims abstract description 9
- 239000000203 mixture Substances 0.000 claims description 98
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 33
- 238000000576 coating method Methods 0.000 claims description 16
- 239000002243 precursor Substances 0.000 claims description 14
- 229910052809 inorganic oxide Inorganic materials 0.000 claims description 13
- 239000011248 coating agent Substances 0.000 claims description 12
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- 230000005611 electricity Effects 0.000 claims description 6
- 238000012360 testing method Methods 0.000 description 47
- 239000012528 membrane Substances 0.000 description 31
- -1 methacryloyl Chemical group 0.000 description 24
- 239000000843 powder Substances 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical class CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 16
- 230000007062 hydrolysis Effects 0.000 description 15
- 238000006460 hydrolysis reaction Methods 0.000 description 15
- 239000000463 material Substances 0.000 description 15
- 239000002904 solvent Substances 0.000 description 15
- 239000003054 catalyst Substances 0.000 description 14
- 239000002270 dispersing agent Substances 0.000 description 14
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 13
- 239000004810 polytetrafluoroethylene Substances 0.000 description 13
- 239000007787 solid Substances 0.000 description 13
- 238000011282 treatment Methods 0.000 description 12
- 241000700605 Viruses Species 0.000 description 11
- 238000001035 drying Methods 0.000 description 11
- 239000011324 bead Substances 0.000 description 10
- 229910052751 metal Inorganic materials 0.000 description 10
- 239000002184 metal Substances 0.000 description 10
- 239000004094 surface-active agent Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 239000013522 chelant Substances 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- POILWHVDKZOXJZ-ARJAWSKDSA-M (z)-4-oxopent-2-en-2-olate Chemical compound C\C([O-])=C\C(C)=O POILWHVDKZOXJZ-ARJAWSKDSA-M 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 229910052782 aluminium Inorganic materials 0.000 description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 6
- 238000007664 blowing Methods 0.000 description 6
- 239000000428 dust Substances 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 239000011521 glass Substances 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 239000000413 hydrolysate Substances 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 6
- 239000002202 Polyethylene glycol Substances 0.000 description 5
- 239000003945 anionic surfactant Substances 0.000 description 5
- 238000009833 condensation Methods 0.000 description 5
- 230000005494 condensation Effects 0.000 description 5
- 239000010949 copper Substances 0.000 description 5
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 239000010687 lubricating oil Substances 0.000 description 5
- 239000002736 nonionic surfactant Substances 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- 238000011144 upstream manufacturing Methods 0.000 description 5
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 108010009736 Protein Hydrolysates Proteins 0.000 description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 4
- 229910021536 Zeolite Inorganic materials 0.000 description 4
- 125000000129 anionic group Chemical group 0.000 description 4
- 230000000840 anti-viral effect Effects 0.000 description 4
- 239000000919 ceramic Substances 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 4
- 238000010030 laminating Methods 0.000 description 4
- 238000011056 performance test Methods 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- 150000003378 silver Chemical class 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 229910052719 titanium Inorganic materials 0.000 description 4
- 239000010936 titanium Substances 0.000 description 4
- 239000010457 zeolite Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 241000711573 Coronaviridae Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 229920001774 Perfluoroether Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 241000315672 SARS coronavirus Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 235000010724 Wisteria floribunda Nutrition 0.000 description 3
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 3
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 239000004745 nonwoven fabric Substances 0.000 description 3
- 125000002524 organometallic group Chemical group 0.000 description 3
- 239000011164 primary particle Substances 0.000 description 3
- 239000011163 secondary particle Substances 0.000 description 3
- 229910001923 silver oxide Inorganic materials 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 229910052726 zirconium Inorganic materials 0.000 description 3
- 229910000166 zirconium phosphate Inorganic materials 0.000 description 3
- LEHFSLREWWMLPU-UHFFFAOYSA-B zirconium(4+);tetraphosphate Chemical compound [Zr+4].[Zr+4].[Zr+4].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LEHFSLREWWMLPU-UHFFFAOYSA-B 0.000 description 3
- ADTHJEKIUIOLBX-UHFFFAOYSA-N 1,1,3,4,4,5,5,6,6,6-decafluoro-3-(trifluoromethyl)hex-1-ene Chemical compound FC(C(F)(F)F)(C(C(C(F)(F)F)(C=C(F)F)F)(F)F)F ADTHJEKIUIOLBX-UHFFFAOYSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004887 air purification Methods 0.000 description 2
- 239000005456 alcohol based solvent Substances 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 229910052586 apatite Inorganic materials 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 239000000378 calcium silicate Substances 0.000 description 2
- 229910052918 calcium silicate Inorganic materials 0.000 description 2
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000001877 deodorizing effect Effects 0.000 description 2
- 230000000249 desinfective effect Effects 0.000 description 2
- 229940028356 diethylene glycol monobutyl ether Drugs 0.000 description 2
- WGAKFMRZYUGMGU-UHFFFAOYSA-L disilver;selenate Chemical compound [Ag+].[Ag+].[O-][Se]([O-])(=O)=O WGAKFMRZYUGMGU-UHFFFAOYSA-L 0.000 description 2
- 238000009837 dry grinding Methods 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000004210 ether based solvent Substances 0.000 description 2
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 2
- IIEWJVIFRVWJOD-UHFFFAOYSA-N ethylcyclohexane Chemical compound CCC1CCCCC1 IIEWJVIFRVWJOD-UHFFFAOYSA-N 0.000 description 2
- 229920000840 ethylene tetrafluoroethylene copolymer Polymers 0.000 description 2
- AOGQPLXWSUTHQB-UHFFFAOYSA-N hexyl acetate Chemical compound CCCCCCOC(C)=O AOGQPLXWSUTHQB-UHFFFAOYSA-N 0.000 description 2
- 239000012943 hotmelt Substances 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000002563 ionic surfactant Substances 0.000 description 2
- MLFHJEHSLIIPHL-UHFFFAOYSA-N isoamyl acetate Chemical compound CC(C)CCOC(C)=O MLFHJEHSLIIPHL-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 description 2
- UAEPNZWRGJTJPN-UHFFFAOYSA-N methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- JCGNDDUYTRNOFT-UHFFFAOYSA-N oxolane-2,4-dione Chemical compound O=C1COC(=O)C1 JCGNDDUYTRNOFT-UHFFFAOYSA-N 0.000 description 2
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 2
- PGMYKACGEOXYJE-UHFFFAOYSA-N pentyl acetate Chemical compound CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 239000005365 phosphate glass Substances 0.000 description 2
- 229920013639 polyalphaolefin Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 239000003505 polymerization initiator Substances 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000011045 prefiltration Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- YKYONYBAUNKHLG-UHFFFAOYSA-N propyl acetate Chemical compound CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 description 2
- 238000001223 reverse osmosis Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 229940096017 silver fluoride Drugs 0.000 description 2
- REYHXKZHIMGNSE-UHFFFAOYSA-M silver monofluoride Chemical compound [F-].[Ag+] REYHXKZHIMGNSE-UHFFFAOYSA-M 0.000 description 2
- RHUVFRWZKMEWNS-UHFFFAOYSA-M silver thiocyanate Chemical compound [Ag+].[S-]C#N RHUVFRWZKMEWNS-UHFFFAOYSA-M 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- LFQCEHFDDXELDD-UHFFFAOYSA-N tetramethyl orthosilicate Chemical compound CO[Si](OC)(OC)OC LFQCEHFDDXELDD-UHFFFAOYSA-N 0.000 description 2
- WGTYBPLFGIVFAS-UHFFFAOYSA-M tetramethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)C WGTYBPLFGIVFAS-UHFFFAOYSA-M 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- 238000001238 wet grinding Methods 0.000 description 2
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- YOBOXHGSEJBUPB-MTOQALJVSA-N (z)-4-hydroxypent-3-en-2-one;zirconium Chemical compound [Zr].C\C(O)=C\C(C)=O.C\C(O)=C\C(C)=O.C\C(O)=C\C(C)=O.C\C(O)=C\C(C)=O YOBOXHGSEJBUPB-MTOQALJVSA-N 0.000 description 1
- CSNIZNHTOVFARY-UHFFFAOYSA-N 1,2-benzothiazole Chemical class C1=CC=C2C=NSC2=C1 CSNIZNHTOVFARY-UHFFFAOYSA-N 0.000 description 1
- LZDKZFUFMNSQCJ-UHFFFAOYSA-N 1,2-diethoxyethane Chemical compound CCOCCOCC LZDKZFUFMNSQCJ-UHFFFAOYSA-N 0.000 description 1
- VPBZZPOGZPKYKX-UHFFFAOYSA-N 1,2-diethoxypropane Chemical compound CCOCC(C)OCC VPBZZPOGZPKYKX-UHFFFAOYSA-N 0.000 description 1
- LEEANUDEDHYDTG-UHFFFAOYSA-N 1,2-dimethoxypropane Chemical compound COCC(C)OC LEEANUDEDHYDTG-UHFFFAOYSA-N 0.000 description 1
- ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- HFZLSTDPRQSZCQ-UHFFFAOYSA-N 1-pyrrolidin-3-ylpyrrolidine Chemical compound C1CCCN1C1CNCC1 HFZLSTDPRQSZCQ-UHFFFAOYSA-N 0.000 description 1
- IWDUDCDZGOLTTJ-UHFFFAOYSA-N 1h-imidazole;silver Chemical compound [Ag].C1=CNC=N1 IWDUDCDZGOLTTJ-UHFFFAOYSA-N 0.000 description 1
- LRMSQVBRUNSOJL-UHFFFAOYSA-N 2,2,3,3,3-pentafluoropropanoic acid Chemical compound OC(=O)C(F)(F)C(F)(F)F LRMSQVBRUNSOJL-UHFFFAOYSA-N 0.000 description 1
- YPJUNDFVDDCYIH-UHFFFAOYSA-M 2,2,3,3,4,4,4-heptafluorobutanoate Chemical compound [O-]C(=O)C(F)(F)C(F)(F)C(F)(F)F YPJUNDFVDDCYIH-UHFFFAOYSA-M 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- COBPKKZHLDDMTB-UHFFFAOYSA-N 2-[2-(2-butoxyethoxy)ethoxy]ethanol Chemical compound CCCCOCCOCCOCCO COBPKKZHLDDMTB-UHFFFAOYSA-N 0.000 description 1
- MXVMODFDROLTFD-UHFFFAOYSA-N 2-[2-[2-(2-butoxyethoxy)ethoxy]ethoxy]ethanol Chemical compound CCCCOCCOCCOCCOCCO MXVMODFDROLTFD-UHFFFAOYSA-N 0.000 description 1
- JKFYKCYQEWQPTM-UHFFFAOYSA-N 2-azaniumyl-2-(4-fluorophenyl)acetate Chemical compound OC(=O)C(N)C1=CC=C(F)C=C1 JKFYKCYQEWQPTM-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- CHHBLJMHCMIDIZ-UHFFFAOYSA-N 2-oxopyrrolidine-1-carboxylic acid;silver Chemical compound [Ag].OC(=O)N1CCCC1=O CHHBLJMHCMIDIZ-UHFFFAOYSA-N 0.000 description 1
- LDMRLRNXHLPZJN-UHFFFAOYSA-N 3-propoxypropan-1-ol Chemical compound CCCOCCCO LDMRLRNXHLPZJN-UHFFFAOYSA-N 0.000 description 1
- GUUULVAMQJLDSY-UHFFFAOYSA-N 4,5-dihydro-1,2-thiazole Chemical class C1CC=NS1 GUUULVAMQJLDSY-UHFFFAOYSA-N 0.000 description 1
- RBWNDBNSJFCLBZ-UHFFFAOYSA-N 7-methyl-5,6,7,8-tetrahydro-3h-[1]benzothiolo[2,3-d]pyrimidine-4-thione Chemical compound N1=CNC(=S)C2=C1SC1=C2CCC(C)C1 RBWNDBNSJFCLBZ-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 239000004812 Fluorinated ethylene propylene Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- 229920001410 Microfiber Polymers 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 229910021612 Silver iodide Inorganic materials 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- ISKQADXMHQSTHK-UHFFFAOYSA-N [4-(aminomethyl)phenyl]methanamine Chemical compound NCC1=CC=C(CN)C=C1 ISKQADXMHQSTHK-UHFFFAOYSA-N 0.000 description 1
- QXXSGHILLPMQKK-DKWTVANSSA-N [Ag].N[C@@H](CC(=O)O)C(=O)O Chemical compound [Ag].N[C@@H](CC(=O)O)C(=O)O QXXSGHILLPMQKK-DKWTVANSSA-N 0.000 description 1
- YRXWPCFZBSHSAU-UHFFFAOYSA-N [Ag].[Ag].[Te] Chemical compound [Ag].[Ag].[Te] YRXWPCFZBSHSAU-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- UKLDJPRMSDWDSL-UHFFFAOYSA-L [dibutyl(dodecanoyloxy)stannyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[Sn](CCCC)(CCCC)OC(=O)CCCCCCCCCCC UKLDJPRMSDWDSL-UHFFFAOYSA-L 0.000 description 1
- 229910052946 acanthite Inorganic materials 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000004378 air conditioning Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 1
- MQQXUGFEQSCYIA-OAWHIZORSA-M aluminum;(z)-4-ethoxy-4-oxobut-2-en-2-olate;propan-2-olate Chemical compound [Al+3].CC(C)[O-].CC(C)[O-].CCOC(=O)\C=C(\C)[O-] MQQXUGFEQSCYIA-OAWHIZORSA-M 0.000 description 1
- YNCDEEFMDXHURQ-UHFFFAOYSA-N aluminum;ethyl 3-oxobutanoate Chemical compound [Al].CCOC(=O)CC(C)=O YNCDEEFMDXHURQ-UHFFFAOYSA-N 0.000 description 1
- 150000003931 anilides Chemical class 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 239000004760 aramid Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 229920003235 aromatic polyamide Polymers 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 229910000416 bismuth oxide Inorganic materials 0.000 description 1
- RRKTZKIUPZVBMF-IBTVXLQLSA-N brucine Chemical compound O([C@@H]1[C@H]([C@H]2C3)[C@@H]4N(C(C1)=O)C=1C=C(C(=CC=11)OC)OC)CC=C2CN2[C@@H]3[C@]41CC2 RRKTZKIUPZVBMF-IBTVXLQLSA-N 0.000 description 1
- RRKTZKIUPZVBMF-UHFFFAOYSA-N brucine Natural products C1=2C=C(OC)C(OC)=CC=2N(C(C2)=O)C3C(C4C5)C2OCC=C4CN2C5C31CC2 RRKTZKIUPZVBMF-UHFFFAOYSA-N 0.000 description 1
- IQBJFLXHQFMQRP-UHFFFAOYSA-K calcium;zinc;phosphate Chemical compound [Ca+2].[Zn+2].[O-]P([O-])([O-])=O IQBJFLXHQFMQRP-UHFFFAOYSA-K 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- CZKMPDNXOGQMFW-UHFFFAOYSA-N chloro(triethyl)germane Chemical compound CC[Ge](Cl)(CC)CC CZKMPDNXOGQMFW-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011362 coarse particle Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- VWTINHYPRWEBQY-UHFFFAOYSA-N denatonium Chemical compound [O-]C(=O)C1=CC=CC=C1.C=1C=CC=CC=1C[N+](CC)(CC)CC(=O)NC1=C(C)C=CC=C1C VWTINHYPRWEBQY-UHFFFAOYSA-N 0.000 description 1
- 229960001610 denatonium benzoate Drugs 0.000 description 1
- GDVKFRBCXAPAQJ-UHFFFAOYSA-A dialuminum;hexamagnesium;carbonate;hexadecahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Al+3].[Al+3].[O-]C([O-])=O GDVKFRBCXAPAQJ-UHFFFAOYSA-A 0.000 description 1
- TYIXMATWDRGMPF-UHFFFAOYSA-N dibismuth;oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Bi+3].[Bi+3] TYIXMATWDRGMPF-UHFFFAOYSA-N 0.000 description 1
- AYOHIQLKSOJJQH-UHFFFAOYSA-N dibutyltin Chemical compound CCCC[Sn]CCCC AYOHIQLKSOJJQH-UHFFFAOYSA-N 0.000 description 1
- 239000012975 dibutyltin dilaurate Substances 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- NJLLQSBAHIKGKF-UHFFFAOYSA-N dipotassium dioxido(oxo)titanium Chemical compound [K+].[K+].[O-][Ti]([O-])=O NJLLQSBAHIKGKF-UHFFFAOYSA-N 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- OJKANDGLELGDHV-UHFFFAOYSA-N disilver;dioxido(dioxo)chromium Chemical compound [Ag+].[Ag+].[O-][Cr]([O-])(=O)=O OJKANDGLELGDHV-UHFFFAOYSA-N 0.000 description 1
- KDSXXMBJKHQCAA-UHFFFAOYSA-N disilver;selenium(2-) Chemical compound [Se-2].[Ag+].[Ag+] KDSXXMBJKHQCAA-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003759 ester based solvent Substances 0.000 description 1
- QHSJIZLJUFMIFP-UHFFFAOYSA-N ethene;1,1,2,2-tetrafluoroethene Chemical group C=C.FC(F)=C(F)F QHSJIZLJUFMIFP-UHFFFAOYSA-N 0.000 description 1
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 1
- 229940093858 ethyl acetoacetate Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- BABIQFTUTNDWMB-UHFFFAOYSA-M fluorosilver;hydrofluoride Chemical compound F.[Ag]F BABIQFTUTNDWMB-UHFFFAOYSA-M 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 229960001545 hydrotalcite Drugs 0.000 description 1
- 229910001701 hydrotalcite Inorganic materials 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 239000011256 inorganic filler Substances 0.000 description 1
- 229910003475 inorganic filler Inorganic materials 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- GJRQTCIYDGXPES-UHFFFAOYSA-N iso-butyl acetate Natural products CC(C)COC(C)=O GJRQTCIYDGXPES-UHFFFAOYSA-N 0.000 description 1
- 229940117955 isoamyl acetate Drugs 0.000 description 1
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 1
- FGKJLKRYENPLQH-UHFFFAOYSA-M isocaproate Chemical compound CC(C)CCC([O-])=O FGKJLKRYENPLQH-UHFFFAOYSA-M 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- 229940011051 isopropyl acetate Drugs 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- OQAGVSWESNCJJT-UHFFFAOYSA-N isovaleric acid methyl ester Natural products COC(=O)CC(C)C OQAGVSWESNCJJT-UHFFFAOYSA-N 0.000 description 1
- 239000005453 ketone based solvent Substances 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 description 1
- 239000003658 microfiber Substances 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- JLPJFSCQKHRSQR-UHFFFAOYSA-N oxolan-3-one Chemical compound O=C1CCOC1 JLPJFSCQKHRSQR-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 229920009441 perflouroethylene propylene Polymers 0.000 description 1
- 150000008379 phenol ethers Chemical class 0.000 description 1
- 229940067107 phenylethyl alcohol Drugs 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000011941 photocatalyst Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- HKSGQTYSSZOJOA-UHFFFAOYSA-N potassium argentocyanide Chemical compound [K+].[Ag+].N#[C-].N#[C-] HKSGQTYSSZOJOA-UHFFFAOYSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 150000003233 pyrroles Chemical class 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 description 1
- 229940071536 silver acetate Drugs 0.000 description 1
- IMGNYAPMSDUASV-UHFFFAOYSA-K silver arsenate Chemical compound [Ag+].[Ag+].[Ag+].[O-][As]([O-])([O-])=O IMGNYAPMSDUASV-UHFFFAOYSA-K 0.000 description 1
- QBFXQJXHEPIJKW-UHFFFAOYSA-N silver azide Chemical compound [Ag+].[N-]=[N+]=[N-] QBFXQJXHEPIJKW-UHFFFAOYSA-N 0.000 description 1
- XQLMNMQWVCXIKR-UHFFFAOYSA-M silver bromate Chemical compound [Ag+].[O-]Br(=O)=O XQLMNMQWVCXIKR-UHFFFAOYSA-M 0.000 description 1
- ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 1
- 229910001958 silver carbonate Inorganic materials 0.000 description 1
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 description 1
- SDLBJIZEEMKQKY-UHFFFAOYSA-M silver chlorate Chemical compound [Ag+].[O-]Cl(=O)=O SDLBJIZEEMKQKY-UHFFFAOYSA-M 0.000 description 1
- 229940071575 silver citrate Drugs 0.000 description 1
- LFAGQMCIGQNPJG-UHFFFAOYSA-N silver cyanide Chemical compound [Ag+].N#[C-] LFAGQMCIGQNPJG-UHFFFAOYSA-N 0.000 description 1
- 229940098221 silver cyanide Drugs 0.000 description 1
- YSVXTGDPTJIEIX-UHFFFAOYSA-M silver iodate Chemical compound [Ag+].[O-]I(=O)=O YSVXTGDPTJIEIX-UHFFFAOYSA-M 0.000 description 1
- 229940045105 silver iodide Drugs 0.000 description 1
- MHLYOTJKDAAHGI-UHFFFAOYSA-N silver molybdate Chemical compound [Ag+].[Ag+].[O-][Mo]([O-])(=O)=O MHLYOTJKDAAHGI-UHFFFAOYSA-N 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- KKKDGYXNGYJJRX-UHFFFAOYSA-M silver nitrite Chemical compound [Ag+].[O-]N=O KKKDGYXNGYJJRX-UHFFFAOYSA-M 0.000 description 1
- XNGYKPINNDWGGF-UHFFFAOYSA-L silver oxalate Chemical compound [Ag+].[Ag+].[O-]C(=O)C([O-])=O XNGYKPINNDWGGF-UHFFFAOYSA-L 0.000 description 1
- FJOLTQXXWSRAIX-UHFFFAOYSA-K silver phosphate Chemical compound [Ag+].[Ag+].[Ag+].[O-]P([O-])([O-])=O FJOLTQXXWSRAIX-UHFFFAOYSA-K 0.000 description 1
- 229910000161 silver phosphate Inorganic materials 0.000 description 1
- 229940019931 silver phosphate Drugs 0.000 description 1
- 229960003600 silver sulfadiazine Drugs 0.000 description 1
- YPNVIBVEFVRZPJ-UHFFFAOYSA-L silver sulfate Chemical compound [Ag+].[Ag+].[O-]S([O-])(=O)=O YPNVIBVEFVRZPJ-UHFFFAOYSA-L 0.000 description 1
- 229910000367 silver sulfate Inorganic materials 0.000 description 1
- 229940056910 silver sulfide Drugs 0.000 description 1
- XUARKZBEFFVFRG-UHFFFAOYSA-N silver sulfide Chemical compound [S-2].[Ag+].[Ag+] XUARKZBEFFVFRG-UHFFFAOYSA-N 0.000 description 1
- WYCFMBAHFPUBDS-UHFFFAOYSA-L silver sulfite Chemical compound [Ag+].[Ag+].[O-]S([O-])=O WYCFMBAHFPUBDS-UHFFFAOYSA-L 0.000 description 1
- 229910001494 silver tetrafluoroborate Inorganic materials 0.000 description 1
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 1
- CHACQUSVOVNARW-LNKPDPKZSA-M silver;(z)-4-oxopent-2-en-2-olate Chemical compound [Ag+].C\C([O-])=C\C(C)=O CHACQUSVOVNARW-LNKPDPKZSA-M 0.000 description 1
- KZJPVUDYAMEDRM-UHFFFAOYSA-M silver;2,2,2-trifluoroacetate Chemical compound [Ag+].[O-]C(=O)C(F)(F)F KZJPVUDYAMEDRM-UHFFFAOYSA-M 0.000 description 1
- KBHCPEPZBVLREH-UHFFFAOYSA-M silver;2,4,6-trinitrophenolate;hydrate Chemical compound O.[Ag+].[O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O KBHCPEPZBVLREH-UHFFFAOYSA-M 0.000 description 1
- LMEWRZSPCQHBOB-UHFFFAOYSA-M silver;2-hydroxypropanoate Chemical compound [Ag+].CC(O)C([O-])=O LMEWRZSPCQHBOB-UHFFFAOYSA-M 0.000 description 1
- JUDUFOKGIZUSFP-UHFFFAOYSA-M silver;4-methylbenzenesulfonate Chemical compound [Ag+].CC1=CC=C(S([O-])(=O)=O)C=C1 JUDUFOKGIZUSFP-UHFFFAOYSA-M 0.000 description 1
- CLDWGXZGFUNWKB-UHFFFAOYSA-M silver;benzoate Chemical compound [Ag+].[O-]C(=O)C1=CC=CC=C1 CLDWGXZGFUNWKB-UHFFFAOYSA-M 0.000 description 1
- SLERPCVQDVNSAK-UHFFFAOYSA-N silver;ethyne Chemical compound [Ag+].[C-]#C SLERPCVQDVNSAK-UHFFFAOYSA-N 0.000 description 1
- DOQQTKLDEQSKIE-UHFFFAOYSA-N silver;isocyanate Chemical compound [Ag+].[N-]=C=O DOQQTKLDEQSKIE-UHFFFAOYSA-N 0.000 description 1
- NSVHDIYWJVLAGH-UHFFFAOYSA-M silver;n,n-diethylcarbamodithioate Chemical compound [Ag+].CCN(CC)C([S-])=S NSVHDIYWJVLAGH-UHFFFAOYSA-M 0.000 description 1
- RAVDHKVWJUPFPT-UHFFFAOYSA-N silver;oxido(dioxo)vanadium Chemical compound [Ag+].[O-][V](=O)=O RAVDHKVWJUPFPT-UHFFFAOYSA-N 0.000 description 1
- CYLMOXYXYHNGHZ-UHFFFAOYSA-M silver;propanoate Chemical compound [Ag+].CCC([O-])=O CYLMOXYXYHNGHZ-UHFFFAOYSA-M 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000009823 thermal lamination Methods 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- JUWGUJSXVOBPHP-UHFFFAOYSA-B titanium(4+);tetraphosphate Chemical compound [Ti+4].[Ti+4].[Ti+4].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O JUWGUJSXVOBPHP-UHFFFAOYSA-B 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
- QUTYHQJYVDNJJA-UHFFFAOYSA-K trisilver;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Ag+].[Ag+].[Ag+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QUTYHQJYVDNJJA-UHFFFAOYSA-K 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L9/00—Disinfection, sterilisation or deodorisation of air
- A61L9/01—Deodorant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L9/00—Disinfection, sterilisation or deodorisation of air
- A61L9/16—Disinfection, sterilisation or deodorisation of air using physical phenomena
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D39/00—Filtering material for liquid or gaseous fluids
- B01D39/14—Other self-supporting filtering material ; Other filtering material
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F24—HEATING; RANGES; VENTILATING
- F24F—AIR-CONDITIONING; AIR-HUMIDIFICATION; VENTILATION; USE OF AIR CURRENTS FOR SCREENING
- F24F8/00—Treatment, e.g. purification, of air supplied to human living or working spaces otherwise than by heating, cooling, humidifying or drying
- F24F8/20—Treatment, e.g. purification, of air supplied to human living or working spaces otherwise than by heating, cooling, humidifying or drying by sterilisation
- F24F8/24—Treatment, e.g. purification, of air supplied to human living or working spaces otherwise than by heating, cooling, humidifying or drying by sterilisation using sterilising media
Definitions
- the present invention relates to an antibacterial filter, a method for manufacturing an antibacterial filter, and an air purifier.
- Patent Document 1 discloses a technique related to an air purifier that includes an air cleaning filter, a dust sensor, a fan, a fan control unit, and the like.
- the present invention aims to provide an antibacterial filter with excellent antibacterial properties. It also aims to provide a method for manufacturing an antibacterial filter and an air purifier.
- An antibacterial filter comprising a filter portion that satisfies requirement A described below, and an antibacterial portion disposed on the filter portion, the antibacterial portion including a silver-based antibacterial agent and a silicate-based compound.
- a method for producing an antibacterial filter comprising a step of contacting a filter that satisfies requirement A described below with a composition for forming an antibacterial portion, the composition for forming an antibacterial portion containing a silver-based antibacterial agent and a silicate-based compound precursor.
- the method for producing an antibacterial filter according to [5] wherein the process includes a coating process of coating the antibacterial portion-forming composition onto the filter.
- the present invention can provide an antibacterial filter with excellent antibacterial properties.
- the present invention can also provide a method for manufacturing an antibacterial filter and an air purifier.
- (meth)acrylate refers to acrylate and/or methacrylate (either one or both of acrylate and methacrylate)
- (meth)acryloyl refers to acryloyl and/or methacryloyl (either one or both of acryloyl and methacryloyl).
- a numerical range expressed using “to” means a range including the numerical values before and after "to" as the lower limit and upper limit.
- each component may use one substance corresponding to the component alone or two or more substances. When two or more substances are used for each component, the content of the component means the total content of the two or more substances, unless otherwise specified.
- the antibacterial filter of the present invention has a filter part (hereinafter simply referred to as the "filter part") that satisfies requirement A, that is, a particle collection rate measured under specified conditions as described below is 99.95% or more, and an antibacterial part disposed on the filter part, and the antibacterial part contains a silver-based antibacterial agent and a silicate-based compound.
- requirement A that is, a particle collection rate measured under specified conditions as described below is 99.95% or more
- the antibacterial part contains a silver-based antibacterial agent and a silicate-based compound.
- the filter section has, for example, a filter medium formed in a sheet shape.
- a filter medium a known material used in air purifier filters and clean rooms, etc. can be used.
- the filter medium may have a single-layer structure made of a single sheet-like filter medium, or a multi-layer structure made of a plurality of sheet-like filter mediums stacked together.
- the filter medium include a fluororesin porous membrane and a filter medium containing glass fibers (glass filter medium), with the fluororesin porous membrane being preferred in terms of low pressure loss.
- fluororesin constituting the fluororesin porous membrane examples include polytetrafluoroethylene (PTFE), fluorinated ethylene propylene, perfluoroalkoxy polymer, poly(ethylene-co-tetrafluoroethylene-co-hexafluoropropylene) (EFEP), tetrafluoroethylene hexafluoropropylene vinylidene fluoride (THV), poly(tetrafluoroethylene-co-hexafluoropropylene) (FEP), perfluoroalkoxy (PFA), and ethylene tetrafluoroethylene (ETFE).
- PTFE polytetrafluoroethylene
- EFEP poly(ethylene-co-tetrafluoroethylene-co-hexafluoropropylene)
- TSV tetrafluoroethylene hexafluoropropylene vinylidene fluoride
- FEP poly(tetrafluoroethylene-co-hexafluoro
- the fluororesin porous membrane may be composed of one type of fluororesin alone, or may be composed of two or more types of fluororesins.
- the fluororesin porous membrane may also be composed by laminating a plurality of membranes composed of fluororesins.
- the content of the fluororesin in the fluororesin porous membrane is preferably 25% by mass or more, more preferably more than 50% by mass and 100% by mass or less, based on the total mass of the fluororesin porous membrane.
- the fluororesin porous membrane may contain, for example, an inorganic filler as a component different from the fluororesin.
- a polytetrafluoroethylene porous membrane (hereinafter also referred to as a "PTFE porous membrane") formed using polytetrafluoroethylene is preferred, since it generates less microfibers and has a smaller increase in pressure loss over time.
- the thickness of the fluororesin porous membrane is not particularly limited, but is preferably 0.1 to 100 ⁇ m, and more preferably 1 to 20 ⁇ m.
- the method for producing the fluororesin porous membrane is not particularly limited, and the membrane can be produced by a known method such as a method in which a sheet-like molded body formed using a fluororesin is biaxially stretched to make it porous.
- the manufacturing method of PTFE porous membrane can be the following method. First, add liquid lubricant to PTFE fine powder to form a paste-like mixture, and preform the mixture into a rod shape under a pressure that does not separate the liquid lubricant from the paste-like mixture. Next, extrude or roll the rod-like preform into a strip. Then, stretch the obtained strip-like molded product in the longitudinal direction and the transverse direction.
- the liquid lubricant is not particularly limited as long as it can provide the mixture surface with appropriate wettability, and examples of the liquid lubricant include hydrocarbons such as liquid paraffin, naphtha, and white oil.
- the liquid lubricant is preferably one that can be removed by extraction or heat treatment.
- the filter section preferably has a multi-layer structure in which multiple filter media are laminated.
- the filter section more preferably has a multi-layer structure in which a fluororesin porous membrane (more preferably a PTFE porous membrane) and a breathable support material are laminated. Since a fluororesin porous membrane is generally a very thin material with high flexibility, laminating a breathable support material improves the strength of the filter media, suppresses deformation due to the passage of airflow, and improves handling.
- breathable support is a nonwoven fabric that is coarser than the fluororesin porous membrane and allows a larger amount of air to pass through per unit area.
- materials constituting the breathable support include polyolefins (polyethylene (PE), polypropylene (PP), etc.), polyamides, polyesters (polyethylene terephthalate (PET), etc.), aromatic polyamides, and composites of these.
- the filter section comprises the above-mentioned fluororesin porous membrane and breathable support material
- at least one breathable support is disposed upstream of the fluororesin porous membrane in the direction of air flow. This makes it possible to suppress adhesion of coarse particles (such as cotton dust) that cause clogging of the fluororesin porous membrane to the fluororesin porous membrane.
- the filter section comprises a fluororesin porous membrane and two breathable supports, and is laminated so that the fluororesin porous membrane is sandwiched between the two breathable supports.
- the method for laminating a plurality of filter media is not particularly limited, and can be, for example, thermal lamination by heating.
- the filter portion may be pleated so that its cross-sectional shape is a continuous W-shape. That is, the filter portion may be in the form of a so-called "filter pack.” It is preferable that the filter portion is pleated, since this increases the surface area and reduces pressure loss.
- the pleated filter portion has a pleated shape in which peaks and valleys are alternately repeated along one direction in the filter surface.
- the pitch of the pleats (e.g., the distance between the peaks of two adjacent peaks with one valley between them) is preferably 2.5 to 5.0 mm, and more preferably 3.0 to 4.0 mm.
- the pleating of the filter portion can be performed by a known method.
- a pleat shape is formed in the filter portion by folding the filter material along mountain folds and valley folds set on the surface of the filter material in one direction within the filter surface using a known pleating machine (rotary pleating machine, reciprocating pleating machine, creasing pleating machine, etc.).
- a spacer may be disposed in the pleated filter section to maintain the pleated shape.
- spacers include resin strings called beads.
- the beads are disposed on the surface of the filter section along a direction perpendicular to the mountain fold lines (valley fold lines). It is preferable that the pleated filter section has a plurality of beads disposed at predetermined intervals in the direction along the mountain fold lines (valley fold lines). It is also preferable that the beads are disposed on both the front and back surfaces of the filter section.
- the bead is formed, for example, from a yarn separator in which the outer circumference of the yarn is coated with an adhesive such as a synthetic resin, or from a hot melt resin, etc. The bead can be formed, for example, by melting the yarn separator or the hot melt resin by heat and attaching it to a predetermined position of the filter portion.
- the filter part of the antibacterial filter of the present invention satisfies requirement A that the particle collection efficiency when particles with a particle size of 0.3 ⁇ m are passed through the filter part in a state where static electricity has been removed according to the procedure specified in JIS B 9927-5:2022, Annex C, at a wind speed of 5.3 cm/s is 99.95% or more.
- a filter that satisfies the above requirement A is characterized in that the particle collection efficiency measured in a state where static electricity has been removed according to a specific static elimination procedure is equal to or greater than the above reference value.
- electrically charged filters electroly charged filters
- the filter material is electrically charged to improve its dust adsorption capacity
- the filtering efficiency of electrically charged filters varies depending on the air volume, and that the adsorption capacity and therefore the filtering efficiency decreases as the amount of dust captured increases.
- the filter section of the antibacterial filter of the present invention has an excellent particle collection rate even in a neutralized state as described above, the above-mentioned effects on filtering efficiency that can occur in electrically charged filters are significantly suppressed, and an antibacterial filter can be obtained that is less likely to lose filtering performance even over long periods of use and has a longer service life.
- test A Whether or not the filter portion satisfies requirement A can be confirmed by carrying out the following measurement test (hereinafter also referred to as "test A").
- the test specimen (filter part) is de-electrified according to the procedure described in JIS B 9927-5:2022, Appendix C, C.3. Specifically, the test specimen is exposed for 24 hours in a chamber filled with saturated IPA vapor at 23 ⁇ 5°C. After the exposure is completed, the test specimen is stabilized by storing it under standard atmospheric conditions (23 ⁇ 5°C, relative humidity (50 ⁇ 15)%) for at least 30 minutes.
- the IPA used for exposure has a purity of more than 99.9% by volume.
- a particle collection test is performed in which particles having a particle size of 0.3 ⁇ m are passed through the test specimen subjected to the above-mentioned static elimination procedure under the condition of a wind speed of 5.3 cm/s, and the particle collection rate is measured.
- particles having a particle size of 0.3 ⁇ m used in the particle collection test include monodisperse aerosols made of polyalphaolefin (PAO, CAS number: 68649-12-7).
- PAO polyalphaolefin
- the particle size of the particles used in the particle collection test refers to the mass average diameter.
- the particles and measuring equipment described in JIS B 9927-2:2022 can be referred to.
- a test specimen is placed in the measuring equipment, and a particle-containing gas diluted to a predetermined concentration with clean air is passed through the test specimen at a speed of 5.3 cm/s using a suction pump or the like, and the particle collection rate can be obtained from the particle count value on the upstream side and downstream side of the test specimen to be measured. If the particle collection efficiency measured by the above test A is 99.95% or more, the filter part satisfies requirement A.
- the filter section in a state where static electricity has been removed in accordance with the procedure prescribed in JIS B 9927-5:2022, Appendix C, has a particle capture rate of 99.97% or more when a particle capture test is conducted in which particles with a diameter of 0.3 ⁇ m are allowed to pass through at a wind speed of 5.3 cm/s.
- a filter that satisfies the above requirements can be produced, for example, by appropriately adjusting the structure and material of the filter medium, as well as the pleat shape formed by the pleating process.
- the antibacterial portion of the antibacterial filter of the present invention is disposed on the filter portion and contains a silver-based antibacterial agent and a silicate-based compound. It is presumed that the antibacterial filter of the present invention, by disposing the antibacterial part containing the above-mentioned predetermined component on the filter part, not only captures bacteria and viruses present in the air passing through the antibacterial filter to purify the air, but also more efficiently inactivates the captured bacteria and viruses, thereby improving the antibacterial properties. As a result, it is considered that the antibacterial filter of the present invention can also reduce the risk of infection caused by bacteria and viruses during long-term use of the antibacterial filter or during replacement of the antibacterial filter.
- the antibacterial portion is "disposed on the filter portion” means that the antibacterial portion is disposed in contact with at least a portion of the filter portion.
- the position of the antibacterial portion on the filter portion is not particularly limited as long as it does not impede the breathability (capture performance) of the antibacterial filter, and the antibacterial portion may be disposed over the entire surface of the filter portion, or may be disposed in islands on the surface of the filter portion.
- the antibacterial portion may also be disposed so as to cover the surfaces of the pores in the filter portion and/or the surfaces of the fibers that make up the filter portion.
- the antibacterial portion contains a silver-based antibacterial agent.
- a silver-based antibacterial agent means an antibacterial agent that contains silver.
- the type of silver-based antibacterial agent is not particularly limited, and examples include known silver-based antibacterial agents.
- composition A When composition A contains a silver-based antibacterial agent, composition A has an antibacterial effect not only against Escherichia coli and pathogenic bacteria, but also has antibacterial properties against fungi such as mold and antiviral properties against viruses.
- viruses against which the antiviral agent is effective include influenza virus, SARS coronavirus (SARS-CoV), and novel coronavirus (SARS-CoV-2).
- SARS-CoV SARS coronavirus
- SARS-CoV-2 novel coronavirus variants
- a known method can be used to evaluate the antiviral activity.
- the method shown in ISO 21702 can be used, and the antiviral activity can be measured by changing the test virus to a target virus such as influenza virus, SARS coronavirus, or novel coronavirus.
- the antiviral activity value may be greater than 1, but is preferably 2.0 or more, and more preferably greater than 2.0.
- the form of silver contained in the silver-based antibacterial agent is not particularly limited, and examples thereof include silver particles, silver ions, silver oxide, and silver salts (including silver complexes).
- silver complexes are included in the scope of silver salts.
- silver salts include silver acetate, silver acetylacetonate, silver azide, silver acetylide, silver arsenate, silver benzoate, silver hydrogen fluoride, silver bromate, silver bromide, silver carbonate, silver chloride, silver chlorate, silver chromate, silver citrate, silver cyanate, silver cyanide, (cis,cis-1,5-cyclooctadiene)-1,1,1,5,5,5-hexafluoroacetylacetonate, silver diethyldithiocarbamate, silver fluoride (I), silver fluoride (II), silver 7,7-dimethyl-1,1,1,2,2,3,3-heptafluoro-4,6-octanedionate,
- silver isothiocyanate examples include silver potassium cyanide, silver lactate, silver molybdate, silver nitrate, silver nitrite, silver oxide (I), silver oxide (II), silver oxalate, silver perchlorate, silver perfluorobutyrate, silver perfluoropropionate, silver permanganate, silver perrhenate, silver phosphate, silver picrate monohydrate, silver propionate, silver selenate, silver selenide, silver selenate, silver sulfadiazine, silver sulfate, silver sulfide, silver sulfite, silver telluride, silver tetrafluoroborate, silver tetraiodomucrylate, silver tetratungstate, silver thiocyanate, silver p-toluenesulfonate, silver trifluoromethanesulfonate, silver trifluoroacetate, and silver vanadate.
- the silver complex examples include a histidine silver complex, a methionine silver complex, a cysteine silver complex, an aspartic acid silver complex, a pyrrolidone carboxylic acid silver complex, an oxotetrahydrofuran carboxylic acid silver complex, and an imidazole silver complex.
- a silver-supported carrier containing a carrier and silver supported on the carrier is preferred.
- the type of the carrier is not particularly limited, and may be any known carrier.
- the carrier include inorganic oxides (e.g., zeolite, silica gel, zirconium phosphate, calcium phosphate, etc.); activated carbon; metal carriers; organic metals; polymer particles, etc.
- the carrier is preferably an inorganic oxide or polymer particles, and more preferably glass or polymer particles.
- a preferred silver-based antibacterial agent is a silver-supported inorganic oxide, which contains an inorganic oxide as a carrier and silver supported on the inorganic oxide.
- the inorganic oxide carrier include zinc calcium phosphate, calcium phosphate, zirconium phosphate, aluminum phosphate, aluminum silicate, calcium silicate, activated carbon, activated alumina, silica gel zeolite, apatite, hydroxyapatite, titanium phosphate, potassium titanate, hydrous bismuth oxide, hydrous zirconium oxide, and hydrotalcite.
- the carrier may be crystalline or non-crystalline (amorphous), but is preferably amorphous, and more preferably glass.
- Examples of materials that can form glass include silicates, borosilicates, and phosphates.
- silicates borosilicates, and phosphates.
- silver-supported inorganic oxide silver-supported zeolite, silver-supported apatite, silver-supported zirconium phosphate, silver-supported phosphate glass, or silver-supported calcium silicate is preferable.
- silver-based antibacterial agents include, for example, silver zeolite-based antibacterial agents such as "Zeomic (registered trademark)” manufactured by Sinanen Zeomic Co., Ltd., "Silwell” manufactured by Fuji Silysia Chemical Co., Ltd., and "Bactenon” manufactured by Japan Electronic Materials Co., Ltd.; silver-based antibacterial agents in which silver is supported on inorganic ion exchange ceramics, such as "Novalon (registered trademark)” manufactured by Toagosei Co., Ltd.
- silver zeolite-based antibacterial agents such as "Zeomic (registered trademark)” manufactured by Sinanen Zeomic Co., Ltd., "Silwell” manufactured by Fuji Silysia Chemical Co., Ltd., and “Bactenon” manufactured by Japan Electronic Materials Co., Ltd.
- silver-based antibacterial agents in which silver is supported on inorganic ion exchange ceramics such as "Novalon (registered trademark)” manufactured by Toagos
- the silver-based antibacterial agent is preferably in particulate form.
- the average particle size is not particularly limited, but is preferably 0.01 ⁇ m or more, more preferably 0.3 ⁇ m or more, and the upper limit is preferably 3.0 ⁇ m or less, more preferably 1.0 ⁇ m or less.
- the average particle size of the silver-based antibacterial agent can be measured using an electron microscope.
- the average particle size is the average value of the diameters of the primary particles and secondary particles (note that "secondary particles” are defined as aggregates formed by the fusion or contact of primary particles) of the silver-based antibacterial agent particles measured from an image of an electron microscope, and the diameters of the particles in a range of 90% of the total number of particles are averaged, excluding the 5% of the number of particles on the smallest diameter side and the 5% of the number of particles on the largest diameter side.
- the average particle size is a value obtained from the primary particles and the secondary particles.
- the diameter refers to the circumscribed circle equivalent diameter of the particle.
- the 50% volume cumulative diameter (D50) may be measured three times using a laser diffraction/scattering type particle size distribution measuring device manufactured by Horiba, Ltd., and the average value of the three measurements may be used as the average particle size.
- the average particle size of the silver-based antibacterial agent can be adjusted by a conventional method, such as dry grinding and wet grinding.
- dry grinding for example, a mortar, a jet mill, a hammer mill, a pin mill, a rotary mill, a vibration mill, a planetary mill, a bead mill, etc. are appropriately used.
- wet grinding for example, various ball mills, high-speed rotary grinders, jet mills, bead mills, ultrasonic homogenizers, high-pressure homogenizers, etc. are appropriately used.
- the average particle size can be controlled by adjusting the diameter, type, and mixing amount of beads serving as media.
- the content of the silver-based antibacterial agent in the antibacterial part is not particularly limited, but is preferably 0.001 to 50 mass%, more preferably 0.01 to 40 mass%, even more preferably 0.01 to 15 mass%, particularly preferably 0.01 to 10 mass%, and most preferably 0.03 to 5 mass%, relative to the total mass of the antibacterial part.
- the silver content in the silver-based antibacterial agent is not particularly limited, but is preferably 0.1 to 30 mass %, more preferably 0.5 to 5 mass %, based on the total mass of the silver-based antibacterial agent.
- the silicate-based compound means a compound selected from the group consisting of a compound having a hydrolyzable group bonded to a silicon atom, a hydrolyzate thereof, and a hydrolyzed condensate thereof. It is presumed that the antibacterial filter of the present invention has an improved capture rate, particularly for hydrophilic aerosol particles, due to the antibacterial portion containing a silver-based antibacterial agent and a silicate-based compound being disposed on the filter portion.
- the silicate-based compound may be, for example, at least one selected from the group consisting of a compound represented by the following formula (1), a hydrolyzate thereof, and a hydrolyzed condensate thereof.
- Si-(OR) 4 (1) R represents an alkyl group having 1 to 4 carbon atoms and may be the same or different.
- the hydrolysate of the compound represented by formula (1) refers to a compound obtained by hydrolysis of the OR group in the compound represented by formula (1).
- the hydrolysate may be one in which all of the OR groups are hydrolyzed (complete hydrolysate) or one in which only a part of the OR groups are hydrolyzed (partial hydrolysate). In other words, the hydrolysate may be a complete hydrolysate, a partial hydrolysate, or a mixture thereof.
- the hydrolysis condensate of the compound represented by formula (1) refers to a compound obtained by hydrolyzing the OR group in the compound represented by formula (1) and condensing the obtained hydrolyzate.
- the hydrolysis condensate may be one in which all OR groups are hydrolyzed and all the hydrolyzates are condensed (complete hydrolysis condensate), or one in which some OR groups are hydrolyzed and some of the hydrolyzates are condensed (partial hydrolysis condensate).
- the hydrolysis condensate may be a complete hydrolysis condensate, a partial hydrolysis condensate, or a mixture thereof.
- the condensation degree of the hydrolysis condensate is preferably 1-100, more preferably 1-20, and even more preferably 3-15.
- silicate-based compound a compound represented by formula (X) is preferred.
- R 1 to R 4 each independently represent an alkyl group having 1 to 4 carbon atoms, and n represents an integer of 2 to 100. n is preferably an integer of 3 to 15, and more preferably an integer of 5 to 10.
- the content of the silicate-based compound in the antibacterial portion is not particularly limited, but is preferably 20 to 99.8 mass% relative to the total mass of the antibacterial portion, more preferably 20 to 90 mass%, and even more preferably 40 to 90 mass%.
- the antibacterial portion may contain other components in addition to the above components, such as alcohol, an antibacterial agent other than the silver-based antibacterial agent, a catalyst for promoting the condensation of a silicate-based compound, a dispersant, a surfactant, a polymerization initiator, and a fragrance.
- the antibacterial portion preferably contains alcohol, since this provides superior disinfecting performance for reducing bacteria and viruses present in the filter portion in which the antibacterial portion is provided.
- the alcohols may be used alone or in combination of two or more. Examples of the alcohol contained in the antibacterial portion include methanol, ethanol, n-propanol, isopropanol, n-butanol, and isobutanol.
- the alcohol content is preferably 1 mass % or less, more preferably 0.5 mass % or less, and even more preferably 0.1 mass % or less, relative to the total mass of the antibacterial portion.
- antibacterial agents other than silver-based antibacterial agents include inorganic antibacterial agents other than silver-based antibacterial agents and organic antibacterial agents.
- inorganic antibacterial agents include antibacterial agents containing metals.
- the metals include copper, zinc, mercury, iron, lead, bismuth, titanium, tin, and nickel.
- the form of the metal contained in the antibacterial agent is not particularly limited, and examples of the form include metal particles, metal ions, metal oxides, and metal salts (including metal complexes).
- the antibacterial agent containing a metal is preferably a metal-supported carrier containing a carrier and a metal other than silver supported on the carrier.
- the carrier including preferred embodiments thereof, is as described above.
- organic antibacterial agents examples include quaternary ammonium salts, phenol ether derivatives, imidazole derivatives, sulfone derivatives, N-haloalkylthio compounds, anilide derivatives, pyrrole derivatives, pyridine compounds, triazine compounds, benzoisothiazoline compounds, and isothiazoline compounds.
- an inorganic antibacterial agent is preferable, and a copper-based antibacterial agent is more preferable, because it can maintain excellent antibacterial properties for a long period of time.
- An example of the copper-based antibacterial agent is an antibacterial agent containing copper ions (Cu + or Cu 2+ ).
- an example of the antibacterial agent is "Imadies" manufactured by Koken Co., Ltd.
- the antibacterial portion contains the other antibacterial agent, it is preferable that the total content of the silver-based antibacterial agent and the other antibacterial agent is within the range of the content of the silver-based antibacterial agent.
- the type of catalyst that promotes the condensation of the silicate-based compound precursor is not particularly limited, but examples thereof include alkali catalysts and organometallic catalysts.
- alkali catalyst include sodium hydroxide, potassium hydroxide, and tetramethylammonium hydroxide.
- organometallic catalyst examples include aluminum chelate compounds such as aluminum bis(ethylacetoacetate)mono(acetylacetonate), aluminum tris(acetylacetonate), and aluminum ethylacetoacetate diisopropylate; zirconium chelate compounds such as zirconium tetrakis(acetylacetonate) and zirconium bis(butoxy)bis(acetylacetonate); titanium chelate compounds such as titanium tetrakis(acetylacetonate) and titanium bis(butoxy)bis(acetylacetonate); and organotin compounds such as dibutyltin diacetate, dibutyltin dilaurate, and dibutyltin dioctiate.
- aluminum chelate compounds such as aluminum bis(ethylacetoacetate)mono(acetylacetonate), aluminum tris(acetylacetonate), and aluminum ethylacetoacetate diiso
- the type of catalyst is not particularly limited, but an organometallic catalyst is preferable, an aluminum chelate compound or a zirconium chelate compound is more preferable, and an aluminum chelate compound is further preferable.
- an organometallic catalyst is preferable, an aluminum chelate compound or a zirconium chelate compound is more preferable, and an aluminum chelate compound is further preferable.
- commercially available products can be used, specifically, Alumichelate A, Alumichelate D, Alumichelate M, ALCH, and ALCH-TR (all trade names) manufactured by Kawaken Fine Chemical Co., Ltd. can be mentioned.
- the antibacterial portion when the antibacterial portion contains a particulate silver-based antibacterial agent, the antibacterial portion preferably contains a dispersant.
- the type of dispersant is not particularly limited, and any known dispersant can be used.
- a nonionic or anionic dispersant is preferred, and from the viewpoint of affinity for the silver-based antibacterial agent, a dispersant having an anionic polar group such as a carboxy group, a phosphate group, or a hydroxyl group (anionic dispersant) is more preferred.
- anionic dispersants can be used, specific examples of which include DISPERBYK (registered trademark) -110, -111, -116, -140, -161, -162, -163, -164, -170, -171, -174, -180, and -182 (all trade names) manufactured by BYK Corporation.
- the antibacterial portion may contain a surfactant, which has the effect of improving the applicability of the antibacterial portion-forming composition described below.
- the surfactant is not particularly limited, and examples thereof include nonionic surfactants and ionic surfactants (for example, anionic surfactants, cationic surfactants, and amphoteric surfactants).
- nonionic surfactants examples include polyethylene glycol monolauryl ether, polyethylene glycol monostearyl ether, polyethylene glycol monocetyl ether, polyethylene glycol monolauryl ester, and polyethylene glycol monostearyl ester.
- An example of the nonionic surfactant is EMALEX (registered trademark) 715 manufactured by Nippon Emulsion Co., Ltd.
- ionic surfactants examples include anionic surfactants such as alkyl sulfates, alkylbenzenesulfonates, and alkyl phosphates; cationic surfactants such as alkyltrimethylammonium salts and dialkyldimethylammonium salts; and amphoteric surfactants such as alkylcarboxybetaines.
- Anionic surfactants include sodium di(2-ethylhexyl)sulfosuccinate.
- the antibacterial portion may contain a fragrance.
- a fragrance There are no limitations on the type of fragrance, and it is preferable to select a fragrance that does not impair the effects of the present invention, such as antibacterial properties.
- the content of the antibacterial portion in the antibacterial filter is not particularly limited, but is preferably 0.05 to 2.0 mass %, more preferably 0.1 to 0.7 mass %, relative to the total mass of the antibacterial filter.
- the content of the antibacterial portion can be calculated from the measurement results by removing the antibacterial portion by immersing the antibacterial filter in a solvent that may be contained in the composition for forming the antibacterial portion described below, and measuring the weight of the filter before and after removal.
- the antibacterial filter of the present invention may be used as a filter unit by providing a frame (support frame) that supports the antibacterial filter so as to surround the periphery of the antibacterial filter, if necessary.
- a frame support frame
- a metal or resin member is used depending on the application of the antibacterial filter.
- the antibacterial filter may be fixed to the frame at the same time as the frame is molded by injection molding.
- an antibacterial portion may be provided on the filter portion by the method described below.
- the antibacterial filter of the present invention preferably has the following properties.
- the antibacterial filter has a more excellent particle collection performance, and when particles having a particle size of 0.3 ⁇ m are passed through the antibacterial filter in a state in which static electricity has been removed according to the procedure specified in JIS B 9927-5:2022, Appendix C, at a wind speed of 5.3 cm/s, the particle collection efficiency is preferably 99.95% or more, and more preferably 99.97% or more. The particle collection efficiency may be 100%.
- the particle capture rate of the antibacterial filter can be measured by a method similar to Test A above.
- the initial pressure loss of the antibacterial filter is not particularly limited, but is preferably 50 to 150 Pa, and more preferably 60 to 100 Pa.
- the initial pressure loss is a value measured on an unused antibacterial filter using clean air according to the method described in "3.2 Pressure Loss Test" in the appendix of JIS B 9927:1999.
- the initial pressure loss of the antibacterial filter can be adjusted by, for example, appropriately selecting the structure and material of the filter medium constituting the filter portion, and the pleat shape of the filter portion.
- the shape and size of the antibacterial filter are not particularly limited and may be adjusted as appropriate depending on the application and/or the device in which it is incorporated.
- An example of a method for producing the antibacterial filter of the present invention is a method in which an antibacterial portion is formed on the filter portion by contacting the filter portion with an antibacterial portion-forming composition described below.
- an antibacterial filter By contacting the filter portion with the antibacterial portion-forming composition to form an antibacterial portion, an antibacterial filter can be produced that not only purifies the air by capturing bacteria and viruses present in the air passing through the antibacterial filter, but also has an excellent function of inactivating the captured bacteria and viruses.
- the present invention includes a method for producing an antibacterial filter, comprising the step of contacting a filter satisfying the above requirement A with a composition for forming an antibacterial portion, the composition containing a silver-based antibacterial agent and a silicate-based compound precursor.
- the method for producing the antibacterial filter of the present invention will be described in more detail below.
- the filter that satisfies requirement A in the manufacturing method of the antibacterial filter of the present invention is the same as the filter portion already explained, including the preferred embodiments.
- composition A contains at least a silver-based antibacterial agent and a silicate-based compound precursor.
- the silver-based antibacterial agent contained in composition A, including preferred embodiments thereof, is as already described above.
- silicate compound precursor examples include compounds that become the above-mentioned silicate-based compounds through one or both of hydrolysis and hydrolysis condensation. That is, the silicate-based compound may be a hydrolysate or hydrolysis condensate of a silicate-based compound precursor.
- the silicate compound precursor may be at least one selected from the group consisting of the compound represented by the above formula (1), its hydrolysate, and its hydrolyzed condensate.
- the compound represented by formula (1), its hydrolysate, and its hydrolyzed condensate are as already explained, including their respective preferred embodiments.
- composition A the compound represented by formula (1) is mixed with water to be at least partially hydrolyzed.
- the hydrolyzate of the compound represented by formula (1) is obtained by reacting the compound represented by formula (1) with water to convert the OR group bonded to silicon to a hydroxy group. It is not necessary for all the OR groups to react during hydrolysis, but it is preferable that as many OR groups as possible are hydrolyzed in order to exhibit hydrophilicity after application.
- the minimum amount of water required during hydrolysis is the same molar amount as the OR group of the compound represented by formula (1), but it is preferable that a large excess of water is present in order to smoothly proceed with the reaction.
- the hydrolysis and condensation reactions of the silicate compound precursor proceed at room temperature, but may be heated to accelerate the reaction. A longer reaction time is preferable because the reaction proceeds more quickly.
- in the presence of a catalyst it is possible to obtain a hydrolyzate in about half a day.
- the content of the silicate compound precursor in composition A is not particularly limited, but is preferably 0.10 to 0.50 mass %, more preferably 0.10 to 0.40 mass %, and even more preferably 0.20 to 0.31 mass %, based on the total mass of the composition.
- the preferred content of the silicate-based compound precursor relative to the total solid content of the composition A may be the same as the preferred content of the silicate-based compound relative to the antibacterial portion described above.
- the solid content refers to the components in the composition excluding the solvent. Even if the components other than the solvent are in a liquid state, they are counted as solids.
- composition A may contain a solvent, and preferably contains a solvent.
- the type of the solvent is not particularly limited, and examples thereof include water and organic solvents.
- the water is preferably purified water, more preferably distilled water, ion-exchanged water, RO (reverse osmosis) water, pure water, or ultrapure water, and is more preferably ion-exchanged water in terms of the stability of the antibacterial agent.
- the electrical conductivity of the water is preferably 0.1 to 0.2 mS/m.
- organic solvents include alcohol-based solvents such as methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, sec-butanol, tert-butanol, n-pentanol, isopentanol, phenylethyl alcohol, capryl alcohol, lauryl alcohol, and myristyl alcohol; methyl cellosolve, ethyl cellosolve, ethylene glycol dimethyl ether, ethylene glycol diethyl ether, propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol monopropyl ether, propylene glycol dimethyl ether, propylene glycol diethyl ether, ethylene glycol monobutyl ether, diethylene glycol monobutyl ether, triethylene glycol monobutyl ether, tetraethylene glycol monobutyl ether, and diethylene glycol mono
- glycol ether solvents such as propylene glycol monobutyl ether; aromatic hydrocarbon solvents such as benzene, toluene, xylene, and ethylbenzene; alicyclic hydrocarbon solvents such as cyclopentane, cyclohexane, methylcyclohexane, and ethylcyclohexane; ether solvents such as tetrahydrofuran, dioxane, diisopropyl ether, and di-n-butyl ether; ketone solvents such as acetone, methyl ethyl ketone, and methyl isobutyl ketone; ester solvents such as methyl acetate, ethyl acetate, n-propyl acetate, isopropyl acetate, n-butyl acetate, isobutyl acetate, n-amyl acetate, isoamyl acetate,
- the solid content of the composition A is not particularly limited, and is preferably 0.001 to 80 mass%, more preferably 0.01 to 10 mass%, still more preferably 0.1 to 5.0 mass%, and particularly preferably 0.1 to 1.0 mass%, based on the total mass of the composition, in terms of superior coating properties. It is preferable to adjust the content of the solvent in the composition so as to obtain the above solid content.
- the solvent may be used alone or in combination of two or more kinds.
- Composition A preferably contains alcohol, since it has better short-term disinfecting performance against pathogens, etc.
- the alcohol include the above-mentioned alcohol-based solvents.
- the content thereof is preferably 82.0% by mass or less based on the total mass of the composition. Although there is no particular lower limit, the content is preferably 20% by mass or more, and more preferably 55.0% by mass or more.
- composition A contains two or more types of alcohol (for example, when ethanol and isopropanol are used), the total amount thereof is preferably within the above range.
- composition A contains alcohol, it is preferable that composition A further contains water as a solvent in that the aggregation stability of the antibacterial agent is superior.
- Composition A may contain other components in addition to the components described above.
- other components include a catalyst that promotes condensation of a silicate-based compound precursor, a dispersant, a surfactant, a polymerization initiator, a film-forming agent, and a fragrance.
- the above components have already been explained as other components that may be contained in the antibacterial portion.
- composition A contains the other components described above, the content of each component is appropriately adjusted based on known techniques within a range that does not impair the effects of the present invention, such as antibacterial properties.
- the content of the catalyst is preferably from 0.005 to 0.0025% by mass, and more preferably from 0.011 to 0.019% by mass, based on the total mass of the composition.
- composition A preferably contains a dispersant.
- the content of the dispersant is preferably 40% by mass or less, more preferably 20% by mass or less, and even more preferably 10% by mass or less, based on the total solid content of the composition.
- the lower limit is not particularly limited, and may be, for example, 0.01% by mass or more based on the total solid content of the composition.
- Composition A preferably contains a surfactant because it has the effect of improving the coatability of composition A.
- the content of the surfactant is not particularly limited, but is preferably 0.01 mass% or more based on the total solid content of the composition.
- the upper limit of the content of the surfactant is not particularly limited, but is preferably 10 mass% or less, more preferably 7 mass% or less, based on the total solid content of the composition.
- the surfactant may be used alone or in combination of two or more. When two or more surfactants are used, a combination of a nonionic surfactant and an anionic surfactant is preferred from the viewpoint of the aggregation stability of the silver-based antibacterial agent.
- composition A is not particularly limited, and it can be prepared by appropriately mixing the above-mentioned components.
- the order in which the above-mentioned components are mixed is not particularly limited.
- composition A is brought into contact with a filter that satisfies requirement A.
- This contact step causes the silver-based antibacterial agent and silicate-based compound precursor, etc., to adhere to the surface (including the pore surface) of the filter medium that constitutes the filter.
- the solvent that has infiltrated the filter is evaporated to form an antibacterial portion that contains the silver-based antibacterial agent and the silicate-based compound and is disposed on the filter.
- Examples of the step of contacting the filter with composition A include a step of applying composition A to the filter and a step of immersing the filter in composition A, and a step of applying composition A to the filter is preferred.
- the method of coating the composition A on the filter includes, for example, a spray method, a roll coater method, a gravure coater method, a screen method, a spin coater method, a flow coater method, an inkjet method, and a wipe method, and the spray method is preferred.
- the composition A may be applied to the filter only once, but it is preferable to carry out the coating a plurality of times. More specifically, it is preferable to repeatedly apply composition A to the filter, dry it to form an antibacterial portion, and then apply composition A again and dry it to form the antibacterial portion. In addition, it is preferable to apply composition A to both main surfaces of the filter at least once in order to form a more uniform antibacterial portion. That is, in the coating process, it is preferable to repeatedly apply composition A to one main surface to form an antibacterial portion at least two times, and to repeatedly apply composition A to the other main surface to form an antibacterial portion at least two times, for a total of four or more applications.
- the number of coatings on each main surface of the filter is preferably 1 to 4 times, more preferably 2 to 4 times, and even more preferably 2 or 3 times.
- the amount of composition A applied to the filter in the application step is preferably 50 to 1000 mL/ m2 , more preferably 100 to 500 mL/ m2 , and even more preferably 150 to 300 mL/ m2 , relative to the area of the main surface of the filter.
- the above-mentioned application amount is the total application amount of the multiple times.
- the "area of the main surface of the filter" means the area calculated from the outer dimensions of the filter.
- a heat treatment (drying treatment) may be carried out to promote removal of the solvent.
- the conditions for the heat treatment are not particularly limited.
- the heating temperature is preferably 50 to 200° C.
- the heating time is preferably 15 to 600 seconds.
- the antibacterial filter of the present invention can be used, for example, in air purifiers, air conditioners, fan coil units for buildings, and air conditioning equipment for clean rooms, etc.
- the effects of the present invention can be more effectively exhibited by using the antibacterial filter of the present invention in an air purifier that has the function of removing harmful substances such as pathogens and purifying the air in spaces where ventilation is difficult, such as the inside of a room or a vehicle.
- the antibacterial filter of the present invention can also be used in a mask that is worn on the human body.
- a preferred embodiment of the antibacterial filter of the present invention is an air purifier equipped with the antibacterial filter of the present invention.
- the air purifier comprises, for example, a casing, an air inlet and an air outlet provided in the casing, the antibacterial filter of the present invention, and air blowing means.
- a flow passage is provided in the casing so that air drawn in from the intake port passes through the antibacterial filter and is then discharged from the exhaust port.
- the blowing means e.g., turbo fan, etc.
- the blowing means is disposed on the intake port side (upstream side) or the exhaust port side (downstream side) with respect to the antibacterial filter.
- the blowing means disposed on the intake port side draws air outside the casing through the intake port into the casing.
- the blowing means disposed on the exhaust port side blows air inside the casing out of the casing.
- the blowing means may be disposed on both the intake port side and the exhaust port side.
- the antibacterial filter of the present invention may be used in combination with a prefilter for removing dust such as cotton dust, a deodorizing filter such as a photocatalyst filter having deodorizing properties, and a known filter such as a VOC adsorption filter. That is, an air purifier equipped with the antibacterial filter of the present invention may further include at least one of the above filters.
- the air purifier includes the above filter, it is preferable that the above filter (particularly the prefilter) is disposed on the air intake side relative to the antibacterial filter.
- the antibacterial particle solution was prepared by adding a dispersant (BYK Corporation's "DISPERBYK-180”) (0.61 g) while stirring ethanol (19.6 g) in a container, followed by stirring for 15 minutes, and then adding a silver-loaded glass dispersion (Fuji Chemical Co., Ltd.'s "Bacterite MP-103DV”) (0.80 g) and stirring for 15 minutes.
- the silver-loaded glass dispersion was a dispersion containing a silver-loaded inorganic oxide in which silver was loaded on an inorganic oxide carrier made of phosphate glass, the solids concentration of the dispersion was 25 mass%, and the silver content relative to the total mass of the silver-loaded carrier was 2 mass%.
- a sheet-like filter medium (“TEMISH (registered trademark) NTF-9307-L03" manufactured by Nitto Denko Corporation) was prepared, which was made by laminating a PTFE porous membrane and two sheets of nonwoven fabric sandwiching the PTFE porous membrane.
- the above filter medium was pleated to produce a filter (filter pack) having outer dimensions of 240 mm in width, 417 mm in length, and 51 mm in thickness, with a pitch of approximately 3.5 mm and pleated shapes having 120 peaks and 120 valleys.
- the produced filter was subjected to static electricity removal in accordance with the method already explained as Test A, and then the particle collection efficiency of particles having a particle diameter of 0.3 ⁇ m was measured under a wind speed of 5.3 cm/s. As a result, it was confirmed that the particle collection efficiency was 9.97% or more and satisfied requirement A.
- the composition A1 prepared above was filled into the container of an air gun (manufactured by Anest Iwata Corporation, product name "WIDER"). Using this air gun, the composition A1 was applied to the entire surface of one of the main surfaces (first surface) of the filter manufactured above, and then the filter on which the coating film of the composition A1 was formed was left in an environment of 20 to 35 ° C. for 1 hour to dry by natural drying. Next, using the air gun, the composition A1 was applied to the entire surface of the other main surface (second surface) opposite to the first surface of the filter, and a drying process was performed under the same conditions.
- an air gun manufactured by Anest Iwata Corporation, product name "WIDER”
- the coating amount of the composition A1 in one coating step was 150 mL/m 2 relative to the area of the main surface of the filter, and the total coating amount of the composition A1 applied to the filter was 300 mL/m 2 relative to the area of the main surface of the filter. In this way, an antibacterial filter of the present invention having a filter portion and an antibacterial portion was produced.
- Example 2 According to the method described in Example 1, a series of treatments consisting of application of composition A1 from the first surface, drying treatment, application of composition A1 from the second surface, and drying treatment were performed, and then a series of treatments consisting of application of composition A1 from the first surface, drying treatment, application of composition A1 from the second surface, and drying treatment were performed again on the filter on which the antibacterial portion was formed.
- the application amount of composition A1 in one application step was 150 mL/ m2 relative to the area of the main surface of the filter, and the total application amount of composition A1 applied to the filter was 600 mL/ m2 relative to the area of the main surface of the filter.
- Example 3 According to the method described in Example 2, a series of processes consisting of applying composition A1 from the first surface, drying treatment, applying composition A1 from the second surface, and drying treatment were repeated twice, and then a series of processes consisting of applying composition A1 from the first surface, drying treatment, applying composition A1 from the second surface, and drying treatment were again performed on the filter on which the antibacterial portion was formed.
- the amount of composition A1 applied in one application step was 150 mL/ m2 relative to the area of the main surface of the filter, and the total amount of composition A1 applied to the filter was 900 mL/ m2 relative to the area of the main surface of the filter.
- Example 2 The antibacterial filter of Example 2 and the reference filter described below were subjected to a filter performance test under the following conditions.
- Evaluation device A filter performance evaluation device conforming to JIS B 9908.
- Test powder SAP test powder 3 type 3 (STP3-3) (calcined Kanto loam) manufactured by the Japan Powder Industry and Technology Association.
- Reference filter Charged HEPA filter ("FZ-14EXSF (product name)" manufactured by Sharp Corporation) Test air volume: 420 m3 /h Each filter sample was placed in the evaluation device.
- test powder was gradually introduced from a powder introduction port provided on the upstream side of the filter sample in the device, so that a mixed gas containing the test powder was passed through the filter sample.
- the flow rate of the mixed gas passing through the filter sample was adjusted by an orifice provided on the downstream side of the filter sample in the device so that it was equal to the test air volume, and thereafter, the air volume was not adjusted until the end of the test.
- the test was terminated when 100 g of the test powder was added. The weight of the filter sample after the test was measured, and the difference (filter weight increase) between the weight of the filter sample before the test, which was measured in advance, was calculated.
- the test powder remaining upstream of the filter sample in the evaluation device after the test was completed was collected, and the total weight (unreached powder weight) was measured.
- the weight of the test powder that reached the filter sample during the test was obtained by subtracting the unreached powder weight measured above from the weight (100 g) of the test powder charged into the evaluation device.
- the percentage of the ratio of the filter weight increase to the obtained reached powder weight was calculated as the powder capture rate (%), and the powder capture performance of the filter sample was evaluated.
- Table 1 shows the test results.
- the upper row of the "Pressure Loss” column shows the pressure loss of each filter sample measured immediately after the completion of the above-mentioned test
- the lower row in parentheses shows the ratio, expressed as a percentage, of the pressure loss measured immediately after the completion of the test to the pressure loss measured before the start of the test.
- the upper row of the "Air Volume” column shows the flow rate of air passing through the filter sample measured immediately after the completion of the above test
- the lower row in parentheses shows the ratio, expressed as a percentage, of the flow rate measured immediately after the completion of the test to the flow rate measured before the start of the test.
- Example means the measurement result of the antibacterial filter of Example 2
- Reference Example means the measurement result of the reference filter.
- two measurements were taken for each filter, and the respective measurement results are shown in “(1)” and "(2)" of “Example” and “Reference Example”.
- the antibacterial filter of Example 2 achieved a powder capture rate of nearly 100%, and was found to have excellent powder capture performance. Moreover, the antibacterial filter of Example 2 also suppresses the pressure loss and reduction in air volume after powder capture, and can be judged to be at a level that has sufficient practicality even in light of the track record of conventional electrically charged filters.
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Combustion & Propulsion (AREA)
- Mechanical Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Filtering Materials (AREA)
Abstract
To provide an antibacterial filter having excellent antibacterial properties. The present invention also addresses the problem of providing a method for manufacturing an antibacterial filter, and an air purifier. The antibacterial filter has a filter part that satisfies Requirement A, and an antibacterial part that is disposed on the filter part. The antibacterial part contains a silver-based antibacterial agent and a silicate-based compound. Requirement A: The particle collection rate is at least 99.95% when particles having a particle diameter of 0.3 μm are passed through the filter part, from which static has been eliminated, under the conditions of a wind velocity of 5.3 cm/s and according to the procedure defined in JIS B 9927-5:2022 Annex C.
Description
本発明は、抗菌フィルタ、抗菌フィルタの製造方法、及び、空気清浄機に関する。
The present invention relates to an antibacterial filter, a method for manufacturing an antibacterial filter, and an air purifier.
従来、室内又は車内等の空間において、装置内部に空気を取り込み、内部を移動する間に空気清浄用フィルタを通過させ、再度空間に排出することにより、空気を清浄化する機能を備えた空気清浄機が知られている。
例えば、特許文献1には、空気清浄用フィルタ、ホコリセンサ、ファン及びファン制御部等を備える空気清浄機に関する技術が開示されている。 Conventionally, air purifiers have been known that have the function of purifying air by taking in air into a space such as a room or a vehicle, passing the air through an air purification filter as it moves inside the device, and then discharging the air back into the space.
For example, Patent Document 1 discloses a technique related to an air purifier that includes an air cleaning filter, a dust sensor, a fan, a fan control unit, and the like.
例えば、特許文献1には、空気清浄用フィルタ、ホコリセンサ、ファン及びファン制御部等を備える空気清浄機に関する技術が開示されている。 Conventionally, air purifiers have been known that have the function of purifying air by taking in air into a space such as a room or a vehicle, passing the air through an air purification filter as it moves inside the device, and then discharging the air back into the space.
For example, Patent Document 1 discloses a technique related to an air purifier that includes an air cleaning filter, a dust sensor, a fan, a fan control unit, and the like.
医療機関等の高品質な空気清浄機能が常に要求されている施設又は場面では、長期間使用しても捕集性能が低下しにくいフィルタ及び空気清浄機が求められている。また、医療機関では、感染症に罹患した患者が治療の目的で滞在するため、単独で或いはエアロゾルに付着して浮遊する病原菌及び病原ウイルス等の病原体が、空間内に多く存在することがある。
ここで、設備上又は医療上の理由で換気が難しい場合、空気清浄機により室内の空気をフィルタリングすることで病原体の除去が図られることが多い。その場合、空気清浄機の長期間の使用により非常に高濃度の病原体がフィルタに付着したままになるおそれが考えられる。その結果、フィルタ交換等の作業に従事する作業者が感染する事態、或いは、捕集効率の低下又はフィルタの破損により病原体が室内に再拡散する事態が生じることも考え得る。 In facilities or situations where high-quality air purification functions are always required, such as medical institutions, filters and air purifiers whose collection performance does not deteriorate even after long-term use are required. In addition, in medical institutions, patients suffering from infectious diseases stay for the purpose of treatment, so there are often many pathogens such as pathogenic bacteria and pathogenic viruses floating alone or attached to aerosols in the space.
Here, when ventilation is difficult for equipment or medical reasons, pathogens are often removed by filtering the indoor air with an air purifier. In such cases, it is possible that a very high concentration of pathogens may remain on the filter due to long-term use of the air purifier. As a result, it is possible that workers who are engaged in tasks such as replacing the filters may become infected, or that pathogens may be re-distributed indoors due to a decrease in collection efficiency or damage to the filter.
ここで、設備上又は医療上の理由で換気が難しい場合、空気清浄機により室内の空気をフィルタリングすることで病原体の除去が図られることが多い。その場合、空気清浄機の長期間の使用により非常に高濃度の病原体がフィルタに付着したままになるおそれが考えられる。その結果、フィルタ交換等の作業に従事する作業者が感染する事態、或いは、捕集効率の低下又はフィルタの破損により病原体が室内に再拡散する事態が生じることも考え得る。 In facilities or situations where high-quality air purification functions are always required, such as medical institutions, filters and air purifiers whose collection performance does not deteriorate even after long-term use are required. In addition, in medical institutions, patients suffering from infectious diseases stay for the purpose of treatment, so there are often many pathogens such as pathogenic bacteria and pathogenic viruses floating alone or attached to aerosols in the space.
Here, when ventilation is difficult for equipment or medical reasons, pathogens are often removed by filtering the indoor air with an air purifier. In such cases, it is possible that a very high concentration of pathogens may remain on the filter due to long-term use of the air purifier. As a result, it is possible that workers who are engaged in tasks such as replacing the filters may become infected, or that pathogens may be re-distributed indoors due to a decrease in collection efficiency or damage to the filter.
本発明は、上記実情に鑑みて、抗菌性に優れた抗菌フィルタを提供することを課題とする。また、本発明は、抗菌フィルタの製造方法、及び、空気清浄機を提供することも課題とする。
In view of the above situation, the present invention aims to provide an antibacterial filter with excellent antibacterial properties. It also aims to provide a method for manufacturing an antibacterial filter and an air purifier.
本発明者は、上記課題を解決すべく鋭意検討した結果、以下の構成により課題を解決できることを見出した。
As a result of extensive research into solving the above problems, the inventors have discovered that the problems can be solved by the following configuration.
〔1〕後述する要件Aを満たすフィルタ部と、上記フィルタ部上に配置されている抗菌部とを有し、上記抗菌部は、銀系抗菌剤及びシリケート系化合物を含む、抗菌フィルタ。
〔2〕上記銀系抗菌剤が、銀担持無機酸化物である、〔1〕に記載の抗菌フィルタ。
〔3〕上記抗菌部がアルコールを含む、〔1〕又は〔2〕に記載の抗菌フィルタ。
〔4〕空気清浄機用である、〔1〕~〔3〕のいずれかに記載の抗菌フィルタ。
〔5〕後述する要件Aを満たすフィルタに抗菌部形成用組成物を接触させる工程を有し、上記抗菌部形成用組成物が、銀系抗菌剤と、シリケート系化合物前駆体とを含む、抗菌フィルタの製造方法。
〔6〕上記工程が、上記フィルタに上記抗菌部形成用組成物を塗布する塗布工程を有する、〔5〕に記載の抗菌フィルタの製造方法。
〔7〕上記塗布工程において上記フィルタに塗布される上記抗菌部形成用組成物の塗布量が、50~1000mL/m2である、〔5〕又は〔6〕に記載の抗菌フィルタの製造方法。
〔8〕上記銀系抗菌剤が、銀担持無機酸化物である、〔5〕~〔7〕のいずれかに記載の抗菌フィルタの製造方法。
〔9〕上記抗菌部形成用組成物がアルコールを含む、〔5〕~〔8〕のいずれかに記載の抗菌フィルタの製造方法。
〔10〕上記抗菌フィルタが空気清浄機用である、〔5〕~〔9〕のいずれかに記載の抗菌フィルタの製造方法。
〔11〕〔1〕~〔4〕のいずれかに記載の抗菌フィルタ、又は、上記〔5〕~〔10〕のいずれかに記載の抗菌フィルタの製造方法で製造された抗菌フィルタを備える空気清浄機。 [1] An antibacterial filter comprising a filter portion that satisfies requirement A described below, and an antibacterial portion disposed on the filter portion, the antibacterial portion including a silver-based antibacterial agent and a silicate-based compound.
[2] The antibacterial filter according to [1], wherein the silver-based antibacterial agent is a silver-supported inorganic oxide.
[3] The antibacterial filter according to [1] or [2], wherein the antibacterial portion contains alcohol.
[4] The antibacterial filter according to any one of [1] to [3], which is for an air purifier.
[5] A method for producing an antibacterial filter, comprising a step of contacting a filter that satisfies requirement A described below with a composition for forming an antibacterial portion, the composition for forming an antibacterial portion containing a silver-based antibacterial agent and a silicate-based compound precursor.
[6] The method for producing an antibacterial filter according to [5], wherein the process includes a coating process of coating the antibacterial portion-forming composition onto the filter.
[7] The method for manufacturing an antibacterial filter according to [5] or [6], wherein the amount of the antibacterial portion-forming composition applied to the filter in the application step is 50 to 1000 mL/ m2 .
[8] The method for producing an antibacterial filter according to any one of [5] to [7], wherein the silver-based antibacterial agent is a silver-supported inorganic oxide.
[9] The method for producing an antibacterial filter according to any one of [5] to [8], wherein the composition for forming the antibacterial portion contains alcohol.
[10] The method for producing an antibacterial filter according to any one of [5] to [9], wherein the antibacterial filter is for an air purifier.
[11] An air purifier comprising an antibacterial filter according to any one of [1] to [4], or an antibacterial filter manufactured by the manufacturing method for an antibacterial filter according to any one of [5] to [10] above.
〔2〕上記銀系抗菌剤が、銀担持無機酸化物である、〔1〕に記載の抗菌フィルタ。
〔3〕上記抗菌部がアルコールを含む、〔1〕又は〔2〕に記載の抗菌フィルタ。
〔4〕空気清浄機用である、〔1〕~〔3〕のいずれかに記載の抗菌フィルタ。
〔5〕後述する要件Aを満たすフィルタに抗菌部形成用組成物を接触させる工程を有し、上記抗菌部形成用組成物が、銀系抗菌剤と、シリケート系化合物前駆体とを含む、抗菌フィルタの製造方法。
〔6〕上記工程が、上記フィルタに上記抗菌部形成用組成物を塗布する塗布工程を有する、〔5〕に記載の抗菌フィルタの製造方法。
〔7〕上記塗布工程において上記フィルタに塗布される上記抗菌部形成用組成物の塗布量が、50~1000mL/m2である、〔5〕又は〔6〕に記載の抗菌フィルタの製造方法。
〔8〕上記銀系抗菌剤が、銀担持無機酸化物である、〔5〕~〔7〕のいずれかに記載の抗菌フィルタの製造方法。
〔9〕上記抗菌部形成用組成物がアルコールを含む、〔5〕~〔8〕のいずれかに記載の抗菌フィルタの製造方法。
〔10〕上記抗菌フィルタが空気清浄機用である、〔5〕~〔9〕のいずれかに記載の抗菌フィルタの製造方法。
〔11〕〔1〕~〔4〕のいずれかに記載の抗菌フィルタ、又は、上記〔5〕~〔10〕のいずれかに記載の抗菌フィルタの製造方法で製造された抗菌フィルタを備える空気清浄機。 [1] An antibacterial filter comprising a filter portion that satisfies requirement A described below, and an antibacterial portion disposed on the filter portion, the antibacterial portion including a silver-based antibacterial agent and a silicate-based compound.
[2] The antibacterial filter according to [1], wherein the silver-based antibacterial agent is a silver-supported inorganic oxide.
[3] The antibacterial filter according to [1] or [2], wherein the antibacterial portion contains alcohol.
[4] The antibacterial filter according to any one of [1] to [3], which is for an air purifier.
[5] A method for producing an antibacterial filter, comprising a step of contacting a filter that satisfies requirement A described below with a composition for forming an antibacterial portion, the composition for forming an antibacterial portion containing a silver-based antibacterial agent and a silicate-based compound precursor.
[6] The method for producing an antibacterial filter according to [5], wherein the process includes a coating process of coating the antibacterial portion-forming composition onto the filter.
[7] The method for manufacturing an antibacterial filter according to [5] or [6], wherein the amount of the antibacterial portion-forming composition applied to the filter in the application step is 50 to 1000 mL/ m2 .
[8] The method for producing an antibacterial filter according to any one of [5] to [7], wherein the silver-based antibacterial agent is a silver-supported inorganic oxide.
[9] The method for producing an antibacterial filter according to any one of [5] to [8], wherein the composition for forming the antibacterial portion contains alcohol.
[10] The method for producing an antibacterial filter according to any one of [5] to [9], wherein the antibacterial filter is for an air purifier.
[11] An air purifier comprising an antibacterial filter according to any one of [1] to [4], or an antibacterial filter manufactured by the manufacturing method for an antibacterial filter according to any one of [5] to [10] above.
本発明によれば、抗菌性に優れた抗菌フィルタを提供できる。また、本発明によれば、抗菌フィルタの製造方法、及び、空気清浄機を提供できる。
The present invention can provide an antibacterial filter with excellent antibacterial properties. The present invention can also provide a method for manufacturing an antibacterial filter and an air purifier.
以下、本発明について詳細に説明する。
以下に記載する構成要件の説明は、本発明の代表的な実施態様に基づいてなされることがあるが、本発明はそのような実施態様に制限されるものではない。
本明細書において、「(メタ)アクリレート」はアクリレート及び/又はメタクリレート(アクリレート及びメタクリレートのいずれか一方又は両方)を表し、「(メタ)アクリロイル」はアクリロイル及び/又はメタクリロイル(アクリロイル及びメタクリロイルのいずれか一方又は両方)を表す。
本明細書において、「~」を用いて表される数値範囲は、「~」の前後に記載される数値を下限値、及び、上限値として含む範囲を意味する。
本明細書において、各成分は、各成分に該当する物質を1種単独で使用してよく、2種以上を使用してもよい。ここで、各成分について2種以上の物質を使用する場合、その成分についての含有量とは、特段の断りが無い限り、2種以上の物質の合計含有量を意味する。 The present invention will be described in detail below.
The following description of the components may be based on representative embodiments of the present invention, but the present invention is not limited to such embodiments.
In this specification, "(meth)acrylate" refers to acrylate and/or methacrylate (either one or both of acrylate and methacrylate), and "(meth)acryloyl" refers to acryloyl and/or methacryloyl (either one or both of acryloyl and methacryloyl).
In this specification, a numerical range expressed using "to" means a range including the numerical values before and after "to" as the lower limit and upper limit.
In the present specification, each component may use one substance corresponding to the component alone or two or more substances. When two or more substances are used for each component, the content of the component means the total content of the two or more substances, unless otherwise specified.
以下に記載する構成要件の説明は、本発明の代表的な実施態様に基づいてなされることがあるが、本発明はそのような実施態様に制限されるものではない。
本明細書において、「(メタ)アクリレート」はアクリレート及び/又はメタクリレート(アクリレート及びメタクリレートのいずれか一方又は両方)を表し、「(メタ)アクリロイル」はアクリロイル及び/又はメタクリロイル(アクリロイル及びメタクリロイルのいずれか一方又は両方)を表す。
本明細書において、「~」を用いて表される数値範囲は、「~」の前後に記載される数値を下限値、及び、上限値として含む範囲を意味する。
本明細書において、各成分は、各成分に該当する物質を1種単独で使用してよく、2種以上を使用してもよい。ここで、各成分について2種以上の物質を使用する場合、その成分についての含有量とは、特段の断りが無い限り、2種以上の物質の合計含有量を意味する。 The present invention will be described in detail below.
The following description of the components may be based on representative embodiments of the present invention, but the present invention is not limited to such embodiments.
In this specification, "(meth)acrylate" refers to acrylate and/or methacrylate (either one or both of acrylate and methacrylate), and "(meth)acryloyl" refers to acryloyl and/or methacryloyl (either one or both of acryloyl and methacryloyl).
In this specification, a numerical range expressed using "to" means a range including the numerical values before and after "to" as the lower limit and upper limit.
In the present specification, each component may use one substance corresponding to the component alone or two or more substances. When two or more substances are used for each component, the content of the component means the total content of the two or more substances, unless otherwise specified.
[抗菌フィルタ]
本発明の抗菌フィルタは、後述するように所定の条件で測定される粒子捕集率が99.95%以上であるとの要件Aを満たすフィルタ部(以下、単に「フィルタ部」ともいう。)と、フィルタ部上に配置されている抗菌部とを有し、抗菌部は、銀系抗菌剤及びシリケート系化合物を含む。
以下、本発明の抗菌フィルタが有するフィルタ部及び抗菌部について、順に説明する。 [Antibacterial filter]
The antibacterial filter of the present invention has a filter part (hereinafter simply referred to as the "filter part") that satisfies requirement A, that is, a particle collection rate measured under specified conditions as described below is 99.95% or more, and an antibacterial part disposed on the filter part, and the antibacterial part contains a silver-based antibacterial agent and a silicate-based compound.
The filter portion and the antibacterial portion of the antibacterial filter of the present invention will be described below in order.
本発明の抗菌フィルタは、後述するように所定の条件で測定される粒子捕集率が99.95%以上であるとの要件Aを満たすフィルタ部(以下、単に「フィルタ部」ともいう。)と、フィルタ部上に配置されている抗菌部とを有し、抗菌部は、銀系抗菌剤及びシリケート系化合物を含む。
以下、本発明の抗菌フィルタが有するフィルタ部及び抗菌部について、順に説明する。 [Antibacterial filter]
The antibacterial filter of the present invention has a filter part (hereinafter simply referred to as the "filter part") that satisfies requirement A, that is, a particle collection rate measured under specified conditions as described below is 99.95% or more, and an antibacterial part disposed on the filter part, and the antibacterial part contains a silver-based antibacterial agent and a silicate-based compound.
The filter portion and the antibacterial portion of the antibacterial filter of the present invention will be described below in order.
〔フィルタ部〕
フィルタ部は、例えば、シート状に形成されたフィルタろ材を有する。フィルタろ材としては、空気清浄機用フィルタ及びクリーンルーム等に用いられている公知の材料が使用できる。フィルタろ材は、単独のシート状のろ材からなる単層構造であってもよく、複数のシート状のろ材が積層してなる複層構造であってもよい。
フィルタろ材としては、例えば、フッ素樹脂多孔質膜、及び、ガラス繊維を含むろ材(ガラスろ材)が挙げられ、圧力損失が少ない点で、フッ素樹脂多孔質膜が好ましい。 [Filter section]
The filter section has, for example, a filter medium formed in a sheet shape. As the filter medium, a known material used in air purifier filters and clean rooms, etc. can be used. The filter medium may have a single-layer structure made of a single sheet-like filter medium, or a multi-layer structure made of a plurality of sheet-like filter mediums stacked together.
Examples of the filter medium include a fluororesin porous membrane and a filter medium containing glass fibers (glass filter medium), with the fluororesin porous membrane being preferred in terms of low pressure loss.
フィルタ部は、例えば、シート状に形成されたフィルタろ材を有する。フィルタろ材としては、空気清浄機用フィルタ及びクリーンルーム等に用いられている公知の材料が使用できる。フィルタろ材は、単独のシート状のろ材からなる単層構造であってもよく、複数のシート状のろ材が積層してなる複層構造であってもよい。
フィルタろ材としては、例えば、フッ素樹脂多孔質膜、及び、ガラス繊維を含むろ材(ガラスろ材)が挙げられ、圧力損失が少ない点で、フッ素樹脂多孔質膜が好ましい。 [Filter section]
The filter section has, for example, a filter medium formed in a sheet shape. As the filter medium, a known material used in air purifier filters and clean rooms, etc. can be used. The filter medium may have a single-layer structure made of a single sheet-like filter medium, or a multi-layer structure made of a plurality of sheet-like filter mediums stacked together.
Examples of the filter medium include a fluororesin porous membrane and a filter medium containing glass fibers (glass filter medium), with the fluororesin porous membrane being preferred in terms of low pressure loss.
フッ素樹脂多孔質膜を構成するフッ素樹脂としては、例えば、ポリテトラフルオロエチレン(PTFE)、フッ素化エチレンプロピレン、ペルフルオロアルコキシポリマー、ポリ(エチレン-コ-テトラフルオロエチレン-コ-ヘキサフルオロプロピレン)(EFEP)、テトラフルオロエチレンヘキサフルオロプロピレンビニリデンフルオリド(THV)、ポリ(テトラフルオロエチレン-コ-ヘキサフルオロプロピレン)(FEP)、ペルフルオロアルコキシ(PFA)、及び、エチレンテトラフルオロエチレン(ETFE)が挙げられる。フッ素樹脂多孔質膜は、1種単独のフッ素樹脂で構成されていてもよく、2種以上のフッ素樹脂で構成されていてもよい。また、フッ素樹脂から構成される膜を複数積層することによりフッ素樹脂多孔質膜が構成されてもよい。
フッ素樹脂多孔質膜におけるフッ素樹脂の含有量は、フッ素樹脂多孔質膜の全質量に対して25質量%以上が好ましく、50質量%超100質量%以下がより好ましい。フッ素樹脂多孔質膜は、フッ素樹脂と異なる成分として、例えば、無機フィラー等を含んでいてもよい。 Examples of the fluororesin constituting the fluororesin porous membrane include polytetrafluoroethylene (PTFE), fluorinated ethylene propylene, perfluoroalkoxy polymer, poly(ethylene-co-tetrafluoroethylene-co-hexafluoropropylene) (EFEP), tetrafluoroethylene hexafluoropropylene vinylidene fluoride (THV), poly(tetrafluoroethylene-co-hexafluoropropylene) (FEP), perfluoroalkoxy (PFA), and ethylene tetrafluoroethylene (ETFE). The fluororesin porous membrane may be composed of one type of fluororesin alone, or may be composed of two or more types of fluororesins. The fluororesin porous membrane may also be composed by laminating a plurality of membranes composed of fluororesins.
The content of the fluororesin in the fluororesin porous membrane is preferably 25% by mass or more, more preferably more than 50% by mass and 100% by mass or less, based on the total mass of the fluororesin porous membrane. The fluororesin porous membrane may contain, for example, an inorganic filler as a component different from the fluororesin.
フッ素樹脂多孔質膜におけるフッ素樹脂の含有量は、フッ素樹脂多孔質膜の全質量に対して25質量%以上が好ましく、50質量%超100質量%以下がより好ましい。フッ素樹脂多孔質膜は、フッ素樹脂と異なる成分として、例えば、無機フィラー等を含んでいてもよい。 Examples of the fluororesin constituting the fluororesin porous membrane include polytetrafluoroethylene (PTFE), fluorinated ethylene propylene, perfluoroalkoxy polymer, poly(ethylene-co-tetrafluoroethylene-co-hexafluoropropylene) (EFEP), tetrafluoroethylene hexafluoropropylene vinylidene fluoride (THV), poly(tetrafluoroethylene-co-hexafluoropropylene) (FEP), perfluoroalkoxy (PFA), and ethylene tetrafluoroethylene (ETFE). The fluororesin porous membrane may be composed of one type of fluororesin alone, or may be composed of two or more types of fluororesins. The fluororesin porous membrane may also be composed by laminating a plurality of membranes composed of fluororesins.
The content of the fluororesin in the fluororesin porous membrane is preferably 25% by mass or more, more preferably more than 50% by mass and 100% by mass or less, based on the total mass of the fluororesin porous membrane. The fluororesin porous membrane may contain, for example, an inorganic filler as a component different from the fluororesin.
フッ素樹脂多孔質膜としては、微小繊維の発生が少なく、使用時間の経過に伴う圧力損失の上昇が少ない点で、ポリテトラフルオロエチレンを用いて形成されたポリテトラフルオロエチレン多孔質膜(以下、「PTFE多孔質膜」ともいう。)が好ましい。
As a fluororesin porous membrane, a polytetrafluoroethylene porous membrane (hereinafter also referred to as a "PTFE porous membrane") formed using polytetrafluoroethylene is preferred, since it generates less microfibers and has a smaller increase in pressure loss over time.
PTFE多孔質膜等のフッ素樹脂多孔質膜の厚みは、特に制限されないが、0.1~100μmが好ましく、1~20μmがより好ましい。
The thickness of the fluororesin porous membrane, such as the PTFE porous membrane, is not particularly limited, but is preferably 0.1 to 100 μm, and more preferably 1 to 20 μm.
フッ素樹脂多孔質膜の製造方法は特に制限されず、フッ素樹脂を用いて形成されたシート状の成形体を2軸延伸して多孔質化する方法等の公知の方法により製造できる。
例えば、PTFE多孔質膜の製造方法としては、以下の方法が挙げられる。まず、PTFEファインパウダーに液状潤滑剤を添加してペースト状の混合物を形成し、ペースト状の混合物から液状潤滑剤が分離しない程度の圧力で、混合物を棒状に予備成形する。次に、棒状の予備成形物を押出成形又は圧延成形することで帯状に成形する。その後、得られた帯状の成形物を長手方向と幅方向とに延伸する。これにより、帯状の成形物が多孔質化(繊維化)され、PTFE多孔質膜が製造される。
液状潤滑剤としては、混合物表面に適度な濡れ性を付与し得るものであれば、特に制限されず、例えば、流動パラフィン、ナフサ及びホワイトオイル等の炭化水素が挙げられる。液状潤滑剤は、抽出処理又は加熱処理によって除去し得るものが好ましい。 The method for producing the fluororesin porous membrane is not particularly limited, and the membrane can be produced by a known method such as a method in which a sheet-like molded body formed using a fluororesin is biaxially stretched to make it porous.
For example, the manufacturing method of PTFE porous membrane can be the following method. First, add liquid lubricant to PTFE fine powder to form a paste-like mixture, and preform the mixture into a rod shape under a pressure that does not separate the liquid lubricant from the paste-like mixture. Next, extrude or roll the rod-like preform into a strip. Then, stretch the obtained strip-like molded product in the longitudinal direction and the transverse direction. This makes the strip-like molded product porous (fibrillated), and produces a PTFE porous membrane.
The liquid lubricant is not particularly limited as long as it can provide the mixture surface with appropriate wettability, and examples of the liquid lubricant include hydrocarbons such as liquid paraffin, naphtha, and white oil. The liquid lubricant is preferably one that can be removed by extraction or heat treatment.
例えば、PTFE多孔質膜の製造方法としては、以下の方法が挙げられる。まず、PTFEファインパウダーに液状潤滑剤を添加してペースト状の混合物を形成し、ペースト状の混合物から液状潤滑剤が分離しない程度の圧力で、混合物を棒状に予備成形する。次に、棒状の予備成形物を押出成形又は圧延成形することで帯状に成形する。その後、得られた帯状の成形物を長手方向と幅方向とに延伸する。これにより、帯状の成形物が多孔質化(繊維化)され、PTFE多孔質膜が製造される。
液状潤滑剤としては、混合物表面に適度な濡れ性を付与し得るものであれば、特に制限されず、例えば、流動パラフィン、ナフサ及びホワイトオイル等の炭化水素が挙げられる。液状潤滑剤は、抽出処理又は加熱処理によって除去し得るものが好ましい。 The method for producing the fluororesin porous membrane is not particularly limited, and the membrane can be produced by a known method such as a method in which a sheet-like molded body formed using a fluororesin is biaxially stretched to make it porous.
For example, the manufacturing method of PTFE porous membrane can be the following method. First, add liquid lubricant to PTFE fine powder to form a paste-like mixture, and preform the mixture into a rod shape under a pressure that does not separate the liquid lubricant from the paste-like mixture. Next, extrude or roll the rod-like preform into a strip. Then, stretch the obtained strip-like molded product in the longitudinal direction and the transverse direction. This makes the strip-like molded product porous (fibrillated), and produces a PTFE porous membrane.
The liquid lubricant is not particularly limited as long as it can provide the mixture surface with appropriate wettability, and examples of the liquid lubricant include hydrocarbons such as liquid paraffin, naphtha, and white oil. The liquid lubricant is preferably one that can be removed by extraction or heat treatment.
なお、フッ素樹脂多孔質膜を製造する際、各工程を実施する装置に帯電対策を施し、成形物等の帯電を抑制することが好ましい。PTFE等の電気抵抗が高いフッ素樹脂は、製造工程において帯電し易いことから、放電現象が生じてろ材に穴が形成される等、品質に影響を及ぼすおそれがある。上記帯電対策を施すことにより、ろ材の帯電に伴う上記影響を低減することができる。
When manufacturing a fluororesin porous membrane, it is preferable to implement anti-static measures in the equipment used in each process to suppress charging of the molded products, etc. Fluororesins with high electrical resistance, such as PTFE, tend to become charged during the manufacturing process, which can lead to discharges that can cause holes to form in the filter material and affect quality. By taking the above-mentioned anti-static measures, it is possible to reduce the above-mentioned effects associated with charging the filter material.
フィルタ部は、複数のフィルタろ材が積層されてなる複層構造を有することが好ましい。中でも、フィルタ部は、フッ素樹脂多孔質膜(より好ましくはPTFE多孔質膜)と通気性支持材とが積層されてなる複層構造を有することがより好ましい。フッ素樹脂多孔質膜は一般に柔軟性に富む極めて薄い材料であることから、通気性を有する支持材が積層されることにより、フィルタろ材の強度を向上し、気流の通過による変形を抑制するとともに、ハンドリング性を向上させることができる。
The filter section preferably has a multi-layer structure in which multiple filter media are laminated. In particular, the filter section more preferably has a multi-layer structure in which a fluororesin porous membrane (more preferably a PTFE porous membrane) and a breathable support material are laminated. Since a fluororesin porous membrane is generally a very thin material with high flexibility, laminating a breathable support material improves the strength of the filter media, suppresses deformation due to the passage of airflow, and improves handling.
通気性支持体としては、例えば、フッ素樹脂多孔質膜よりも目が粗く、単膜での通過風量がより多い不織布が挙げられる。
通気性支持体(不織布)を構成する材料としては、例えば、ポリオレフィン(ポリエチレン(PE)、ポリプロピレン(PP)等)、ポリアミド、ポリエステル(ポリエチレンテレフタレート(PET)等)、芳香族ポリアミド、並びに、これらの複合材が挙げられる。 An example of the breathable support is a nonwoven fabric that is coarser than the fluororesin porous membrane and allows a larger amount of air to pass through per unit area.
Examples of materials constituting the breathable support (nonwoven fabric) include polyolefins (polyethylene (PE), polypropylene (PP), etc.), polyamides, polyesters (polyethylene terephthalate (PET), etc.), aromatic polyamides, and composites of these.
通気性支持体(不織布)を構成する材料としては、例えば、ポリオレフィン(ポリエチレン(PE)、ポリプロピレン(PP)等)、ポリアミド、ポリエステル(ポリエチレンテレフタレート(PET)等)、芳香族ポリアミド、並びに、これらの複合材が挙げられる。 An example of the breathable support is a nonwoven fabric that is coarser than the fluororesin porous membrane and allows a larger amount of air to pass through per unit area.
Examples of materials constituting the breathable support (nonwoven fabric) include polyolefins (polyethylene (PE), polypropylene (PP), etc.), polyamides, polyesters (polyethylene terephthalate (PET), etc.), aromatic polyamides, and composites of these.
フィルタ部が上記のフッ素樹脂多孔質膜と通気性支持材とを備える場合、フッ素樹脂多孔質膜に対して気流が流れる方向の上流側に少なくとも1つの通気性支持体が配置されていることが好ましい。これにより、フッ素樹脂多孔質膜の目詰まりを引き起こす粗大粒子(綿埃等)のフッ素樹脂多孔質膜への付着を抑制できる。フィルタ部は、フッ素樹脂多孔質膜と2つの通気性支持体とを備え、フッ素樹脂多孔質膜が2つの通気性支持体の間に挟まれるように積層されていることがより好ましい。
複数のフィルタろ材の積層方法は、特に制限されず、例えば、加熱による熱ラミネートにより実施できる。 When the filter section comprises the above-mentioned fluororesin porous membrane and breathable support material, it is preferable that at least one breathable support is disposed upstream of the fluororesin porous membrane in the direction of air flow. This makes it possible to suppress adhesion of coarse particles (such as cotton dust) that cause clogging of the fluororesin porous membrane to the fluororesin porous membrane. It is more preferable that the filter section comprises a fluororesin porous membrane and two breathable supports, and is laminated so that the fluororesin porous membrane is sandwiched between the two breathable supports.
The method for laminating a plurality of filter media is not particularly limited, and can be, for example, thermal lamination by heating.
複数のフィルタろ材の積層方法は、特に制限されず、例えば、加熱による熱ラミネートにより実施できる。 When the filter section comprises the above-mentioned fluororesin porous membrane and breathable support material, it is preferable that at least one breathable support is disposed upstream of the fluororesin porous membrane in the direction of air flow. This makes it possible to suppress adhesion of coarse particles (such as cotton dust) that cause clogging of the fluororesin porous membrane to the fluororesin porous membrane. It is more preferable that the filter section comprises a fluororesin porous membrane and two breathable supports, and is laminated so that the fluororesin porous membrane is sandwiched between the two breathable supports.
The method for laminating a plurality of filter media is not particularly limited, and can be, for example, thermal lamination by heating.
フィルタ部は、その断面形状が連続的なW字状になるようにひだ状に折り畳まれるプリーツ加工が施されていてもよい。即ちフィルタ部は、いわゆる「フィルタパック」の形態であってよい。表面積が大きくなり、圧力損失を低減できる点で、フィルタ部はプリーツ加工が施されていることが好ましい。
プリーツ加工されたフィルタ部には、フィルタ面内の1方向に沿って山部と谷部が交互に繰り返されてなるひだ形状が形成されている。上記ひだ形状のピッチ(例えば、1つの谷部を挟んで隣接する2つの山部のピーク間の距離)は、2.5~5.0mmが好ましく、3.0~4.0mmがより好ましい。 The filter portion may be pleated so that its cross-sectional shape is a continuous W-shape. That is, the filter portion may be in the form of a so-called "filter pack." It is preferable that the filter portion is pleated, since this increases the surface area and reduces pressure loss.
The pleated filter portion has a pleated shape in which peaks and valleys are alternately repeated along one direction in the filter surface. The pitch of the pleats (e.g., the distance between the peaks of two adjacent peaks with one valley between them) is preferably 2.5 to 5.0 mm, and more preferably 3.0 to 4.0 mm.
プリーツ加工されたフィルタ部には、フィルタ面内の1方向に沿って山部と谷部が交互に繰り返されてなるひだ形状が形成されている。上記ひだ形状のピッチ(例えば、1つの谷部を挟んで隣接する2つの山部のピーク間の距離)は、2.5~5.0mmが好ましく、3.0~4.0mmがより好ましい。 The filter portion may be pleated so that its cross-sectional shape is a continuous W-shape. That is, the filter portion may be in the form of a so-called "filter pack." It is preferable that the filter portion is pleated, since this increases the surface area and reduces pressure loss.
The pleated filter portion has a pleated shape in which peaks and valleys are alternately repeated along one direction in the filter surface. The pitch of the pleats (e.g., the distance between the peaks of two adjacent peaks with one valley between them) is preferably 2.5 to 5.0 mm, and more preferably 3.0 to 4.0 mm.
フィルタ部のプリーツ加工は、公知の方法で実施できる。例えば、公知のプリーツ加工機(ロータリープリーツ機、レシプロプリーツ機、筋付けプリーツ機等)を用いて、フィルタ面内の1方向に沿ってろ材表面に設定された山折り線及び谷折り線でフィルタろ材を折り込むことにより、フィルタ部にひだ形状が形成される。
The pleating of the filter portion can be performed by a known method. For example, a pleat shape is formed in the filter portion by folding the filter material along mountain folds and valley folds set on the surface of the filter material in one direction within the filter surface using a known pleating machine (rotary pleating machine, reciprocating pleating machine, creasing pleating machine, etc.).
プリーツ加工されたフィルタ部には、ひだ形状を維持するためにスペーサーが配置されることがある。スペーサーとしては、例えば、ビードと称される樹脂の紐状体が挙げられる。ビードは、山折り線(谷折り線)に直交する方向に沿ってフィルタ部の表面に配置される。プリーツ加工されたフィルタ部には、山折り線(谷折り線)に沿った方向において所定の間隔を空けて、複数のビードが配置されていることが好ましい。また、ビードは、フィルタ部の表面及び裏面の双方に配置されていることが好ましい。
ビードは、例えば、糸の外周が合成樹脂等の接着剤で被膜された糸セパレータ、又は、ホットメルト樹脂等で構成される。ビードは、例えば、上記糸セパレータ又はホットメルト樹脂を熱により溶融してフィルタ部の所定の位置に付着させることにより、形成できる。 A spacer may be disposed in the pleated filter section to maintain the pleated shape. Examples of spacers include resin strings called beads. The beads are disposed on the surface of the filter section along a direction perpendicular to the mountain fold lines (valley fold lines). It is preferable that the pleated filter section has a plurality of beads disposed at predetermined intervals in the direction along the mountain fold lines (valley fold lines). It is also preferable that the beads are disposed on both the front and back surfaces of the filter section.
The bead is formed, for example, from a yarn separator in which the outer circumference of the yarn is coated with an adhesive such as a synthetic resin, or from a hot melt resin, etc. The bead can be formed, for example, by melting the yarn separator or the hot melt resin by heat and attaching it to a predetermined position of the filter portion.
ビードは、例えば、糸の外周が合成樹脂等の接着剤で被膜された糸セパレータ、又は、ホットメルト樹脂等で構成される。ビードは、例えば、上記糸セパレータ又はホットメルト樹脂を熱により溶融してフィルタ部の所定の位置に付着させることにより、形成できる。 A spacer may be disposed in the pleated filter section to maintain the pleated shape. Examples of spacers include resin strings called beads. The beads are disposed on the surface of the filter section along a direction perpendicular to the mountain fold lines (valley fold lines). It is preferable that the pleated filter section has a plurality of beads disposed at predetermined intervals in the direction along the mountain fold lines (valley fold lines). It is also preferable that the beads are disposed on both the front and back surfaces of the filter section.
The bead is formed, for example, from a yarn separator in which the outer circumference of the yarn is coated with an adhesive such as a synthetic resin, or from a hot melt resin, etc. The bead can be formed, for example, by melting the yarn separator or the hot melt resin by heat and attaching it to a predetermined position of the filter portion.
<物性等>
(要件A)
本発明の抗菌フィルタが有するフィルタ部は、JIS B 9927-5:2022附属書Cに規定される手順に従って除電された状態のフィルタ部に対して、風速5.3cm/sの条件で粒径が0.3μmである粒子を通過させた際の粒子捕集率が、99.95%以上であるとの要件Aを満たす。 <Physical properties, etc.>
(Requirement A)
The filter part of the antibacterial filter of the present invention satisfies requirement A that the particle collection efficiency when particles with a particle size of 0.3 μm are passed through the filter part in a state where static electricity has been removed according to the procedure specified in JIS B 9927-5:2022, Annex C, at a wind speed of 5.3 cm/s is 99.95% or more.
(要件A)
本発明の抗菌フィルタが有するフィルタ部は、JIS B 9927-5:2022附属書Cに規定される手順に従って除電された状態のフィルタ部に対して、風速5.3cm/sの条件で粒径が0.3μmである粒子を通過させた際の粒子捕集率が、99.95%以上であるとの要件Aを満たす。 <Physical properties, etc.>
(Requirement A)
The filter part of the antibacterial filter of the present invention satisfies requirement A that the particle collection efficiency when particles with a particle size of 0.3 μm are passed through the filter part in a state where static electricity has been removed according to the procedure specified in JIS B 9927-5:2022, Annex C, at a wind speed of 5.3 cm/s is 99.95% or more.
上記要件Aを満たすフィルタは、特定の除電手順に従って除電された状態で測定された粒子捕集率が上記基準値以上であることを特徴とする。
従来、室内又は車内等の空間内の空気を清浄化する機能を有するフィルタとして、フィルタろ材を帯電させ粉塵の吸着能力を向上させた帯電フィルタ(エレクトレットフィルタ)が多く用いられている。しかしながら、帯電フィルタは、風量により捕集効率が変化し、また、粉塵の捕集量の増加に伴って吸着能力ひいては捕集効率が低下することが知られている。本発明の抗菌フィルタが有するフィルタ部は、上記の通り除電された状態においても優れた粒子捕集率を有することから、帯電フィルタに起こり得る上記の捕集効率への影響が著しく抑制され、長期間使用しても捕集性能が低下し難く、耐用期間がより長い抗菌フィルタが得られる。 A filter that satisfies the above requirement A is characterized in that the particle collection efficiency measured in a state where static electricity has been removed according to a specific static elimination procedure is equal to or greater than the above reference value.
Conventionally, electrically charged filters (electret filters) in which the filter material is electrically charged to improve its dust adsorption capacity have been widely used as filters that have the function of purifying the air in spaces such as indoors or vehicle interiors. However, it is known that the filtering efficiency of electrically charged filters varies depending on the air volume, and that the adsorption capacity and therefore the filtering efficiency decreases as the amount of dust captured increases. Because the filter section of the antibacterial filter of the present invention has an excellent particle collection rate even in a neutralized state as described above, the above-mentioned effects on filtering efficiency that can occur in electrically charged filters are significantly suppressed, and an antibacterial filter can be obtained that is less likely to lose filtering performance even over long periods of use and has a longer service life.
従来、室内又は車内等の空間内の空気を清浄化する機能を有するフィルタとして、フィルタろ材を帯電させ粉塵の吸着能力を向上させた帯電フィルタ(エレクトレットフィルタ)が多く用いられている。しかしながら、帯電フィルタは、風量により捕集効率が変化し、また、粉塵の捕集量の増加に伴って吸着能力ひいては捕集効率が低下することが知られている。本発明の抗菌フィルタが有するフィルタ部は、上記の通り除電された状態においても優れた粒子捕集率を有することから、帯電フィルタに起こり得る上記の捕集効率への影響が著しく抑制され、長期間使用しても捕集性能が低下し難く、耐用期間がより長い抗菌フィルタが得られる。 A filter that satisfies the above requirement A is characterized in that the particle collection efficiency measured in a state where static electricity has been removed according to a specific static elimination procedure is equal to or greater than the above reference value.
Conventionally, electrically charged filters (electret filters) in which the filter material is electrically charged to improve its dust adsorption capacity have been widely used as filters that have the function of purifying the air in spaces such as indoors or vehicle interiors. However, it is known that the filtering efficiency of electrically charged filters varies depending on the air volume, and that the adsorption capacity and therefore the filtering efficiency decreases as the amount of dust captured increases. Because the filter section of the antibacterial filter of the present invention has an excellent particle collection rate even in a neutralized state as described above, the above-mentioned effects on filtering efficiency that can occur in electrically charged filters are significantly suppressed, and an antibacterial filter can be obtained that is less likely to lose filtering performance even over long periods of use and has a longer service life.
フィルタ部が要件Aを満たすか否かは、下記測定試験(以下、「試験A」ともいう。)を実施することにより確認できる。
まず、JIS B 9927-5:2022附属書CのC.3に記載されている手順に従って試験体(フィルタ部)を除電する。具体的には、23±5℃の飽和IPA蒸気が充満したチャンバ内において、試験体を24時間暴露する。暴露終了後、試験体を標準雰囲気条件(23±5℃、相対湿度(50±15)%)下で少なくとも30分間保管することにより、試験体を安定化させる。暴露に用いるIPAは、純度が99.9体積%よりも高いものを使用する。
次いで、上記除電手順を施した試験体に、風速5.3cm/sの条件で粒径が0.3μmである粒子を通過させる粒子捕集試験を行い、粒子捕集率を測定する。粒子捕集試験に用いられる粒径が0.3μmの粒子としては、例えば、ポリアルファオレフィン(PAO、CAS番号:68649-12-7)からなる単分散エアロゾルが挙げられる。また、粒子捕集試験に用いられる粒子の粒径は、質量平均径を意味する。粒子捕集試験に用いられる粒子及び測定機器については、JIS B 9927-2:2022に記載の粒子及び測定機器が参照できる。上記測定機器に試験体を設置し、吸引ポンプ等を用いて、清浄な空気によって所定の濃度に希釈された粒子含有ガスを5.3cm/sの速度で試験体を通過させ、測定される試験体の上流側及び下流側における粒子の計数値から、粒子捕集率を求めることができる。
上記試験Aにより測定された粒子捕集率が99.95%以上である場合、そのフィルタ部は要件Aを満たすことになる。 Whether or not the filter portion satisfies requirement A can be confirmed by carrying out the following measurement test (hereinafter also referred to as "test A").
First, the test specimen (filter part) is de-electrified according to the procedure described in JIS B 9927-5:2022, Appendix C, C.3. Specifically, the test specimen is exposed for 24 hours in a chamber filled with saturated IPA vapor at 23±5°C. After the exposure is completed, the test specimen is stabilized by storing it under standard atmospheric conditions (23±5°C, relative humidity (50±15)%) for at least 30 minutes. The IPA used for exposure has a purity of more than 99.9% by volume.
Next, a particle collection test is performed in which particles having a particle size of 0.3 μm are passed through the test specimen subjected to the above-mentioned static elimination procedure under the condition of a wind speed of 5.3 cm/s, and the particle collection rate is measured. Examples of particles having a particle size of 0.3 μm used in the particle collection test include monodisperse aerosols made of polyalphaolefin (PAO, CAS number: 68649-12-7). The particle size of the particles used in the particle collection test refers to the mass average diameter. For the particles and measuring equipment used in the particle collection test, the particles and measuring equipment described in JIS B 9927-2:2022 can be referred to. A test specimen is placed in the measuring equipment, and a particle-containing gas diluted to a predetermined concentration with clean air is passed through the test specimen at a speed of 5.3 cm/s using a suction pump or the like, and the particle collection rate can be obtained from the particle count value on the upstream side and downstream side of the test specimen to be measured.
If the particle collection efficiency measured by the above test A is 99.95% or more, the filter part satisfies requirement A.
まず、JIS B 9927-5:2022附属書CのC.3に記載されている手順に従って試験体(フィルタ部)を除電する。具体的には、23±5℃の飽和IPA蒸気が充満したチャンバ内において、試験体を24時間暴露する。暴露終了後、試験体を標準雰囲気条件(23±5℃、相対湿度(50±15)%)下で少なくとも30分間保管することにより、試験体を安定化させる。暴露に用いるIPAは、純度が99.9体積%よりも高いものを使用する。
次いで、上記除電手順を施した試験体に、風速5.3cm/sの条件で粒径が0.3μmである粒子を通過させる粒子捕集試験を行い、粒子捕集率を測定する。粒子捕集試験に用いられる粒径が0.3μmの粒子としては、例えば、ポリアルファオレフィン(PAO、CAS番号:68649-12-7)からなる単分散エアロゾルが挙げられる。また、粒子捕集試験に用いられる粒子の粒径は、質量平均径を意味する。粒子捕集試験に用いられる粒子及び測定機器については、JIS B 9927-2:2022に記載の粒子及び測定機器が参照できる。上記測定機器に試験体を設置し、吸引ポンプ等を用いて、清浄な空気によって所定の濃度に希釈された粒子含有ガスを5.3cm/sの速度で試験体を通過させ、測定される試験体の上流側及び下流側における粒子の計数値から、粒子捕集率を求めることができる。
上記試験Aにより測定された粒子捕集率が99.95%以上である場合、そのフィルタ部は要件Aを満たすことになる。 Whether or not the filter portion satisfies requirement A can be confirmed by carrying out the following measurement test (hereinafter also referred to as "test A").
First, the test specimen (filter part) is de-electrified according to the procedure described in JIS B 9927-5:2022, Appendix C, C.3. Specifically, the test specimen is exposed for 24 hours in a chamber filled with saturated IPA vapor at 23±5°C. After the exposure is completed, the test specimen is stabilized by storing it under standard atmospheric conditions (23±5°C, relative humidity (50±15)%) for at least 30 minutes. The IPA used for exposure has a purity of more than 99.9% by volume.
Next, a particle collection test is performed in which particles having a particle size of 0.3 μm are passed through the test specimen subjected to the above-mentioned static elimination procedure under the condition of a wind speed of 5.3 cm/s, and the particle collection rate is measured. Examples of particles having a particle size of 0.3 μm used in the particle collection test include monodisperse aerosols made of polyalphaolefin (PAO, CAS number: 68649-12-7). The particle size of the particles used in the particle collection test refers to the mass average diameter. For the particles and measuring equipment used in the particle collection test, the particles and measuring equipment described in JIS B 9927-2:2022 can be referred to. A test specimen is placed in the measuring equipment, and a particle-containing gas diluted to a predetermined concentration with clean air is passed through the test specimen at a speed of 5.3 cm/s using a suction pump or the like, and the particle collection rate can be obtained from the particle count value on the upstream side and downstream side of the test specimen to be measured.
If the particle collection efficiency measured by the above test A is 99.95% or more, the filter part satisfies requirement A.
フィルタ部は、上記の観点から、JIS B 9927-5:2022附属書Cに規定される手順に従って除電された状態において、風速5.3cm/sの条件で粒径が0.3μmである粒子を通過させる粒子捕集試験を実施した際の粒子捕集率が、99.97%以上であることが好ましい。
From the above viewpoint, it is preferable that the filter section, in a state where static electricity has been removed in accordance with the procedure prescribed in JIS B 9927-5:2022, Appendix C, has a particle capture rate of 99.97% or more when a particle capture test is conducted in which particles with a diameter of 0.3 μm are allowed to pass through at a wind speed of 5.3 cm/s.
なお、上記要件を満たすフィルタは、例えば、フィルタろ材の構造及び材料、並びに、上記プリーツ加工により形成されるひだ形状等を適宜調整することによって作製できる。
Furthermore, a filter that satisfies the above requirements can be produced, for example, by appropriately adjusting the structure and material of the filter medium, as well as the pleat shape formed by the pleating process.
〔抗菌部〕
本発明の抗菌フィルタが有する抗菌部は、フィルタ部上に配置され、銀系抗菌剤及びシリケート系化合物を含む。
本発明の抗菌フィルタは、上記所定の成分を含む抗菌部がフィルタ部上に配置されることにより、抗菌フィルタを通過する空気に存在する菌及びウイルスを捕集して空気を清浄化するだけでなく、捕集した菌及びウイルスをより効率的に不活化でき、抗菌性がより向上したものと推測される。これにより、本発明の抗菌フィルタは、抗菌フィルタの長期使用又は抗菌フィルタの交換作業における菌及びウイルスに起因する感染のおそれをも低減できると考えられる。 [Antibacterial Section]
The antibacterial portion of the antibacterial filter of the present invention is disposed on the filter portion and contains a silver-based antibacterial agent and a silicate-based compound.
It is presumed that the antibacterial filter of the present invention, by disposing the antibacterial part containing the above-mentioned predetermined component on the filter part, not only captures bacteria and viruses present in the air passing through the antibacterial filter to purify the air, but also more efficiently inactivates the captured bacteria and viruses, thereby improving the antibacterial properties. As a result, it is considered that the antibacterial filter of the present invention can also reduce the risk of infection caused by bacteria and viruses during long-term use of the antibacterial filter or during replacement of the antibacterial filter.
本発明の抗菌フィルタが有する抗菌部は、フィルタ部上に配置され、銀系抗菌剤及びシリケート系化合物を含む。
本発明の抗菌フィルタは、上記所定の成分を含む抗菌部がフィルタ部上に配置されることにより、抗菌フィルタを通過する空気に存在する菌及びウイルスを捕集して空気を清浄化するだけでなく、捕集した菌及びウイルスをより効率的に不活化でき、抗菌性がより向上したものと推測される。これにより、本発明の抗菌フィルタは、抗菌フィルタの長期使用又は抗菌フィルタの交換作業における菌及びウイルスに起因する感染のおそれをも低減できると考えられる。 [Antibacterial Section]
The antibacterial portion of the antibacterial filter of the present invention is disposed on the filter portion and contains a silver-based antibacterial agent and a silicate-based compound.
It is presumed that the antibacterial filter of the present invention, by disposing the antibacterial part containing the above-mentioned predetermined component on the filter part, not only captures bacteria and viruses present in the air passing through the antibacterial filter to purify the air, but also more efficiently inactivates the captured bacteria and viruses, thereby improving the antibacterial properties. As a result, it is considered that the antibacterial filter of the present invention can also reduce the risk of infection caused by bacteria and viruses during long-term use of the antibacterial filter or during replacement of the antibacterial filter.
本明細書において、抗菌部が「フィルタ部上に配置されている」とは、抗菌部がフィルタ部の少なくとも一部に接して配置されていることを意味する。フィルタ部における抗菌部の配置位置は、抗菌フィルタの通気性能(捕集性能)を妨げない範囲において特に制限されず、フィルタ部の表面全面に配置されていてもよく、フィルタ部の表面に島状に点在して配置されていてもよい。また、抗菌部は、フィルタ部が有する細孔の表面、及び/又は、フィルタ部を構成する繊維の表面を被覆するように配置されていてもよい。
In this specification, the antibacterial portion is "disposed on the filter portion" means that the antibacterial portion is disposed in contact with at least a portion of the filter portion. The position of the antibacterial portion on the filter portion is not particularly limited as long as it does not impede the breathability (capture performance) of the antibacterial filter, and the antibacterial portion may be disposed over the entire surface of the filter portion, or may be disposed in islands on the surface of the filter portion. The antibacterial portion may also be disposed so as to cover the surfaces of the pores in the filter portion and/or the surfaces of the fibers that make up the filter portion.
<成分>
(銀系抗菌剤)
抗菌部は、銀系抗菌剤を含む。
本明細書において、銀系抗菌剤とは、銀を含む抗菌剤を意味する。
銀系抗菌剤の種類は特に制限されず、公知の銀系抗菌剤が挙げられる。 <Ingredients>
(Silver-based antibacterial agent)
The antibacterial portion contains a silver-based antibacterial agent.
In this specification, a silver-based antibacterial agent means an antibacterial agent that contains silver.
The type of silver-based antibacterial agent is not particularly limited, and examples include known silver-based antibacterial agents.
(銀系抗菌剤)
抗菌部は、銀系抗菌剤を含む。
本明細書において、銀系抗菌剤とは、銀を含む抗菌剤を意味する。
銀系抗菌剤の種類は特に制限されず、公知の銀系抗菌剤が挙げられる。 <Ingredients>
(Silver-based antibacterial agent)
The antibacterial portion contains a silver-based antibacterial agent.
In this specification, a silver-based antibacterial agent means an antibacterial agent that contains silver.
The type of silver-based antibacterial agent is not particularly limited, and examples include known silver-based antibacterial agents.
組成物Aが銀系抗菌剤を有する場合、組成物Aは、大腸菌及び病原性細菌類への抗菌効果だけでなく、カビ等の菌類に対する抗菌性、及び、ウイルスに対する抗ウイルス性を有する。
効果のあるウイルスとして、インフルエンザウイルス、SARSコロナウイルス(SARS-CoV)、及び、新型コロナウイルス(SARS-CoV-2)が挙げられる。また、新型コロナウィルス変異株(SARS-CoV-2 B.1.17, B.1.351,P.1,B.1.617.2等)への効果も期待できる。抗ウイルス性の評価方法として、公知の手段を用いることができる。例えば、ISO 21702に示される方法を用い、試験ウイルスを、インフルエンザウイルス、SARSコロナウイルス又は新型コロナウイルス等の目的のウイルスに変更することで測定できる。抗ウイルス活性値は1より大きければよいが、2.0以上であることが好ましく、2.0超であることがより好ましい。 When composition A contains a silver-based antibacterial agent, composition A has an antibacterial effect not only against Escherichia coli and pathogenic bacteria, but also has antibacterial properties against fungi such as mold and antiviral properties against viruses.
Examples of viruses against which the antiviral agent is effective include influenza virus, SARS coronavirus (SARS-CoV), and novel coronavirus (SARS-CoV-2). The agent is also expected to be effective against novel coronavirus variants (SARS-CoV-2 B.1.17, B.1.351, P.1, B.1.617.2, etc.). A known method can be used to evaluate the antiviral activity. For example, the method shown in ISO 21702 can be used, and the antiviral activity can be measured by changing the test virus to a target virus such as influenza virus, SARS coronavirus, or novel coronavirus. The antiviral activity value may be greater than 1, but is preferably 2.0 or more, and more preferably greater than 2.0.
効果のあるウイルスとして、インフルエンザウイルス、SARSコロナウイルス(SARS-CoV)、及び、新型コロナウイルス(SARS-CoV-2)が挙げられる。また、新型コロナウィルス変異株(SARS-CoV-2 B.1.17, B.1.351,P.1,B.1.617.2等)への効果も期待できる。抗ウイルス性の評価方法として、公知の手段を用いることができる。例えば、ISO 21702に示される方法を用い、試験ウイルスを、インフルエンザウイルス、SARSコロナウイルス又は新型コロナウイルス等の目的のウイルスに変更することで測定できる。抗ウイルス活性値は1より大きければよいが、2.0以上であることが好ましく、2.0超であることがより好ましい。 When composition A contains a silver-based antibacterial agent, composition A has an antibacterial effect not only against Escherichia coli and pathogenic bacteria, but also has antibacterial properties against fungi such as mold and antiviral properties against viruses.
Examples of viruses against which the antiviral agent is effective include influenza virus, SARS coronavirus (SARS-CoV), and novel coronavirus (SARS-CoV-2). The agent is also expected to be effective against novel coronavirus variants (SARS-CoV-2 B.1.17, B.1.351, P.1, B.1.617.2, etc.). A known method can be used to evaluate the antiviral activity. For example, the method shown in ISO 21702 can be used, and the antiviral activity can be measured by changing the test virus to a target virus such as influenza virus, SARS coronavirus, or novel coronavirus. The antiviral activity value may be greater than 1, but is preferably 2.0 or more, and more preferably greater than 2.0.
銀系抗菌剤に含まれる銀の形態は特に制限されず、例えば、銀粒子、銀イオン、銀酸化物、及び、銀塩(銀錯体を含む)等の形態が挙げられる。なお、本明細書では、銀錯体は銀塩の範囲に含まれる。
銀塩としては、例えば、酢酸銀、アセチルアセトン酸銀、アジ化銀、銀アセチリド、ヒ酸銀、安息香酸銀、フッ化水素銀、臭素酸銀、臭化銀、炭酸銀、塩化銀、塩素酸銀、クロム酸銀、クエン酸銀、シアン酸銀、シアン化銀、(cis,cis-1,5-シクロオクタジエン)-1,1,1,5,5,5-ヘキサフルオロアセチルアセトン酸銀、ジエチルジチオカルバミン酸銀、フッ化銀(I)、フッ化銀(II)、7,7-ジメチル-1,1,1,2,2,3,3-ヘプタフルオロ-4,6-オクタンジオン酸銀、ヘキサフルオロアンチモン酸銀、ヘキサフルオロヒ酸銀、ヘキサフルオロリン酸銀、ヨウ素酸銀、ヨウ化銀、イソチオシアン酸銀、シアン化銀カリウム、乳酸銀、モリブデン酸銀、硝酸銀、亜硝酸銀、酸化銀(I)、酸化銀(II)、シュウ酸銀、過塩素酸銀、ペルフルオロ酪酸銀、ペルフルオロプロピオン酸銀、過マンガン酸銀、過レニウム酸銀、リン酸銀、ピクリン酸銀一水和物、プロピオン酸銀、セレン酸銀、セレン化銀、亜セレン酸銀、スルファジアジン銀、硫酸銀、硫化銀、亜硫酸銀、テルル化銀、テトラフルオロ硼酸銀、テトラヨードムキュリウム酸銀、テトラタングステン酸銀、チオシアン酸銀、p-トルエンスルホン酸銀、トリフルオロメタンスルホン酸銀、トリフルオロ酢酸銀、及び、バナジン酸銀等が挙げられる。
また、銀錯体としては、例えば、ヒスチジン銀錯体、メチオニン銀錯体、システイン銀錯体、アスパラギン酸銀錯体、ピロリドンカルボン酸銀錯体、オキソテトラヒドロフランカルボン酸銀錯体、及び、イミダゾール銀錯体等が挙げられる。 The form of silver contained in the silver-based antibacterial agent is not particularly limited, and examples thereof include silver particles, silver ions, silver oxide, and silver salts (including silver complexes). In this specification, silver complexes are included in the scope of silver salts.
Examples of silver salts include silver acetate, silver acetylacetonate, silver azide, silver acetylide, silver arsenate, silver benzoate, silver hydrogen fluoride, silver bromate, silver bromide, silver carbonate, silver chloride, silver chlorate, silver chromate, silver citrate, silver cyanate, silver cyanide, (cis,cis-1,5-cyclooctadiene)-1,1,1,5,5,5-hexafluoroacetylacetonate, silver diethyldithiocarbamate, silver fluoride (I), silver fluoride (II), silver 7,7-dimethyl-1,1,1,2,2,3,3-heptafluoro-4,6-octanedionate, silver hexafluoroantimonate, silver hexafluoroarsenate, silver hexafluorophosphate, silver iodate, and silver iodide. Examples of silver isothiocyanate include silver potassium cyanide, silver lactate, silver molybdate, silver nitrate, silver nitrite, silver oxide (I), silver oxide (II), silver oxalate, silver perchlorate, silver perfluorobutyrate, silver perfluoropropionate, silver permanganate, silver perrhenate, silver phosphate, silver picrate monohydrate, silver propionate, silver selenate, silver selenide, silver selenate, silver sulfadiazine, silver sulfate, silver sulfide, silver sulfite, silver telluride, silver tetrafluoroborate, silver tetraiodomucrylate, silver tetratungstate, silver thiocyanate, silver p-toluenesulfonate, silver trifluoromethanesulfonate, silver trifluoroacetate, and silver vanadate.
Examples of the silver complex include a histidine silver complex, a methionine silver complex, a cysteine silver complex, an aspartic acid silver complex, a pyrrolidone carboxylic acid silver complex, an oxotetrahydrofuran carboxylic acid silver complex, and an imidazole silver complex.
銀塩としては、例えば、酢酸銀、アセチルアセトン酸銀、アジ化銀、銀アセチリド、ヒ酸銀、安息香酸銀、フッ化水素銀、臭素酸銀、臭化銀、炭酸銀、塩化銀、塩素酸銀、クロム酸銀、クエン酸銀、シアン酸銀、シアン化銀、(cis,cis-1,5-シクロオクタジエン)-1,1,1,5,5,5-ヘキサフルオロアセチルアセトン酸銀、ジエチルジチオカルバミン酸銀、フッ化銀(I)、フッ化銀(II)、7,7-ジメチル-1,1,1,2,2,3,3-ヘプタフルオロ-4,6-オクタンジオン酸銀、ヘキサフルオロアンチモン酸銀、ヘキサフルオロヒ酸銀、ヘキサフルオロリン酸銀、ヨウ素酸銀、ヨウ化銀、イソチオシアン酸銀、シアン化銀カリウム、乳酸銀、モリブデン酸銀、硝酸銀、亜硝酸銀、酸化銀(I)、酸化銀(II)、シュウ酸銀、過塩素酸銀、ペルフルオロ酪酸銀、ペルフルオロプロピオン酸銀、過マンガン酸銀、過レニウム酸銀、リン酸銀、ピクリン酸銀一水和物、プロピオン酸銀、セレン酸銀、セレン化銀、亜セレン酸銀、スルファジアジン銀、硫酸銀、硫化銀、亜硫酸銀、テルル化銀、テトラフルオロ硼酸銀、テトラヨードムキュリウム酸銀、テトラタングステン酸銀、チオシアン酸銀、p-トルエンスルホン酸銀、トリフルオロメタンスルホン酸銀、トリフルオロ酢酸銀、及び、バナジン酸銀等が挙げられる。
また、銀錯体としては、例えば、ヒスチジン銀錯体、メチオニン銀錯体、システイン銀錯体、アスパラギン酸銀錯体、ピロリドンカルボン酸銀錯体、オキソテトラヒドロフランカルボン酸銀錯体、及び、イミダゾール銀錯体等が挙げられる。 The form of silver contained in the silver-based antibacterial agent is not particularly limited, and examples thereof include silver particles, silver ions, silver oxide, and silver salts (including silver complexes). In this specification, silver complexes are included in the scope of silver salts.
Examples of silver salts include silver acetate, silver acetylacetonate, silver azide, silver acetylide, silver arsenate, silver benzoate, silver hydrogen fluoride, silver bromate, silver bromide, silver carbonate, silver chloride, silver chlorate, silver chromate, silver citrate, silver cyanate, silver cyanide, (cis,cis-1,5-cyclooctadiene)-1,1,1,5,5,5-hexafluoroacetylacetonate, silver diethyldithiocarbamate, silver fluoride (I), silver fluoride (II), silver 7,7-dimethyl-1,1,1,2,2,3,3-heptafluoro-4,6-octanedionate, silver hexafluoroantimonate, silver hexafluoroarsenate, silver hexafluorophosphate, silver iodate, and silver iodide. Examples of silver isothiocyanate include silver potassium cyanide, silver lactate, silver molybdate, silver nitrate, silver nitrite, silver oxide (I), silver oxide (II), silver oxalate, silver perchlorate, silver perfluorobutyrate, silver perfluoropropionate, silver permanganate, silver perrhenate, silver phosphate, silver picrate monohydrate, silver propionate, silver selenate, silver selenide, silver selenate, silver sulfadiazine, silver sulfate, silver sulfide, silver sulfite, silver telluride, silver tetrafluoroborate, silver tetraiodomucrylate, silver tetratungstate, silver thiocyanate, silver p-toluenesulfonate, silver trifluoromethanesulfonate, silver trifluoroacetate, and silver vanadate.
Examples of the silver complex include a histidine silver complex, a methionine silver complex, a cysteine silver complex, an aspartic acid silver complex, a pyrrolidone carboxylic acid silver complex, an oxotetrahydrofuran carboxylic acid silver complex, and an imidazole silver complex.
銀系抗菌剤としては、担体と、担体上に担持された銀を含む銀担持担体が好ましい。
担体の種類は特に制限されず、公知の担体が挙げられる。担体としては、例えば、無機酸化物(例えば、ゼオライト、シリカゲル、リン酸ジルコニウム、及び、リン酸カルシウム等);活性炭;金属担体;有機金属;ポリマー粒子等が挙げられる。組成物Aの抗菌性がより優れる点で、担体としては、無機酸化物、又は、ポリマー粒子が好ましく、ガラス、又は、ポリマー粒子がより好ましい。 As the silver-based antibacterial agent, a silver-supported carrier containing a carrier and silver supported on the carrier is preferred.
The type of the carrier is not particularly limited, and may be any known carrier. Examples of the carrier include inorganic oxides (e.g., zeolite, silica gel, zirconium phosphate, calcium phosphate, etc.); activated carbon; metal carriers; organic metals; polymer particles, etc. In terms of superior antibacterial properties of the composition A, the carrier is preferably an inorganic oxide or polymer particles, and more preferably glass or polymer particles.
担体の種類は特に制限されず、公知の担体が挙げられる。担体としては、例えば、無機酸化物(例えば、ゼオライト、シリカゲル、リン酸ジルコニウム、及び、リン酸カルシウム等);活性炭;金属担体;有機金属;ポリマー粒子等が挙げられる。組成物Aの抗菌性がより優れる点で、担体としては、無機酸化物、又は、ポリマー粒子が好ましく、ガラス、又は、ポリマー粒子がより好ましい。 As the silver-based antibacterial agent, a silver-supported carrier containing a carrier and silver supported on the carrier is preferred.
The type of the carrier is not particularly limited, and may be any known carrier. Examples of the carrier include inorganic oxides (e.g., zeolite, silica gel, zirconium phosphate, calcium phosphate, etc.); activated carbon; metal carriers; organic metals; polymer particles, etc. In terms of superior antibacterial properties of the composition A, the carrier is preferably an inorganic oxide or polymer particles, and more preferably glass or polymer particles.
銀系抗菌剤としては、銀担持無機酸化物が好ましい。銀担持無機酸化物は、担体である無機酸化物と、無機酸化物上に担持された銀とを含む。
担体である無機酸化物としては、より具体的には、リン酸亜鉛カルシウム、リン酸カルシウム、リン酸ジルコニウム、リン酸アルミニウム、ケイ酸アルミニウム、ケイ酸カルシウム、活性炭、活性アルミナ、シリカゲルゼオライト、アパタイト、ヒドロキシアパタイト、リン酸チタン、チタン酸カリウム、含水酸化ビスマス、含水酸化ジルコニウム、及び、ハイドロタルサイト等が挙げられる。
なお、担体は、結晶性であっても非晶性(アモルファス)であってもよいが、非晶性であることが好ましく、ガラスであることがより好ましい。ガラスを構成し得る材料としては、例えば、ケイ酸塩、ホウケイ酸塩、及び、リン酸塩等が挙げられる。
銀担持無機酸化物としては、銀担持ゼオライト、銀担持アパタイト、銀担持リン酸ジルコニウム、銀担持リン酸ガラス、又は、銀担持ケイ酸カルシウムが好ましい。 A preferred silver-based antibacterial agent is a silver-supported inorganic oxide, which contains an inorganic oxide as a carrier and silver supported on the inorganic oxide.
More specific examples of the inorganic oxide carrier include zinc calcium phosphate, calcium phosphate, zirconium phosphate, aluminum phosphate, aluminum silicate, calcium silicate, activated carbon, activated alumina, silica gel zeolite, apatite, hydroxyapatite, titanium phosphate, potassium titanate, hydrous bismuth oxide, hydrous zirconium oxide, and hydrotalcite.
The carrier may be crystalline or non-crystalline (amorphous), but is preferably amorphous, and more preferably glass. Examples of materials that can form glass include silicates, borosilicates, and phosphates.
As the silver-supported inorganic oxide, silver-supported zeolite, silver-supported apatite, silver-supported zirconium phosphate, silver-supported phosphate glass, or silver-supported calcium silicate is preferable.
担体である無機酸化物としては、より具体的には、リン酸亜鉛カルシウム、リン酸カルシウム、リン酸ジルコニウム、リン酸アルミニウム、ケイ酸アルミニウム、ケイ酸カルシウム、活性炭、活性アルミナ、シリカゲルゼオライト、アパタイト、ヒドロキシアパタイト、リン酸チタン、チタン酸カリウム、含水酸化ビスマス、含水酸化ジルコニウム、及び、ハイドロタルサイト等が挙げられる。
なお、担体は、結晶性であっても非晶性(アモルファス)であってもよいが、非晶性であることが好ましく、ガラスであることがより好ましい。ガラスを構成し得る材料としては、例えば、ケイ酸塩、ホウケイ酸塩、及び、リン酸塩等が挙げられる。
銀担持無機酸化物としては、銀担持ゼオライト、銀担持アパタイト、銀担持リン酸ジルコニウム、銀担持リン酸ガラス、又は、銀担持ケイ酸カルシウムが好ましい。 A preferred silver-based antibacterial agent is a silver-supported inorganic oxide, which contains an inorganic oxide as a carrier and silver supported on the inorganic oxide.
More specific examples of the inorganic oxide carrier include zinc calcium phosphate, calcium phosphate, zirconium phosphate, aluminum phosphate, aluminum silicate, calcium silicate, activated carbon, activated alumina, silica gel zeolite, apatite, hydroxyapatite, titanium phosphate, potassium titanate, hydrous bismuth oxide, hydrous zirconium oxide, and hydrotalcite.
The carrier may be crystalline or non-crystalline (amorphous), but is preferably amorphous, and more preferably glass. Examples of materials that can form glass include silicates, borosilicates, and phosphates.
As the silver-supported inorganic oxide, silver-supported zeolite, silver-supported apatite, silver-supported zirconium phosphate, silver-supported phosphate glass, or silver-supported calcium silicate is preferable.
市販の銀系抗菌剤としては、例えば、株式会社シナネンゼオミック製「ゼオミック(登録商標)」、富士シリシア化学株式会社製「シルウェル」及び日本電子材料株式会社製「バクテノン」等の銀ゼオライト系抗菌剤;東亞合成株式会社製「ノバロン(登録商標)」及び触媒化成工業株式会社製「アトミーボール(登録商標)」等の銀を無機イオン交換体セラミックスに担持させてなる銀系抗菌剤;日本イオン株式会社製「ナノシルバー」等の銀粒子;並びに、富士ケミカル株式会社製「バクテキラー(登録商標)」及び「バクテライト(登録商標)」等のセラミックスに対して銀を化学的に結合させた銀担持セラミックス粒子(銀セラミックス粒子)が挙げられる。
Commercially available silver-based antibacterial agents include, for example, silver zeolite-based antibacterial agents such as "Zeomic (registered trademark)" manufactured by Sinanen Zeomic Co., Ltd., "Silwell" manufactured by Fuji Silysia Chemical Co., Ltd., and "Bactenon" manufactured by Japan Electronic Materials Co., Ltd.; silver-based antibacterial agents in which silver is supported on inorganic ion exchange ceramics, such as "Novalon (registered trademark)" manufactured by Toagosei Co., Ltd. and "Atomy Ball (registered trademark)" manufactured by Catalysts and Chemicals Industry Co., Ltd.; silver particles such as "Nano Silver" manufactured by Nippon Ion Co., Ltd.; and silver-supported ceramic particles (silver ceramic particles) in which silver is chemically bonded to ceramics, such as "Bactekiller (registered trademark)" and "Bacterite (registered trademark)" manufactured by Fuji Chemical Co., Ltd.
銀系抗菌剤は、粒子状であることが好ましい。
銀系抗菌剤が粒子状である場合、その平均粒径は特に制限されないが、0.01μm以上が好ましく、0.3μm以上がより好ましい。なお、その上限は、3.0μm以下が好ましく、1.0μm以下がより好ましい。
銀系抗菌剤の平均粒径は、電子顕微鏡を用いて測定できる。具体的には、上記平均粒径は、銀系抗菌剤の粒子について、1次粒子及び2次粒子(なお、「2次粒子」とは、1次粒子同士が融合あるいは接触して構成される集合体と定義する。)の直径を電子顕微鏡の画像から計測し、全粒子数の中の最も直径が小さい側の粒子数5%と、最も直径が大きい側の粒子数5%を除いた、90%の範囲の粒子の直径を平均した値である。つまり、平均粒径は、1次粒子及び2次粒子から求められる値である。また、直径とは、粒子の外接円相当直径のことをいう。
また、粒子形状に大きく違いがない場合、株式会社堀場製作所製のレーザー回折/散乱式粒度分布測定装置を用いて50%体積累積径(D50)を3回測定して、3回測定した値の平均値を平均粒径として代用してもよい。 The silver-based antibacterial agent is preferably in particulate form.
When the silver-based antibacterial agent is in the form of particles, the average particle size is not particularly limited, but is preferably 0.01 μm or more, more preferably 0.3 μm or more, and the upper limit is preferably 3.0 μm or less, more preferably 1.0 μm or less.
The average particle size of the silver-based antibacterial agent can be measured using an electron microscope. Specifically, the average particle size is the average value of the diameters of the primary particles and secondary particles (note that "secondary particles" are defined as aggregates formed by the fusion or contact of primary particles) of the silver-based antibacterial agent particles measured from an image of an electron microscope, and the diameters of the particles in a range of 90% of the total number of particles are averaged, excluding the 5% of the number of particles on the smallest diameter side and the 5% of the number of particles on the largest diameter side. In other words, the average particle size is a value obtained from the primary particles and the secondary particles. The diameter refers to the circumscribed circle equivalent diameter of the particle.
In addition, when there is no significant difference in particle shape, the 50% volume cumulative diameter (D50) may be measured three times using a laser diffraction/scattering type particle size distribution measuring device manufactured by Horiba, Ltd., and the average value of the three measurements may be used as the average particle size.
銀系抗菌剤が粒子状である場合、その平均粒径は特に制限されないが、0.01μm以上が好ましく、0.3μm以上がより好ましい。なお、その上限は、3.0μm以下が好ましく、1.0μm以下がより好ましい。
銀系抗菌剤の平均粒径は、電子顕微鏡を用いて測定できる。具体的には、上記平均粒径は、銀系抗菌剤の粒子について、1次粒子及び2次粒子(なお、「2次粒子」とは、1次粒子同士が融合あるいは接触して構成される集合体と定義する。)の直径を電子顕微鏡の画像から計測し、全粒子数の中の最も直径が小さい側の粒子数5%と、最も直径が大きい側の粒子数5%を除いた、90%の範囲の粒子の直径を平均した値である。つまり、平均粒径は、1次粒子及び2次粒子から求められる値である。また、直径とは、粒子の外接円相当直径のことをいう。
また、粒子形状に大きく違いがない場合、株式会社堀場製作所製のレーザー回折/散乱式粒度分布測定装置を用いて50%体積累積径(D50)を3回測定して、3回測定した値の平均値を平均粒径として代用してもよい。 The silver-based antibacterial agent is preferably in particulate form.
When the silver-based antibacterial agent is in the form of particles, the average particle size is not particularly limited, but is preferably 0.01 μm or more, more preferably 0.3 μm or more, and the upper limit is preferably 3.0 μm or less, more preferably 1.0 μm or less.
The average particle size of the silver-based antibacterial agent can be measured using an electron microscope. Specifically, the average particle size is the average value of the diameters of the primary particles and secondary particles (note that "secondary particles" are defined as aggregates formed by the fusion or contact of primary particles) of the silver-based antibacterial agent particles measured from an image of an electron microscope, and the diameters of the particles in a range of 90% of the total number of particles are averaged, excluding the 5% of the number of particles on the smallest diameter side and the 5% of the number of particles on the largest diameter side. In other words, the average particle size is a value obtained from the primary particles and the secondary particles. The diameter refers to the circumscribed circle equivalent diameter of the particle.
In addition, when there is no significant difference in particle shape, the 50% volume cumulative diameter (D50) may be measured three times using a laser diffraction/scattering type particle size distribution measuring device manufactured by Horiba, Ltd., and the average value of the three measurements may be used as the average particle size.
銀系抗菌剤の平均粒径は従来公知の方法により調節でき、例えば、乾式粉砕及び湿式粉砕等の方法が挙げられる。乾式粉砕においては、例えば、乳鉢、ジェットミル、ハンマーミル、ピンミル、回転ミル、振動ミル、遊星ミル、及び、ビーズミル等が適宜用いられる。また、湿式粉砕においては、例えば、各種ボールミル、高速回転粉砕機、ジェットミル、ビーズミル、超音波ホモジナイザー、及び、高圧ホモジナイザー等が適宜用いられる。
例えば、ビーズミルにおいては、メディアとなるビーズの径、種類、及び、混合量等を調節することで平均粒径を制御できる。 The average particle size of the silver-based antibacterial agent can be adjusted by a conventional method, such as dry grinding and wet grinding. In dry grinding, for example, a mortar, a jet mill, a hammer mill, a pin mill, a rotary mill, a vibration mill, a planetary mill, a bead mill, etc. are appropriately used. In wet grinding, for example, various ball mills, high-speed rotary grinders, jet mills, bead mills, ultrasonic homogenizers, high-pressure homogenizers, etc. are appropriately used.
For example, in a bead mill, the average particle size can be controlled by adjusting the diameter, type, and mixing amount of beads serving as media.
例えば、ビーズミルにおいては、メディアとなるビーズの径、種類、及び、混合量等を調節することで平均粒径を制御できる。 The average particle size of the silver-based antibacterial agent can be adjusted by a conventional method, such as dry grinding and wet grinding. In dry grinding, for example, a mortar, a jet mill, a hammer mill, a pin mill, a rotary mill, a vibration mill, a planetary mill, a bead mill, etc. are appropriately used. In wet grinding, for example, various ball mills, high-speed rotary grinders, jet mills, bead mills, ultrasonic homogenizers, high-pressure homogenizers, etc. are appropriately used.
For example, in a bead mill, the average particle size can be controlled by adjusting the diameter, type, and mixing amount of beads serving as media.
抗菌部における銀系抗菌剤の含有量は特に制限されないが、抗菌部の全質量に対して、0.001~50質量%が好ましく、0.01~40質量%がより好ましく、0.01~15質量%が更に好ましく、0.01~10質量%が特に好ましく、0.03~5質量%が最も好ましい。
銀系抗菌剤における銀の含有量は、特に制限されないが、銀系抗菌剤の全質量に対して、0.1~30質量%が好ましく、0.5~5質量%がより好ましい。 The content of the silver-based antibacterial agent in the antibacterial part is not particularly limited, but is preferably 0.001 to 50 mass%, more preferably 0.01 to 40 mass%, even more preferably 0.01 to 15 mass%, particularly preferably 0.01 to 10 mass%, and most preferably 0.03 to 5 mass%, relative to the total mass of the antibacterial part.
The silver content in the silver-based antibacterial agent is not particularly limited, but is preferably 0.1 to 30 mass %, more preferably 0.5 to 5 mass %, based on the total mass of the silver-based antibacterial agent.
銀系抗菌剤における銀の含有量は、特に制限されないが、銀系抗菌剤の全質量に対して、0.1~30質量%が好ましく、0.5~5質量%がより好ましい。 The content of the silver-based antibacterial agent in the antibacterial part is not particularly limited, but is preferably 0.001 to 50 mass%, more preferably 0.01 to 40 mass%, even more preferably 0.01 to 15 mass%, particularly preferably 0.01 to 10 mass%, and most preferably 0.03 to 5 mass%, relative to the total mass of the antibacterial part.
The silver content in the silver-based antibacterial agent is not particularly limited, but is preferably 0.1 to 30 mass %, more preferably 0.5 to 5 mass %, based on the total mass of the silver-based antibacterial agent.
(シリケート系化合物)
本明細書において、シリケート系化合物とは、ケイ素原子に加水分解性基が結合した化合物、その加水分解物、及び、その加水分解縮合物からなる群より選ばれる化合物を意味する。
本発明の抗菌フィルタは、フィルタ部上に銀系抗菌剤及びシリケート系化合物を含む抗菌部が配置されていることにより、特に親水性のエアロゾル粒子の捕集率が向上しているものと推測される。 (Silicate compounds)
In this specification, the silicate-based compound means a compound selected from the group consisting of a compound having a hydrolyzable group bonded to a silicon atom, a hydrolyzate thereof, and a hydrolyzed condensate thereof.
It is presumed that the antibacterial filter of the present invention has an improved capture rate, particularly for hydrophilic aerosol particles, due to the antibacterial portion containing a silver-based antibacterial agent and a silicate-based compound being disposed on the filter portion.
本明細書において、シリケート系化合物とは、ケイ素原子に加水分解性基が結合した化合物、その加水分解物、及び、その加水分解縮合物からなる群より選ばれる化合物を意味する。
本発明の抗菌フィルタは、フィルタ部上に銀系抗菌剤及びシリケート系化合物を含む抗菌部が配置されていることにより、特に親水性のエアロゾル粒子の捕集率が向上しているものと推測される。 (Silicate compounds)
In this specification, the silicate-based compound means a compound selected from the group consisting of a compound having a hydrolyzable group bonded to a silicon atom, a hydrolyzate thereof, and a hydrolyzed condensate thereof.
It is presumed that the antibacterial filter of the present invention has an improved capture rate, particularly for hydrophilic aerosol particles, due to the antibacterial portion containing a silver-based antibacterial agent and a silicate-based compound being disposed on the filter portion.
シリケート系化合物としては、例えば、下記式(1)で表される化合物、その加水分解物、及び、その加水分解縮合物からなる群より選ばれる少なくとも1種が挙げられる。
Si-(OR)4 (1)
上記式(1)中、Rは、炭素数1~4のアルキル基を表し、同一でも異なっていてもよい。
式(1)で表される化合物の加水分解物とは、式(1)で表される化合物中のOR基が加水分解して得られる化合物を意図する。なお、上記加水分解物は、OR基のすべてが加水分解されているもの(完全加水分解物)であっても、OR基の一部が加水分解されているもの(部分加水分解物)であってもよい。つまり、上記加水分解物は、完全加水分解物、部分加水分解物、又は、これらの混合物であってもよい。 The silicate-based compound may be, for example, at least one selected from the group consisting of a compound represented by the following formula (1), a hydrolyzate thereof, and a hydrolyzed condensate thereof.
Si-(OR) 4 (1)
In the above formula (1), R represents an alkyl group having 1 to 4 carbon atoms and may be the same or different.
The hydrolysate of the compound represented by formula (1) refers to a compound obtained by hydrolysis of the OR group in the compound represented by formula (1). The hydrolysate may be one in which all of the OR groups are hydrolyzed (complete hydrolysate) or one in which only a part of the OR groups are hydrolyzed (partial hydrolysate). In other words, the hydrolysate may be a complete hydrolysate, a partial hydrolysate, or a mixture thereof.
Si-(OR)4 (1)
上記式(1)中、Rは、炭素数1~4のアルキル基を表し、同一でも異なっていてもよい。
式(1)で表される化合物の加水分解物とは、式(1)で表される化合物中のOR基が加水分解して得られる化合物を意図する。なお、上記加水分解物は、OR基のすべてが加水分解されているもの(完全加水分解物)であっても、OR基の一部が加水分解されているもの(部分加水分解物)であってもよい。つまり、上記加水分解物は、完全加水分解物、部分加水分解物、又は、これらの混合物であってもよい。 The silicate-based compound may be, for example, at least one selected from the group consisting of a compound represented by the following formula (1), a hydrolyzate thereof, and a hydrolyzed condensate thereof.
Si-(OR) 4 (1)
In the above formula (1), R represents an alkyl group having 1 to 4 carbon atoms and may be the same or different.
The hydrolysate of the compound represented by formula (1) refers to a compound obtained by hydrolysis of the OR group in the compound represented by formula (1). The hydrolysate may be one in which all of the OR groups are hydrolyzed (complete hydrolysate) or one in which only a part of the OR groups are hydrolyzed (partial hydrolysate). In other words, the hydrolysate may be a complete hydrolysate, a partial hydrolysate, or a mixture thereof.
また、式(1)で表される化合物の加水分解縮合物とは、式(1)で表される化合物中のOR基が加水分解し、得られた加水分解物を縮合して得られる化合物を意図する。なお、上記加水分解縮合物としては、すべてのOR基が加水分解され、かつ、加水分解物がすべて縮合されているもの(完全加水分解縮合物)であっても、一部のOR基が加水分解され、一部の加水分解物が縮合しているもの(部分加水分解縮合物)であってもよい。つまり、上記加水分解縮合物は、完全加水分解縮合物、部分加水分解縮合物、又は、これらの混合物であってもよい。
なお、加水分解縮合物の縮合度としては、1~100が好ましく、1~20がより好ましく、3~15が更に好ましい。 In addition, the hydrolysis condensate of the compound represented by formula (1) refers to a compound obtained by hydrolyzing the OR group in the compound represented by formula (1) and condensing the obtained hydrolyzate.The hydrolysis condensate may be one in which all OR groups are hydrolyzed and all the hydrolyzates are condensed (complete hydrolysis condensate), or one in which some OR groups are hydrolyzed and some of the hydrolyzates are condensed (partial hydrolysis condensate).In other words, the hydrolysis condensate may be a complete hydrolysis condensate, a partial hydrolysis condensate, or a mixture thereof.
The condensation degree of the hydrolysis condensate is preferably 1-100, more preferably 1-20, and even more preferably 3-15.
なお、加水分解縮合物の縮合度としては、1~100が好ましく、1~20がより好ましく、3~15が更に好ましい。 In addition, the hydrolysis condensate of the compound represented by formula (1) refers to a compound obtained by hydrolyzing the OR group in the compound represented by formula (1) and condensing the obtained hydrolyzate.The hydrolysis condensate may be one in which all OR groups are hydrolyzed and all the hydrolyzates are condensed (complete hydrolysis condensate), or one in which some OR groups are hydrolyzed and some of the hydrolyzates are condensed (partial hydrolysis condensate).In other words, the hydrolysis condensate may be a complete hydrolysis condensate, a partial hydrolysis condensate, or a mixture thereof.
The condensation degree of the hydrolysis condensate is preferably 1-100, more preferably 1-20, and even more preferably 3-15.
上記シリケート系化合物としては、式(X)で表される化合物が好ましい。
As the silicate-based compound, a compound represented by formula (X) is preferred.
式(X)中、R1~R4は、それぞれ独立に、炭素数1~4のアルキル基を表す。また、nは2~100の整数を表す。
nは、3~15が好ましく、5~10がより好ましい。 In formula (X), R 1 to R 4 each independently represent an alkyl group having 1 to 4 carbon atoms, and n represents an integer of 2 to 100.
n is preferably an integer of 3 to 15, and more preferably an integer of 5 to 10.
nは、3~15が好ましく、5~10がより好ましい。 In formula (X), R 1 to R 4 each independently represent an alkyl group having 1 to 4 carbon atoms, and n represents an integer of 2 to 100.
n is preferably an integer of 3 to 15, and more preferably an integer of 5 to 10.
式(X)で表される化合物の市販品としては、例えば、コルコート株式会社製「エチルシリケート48」、「メチルシリケート51」及び「メチルシリケート53」、並びに、三菱ケミカル株式会社製「MKCシリケート MS51」等が挙げられる。
Commercially available products of the compound represented by formula (X) include, for example, "Ethyl Silicate 48," "Methyl Silicate 51," and "Methyl Silicate 53" manufactured by Colcoat Co., Ltd., and "MKC Silicate MS51" manufactured by Mitsubishi Chemical Corporation.
抗菌部におけるシリケート系化合物の含有量は、特に制限されないが、抗菌部の全質量に対して、20~99.8質量%が好ましく、20~90質量%がより好ましく、40~90質量%が更に好ましい。
The content of the silicate-based compound in the antibacterial portion is not particularly limited, but is preferably 20 to 99.8 mass% relative to the total mass of the antibacterial portion, more preferably 20 to 90 mass%, and even more preferably 40 to 90 mass%.
(他の成分)
抗菌部は、上記成分以外の他の成分を含んでいてもよい。他の成分としては、アルコール、銀系抗菌剤以外の他の抗菌剤、シリケート系化合物の縮合を促進する触媒、分散剤、界面活性剤、重合開始剤、及び、香料が挙げられる。 (Other ingredients)
The antibacterial portion may contain other components in addition to the above components, such as alcohol, an antibacterial agent other than the silver-based antibacterial agent, a catalyst for promoting the condensation of a silicate-based compound, a dispersant, a surfactant, a polymerization initiator, and a fragrance.
抗菌部は、上記成分以外の他の成分を含んでいてもよい。他の成分としては、アルコール、銀系抗菌剤以外の他の抗菌剤、シリケート系化合物の縮合を促進する触媒、分散剤、界面活性剤、重合開始剤、及び、香料が挙げられる。 (Other ingredients)
The antibacterial portion may contain other components in addition to the above components, such as alcohol, an antibacterial agent other than the silver-based antibacterial agent, a catalyst for promoting the condensation of a silicate-based compound, a dispersant, a surfactant, a polymerization initiator, and a fragrance.
抗菌部は、抗菌部を設けるフィルタ部に存在する菌及びウイルスを低減する消毒性能がより優れる点で、アルコールを含むことが好ましい。
アルコールは、1種を単独で用いても、2種以上を併用してもよい。
抗菌部に含まれるアルコールとしては、例えば、メタノール、エタノール、n-プロパノール、イソプロパール、n-ブタノール、及び、イソブタノール等が挙げられる。
抗菌部がアルコールを含む場合、アルコールの含有量は、抗菌部の全質量に対して、1質量%以下が好ましく、0.5質量%以下がより好ましく、0.1質量%以下が更に好ましい。 The antibacterial portion preferably contains alcohol, since this provides superior disinfecting performance for reducing bacteria and viruses present in the filter portion in which the antibacterial portion is provided.
The alcohols may be used alone or in combination of two or more.
Examples of the alcohol contained in the antibacterial portion include methanol, ethanol, n-propanol, isopropanol, n-butanol, and isobutanol.
When the antibacterial portion contains alcohol, the alcohol content is preferably 1 mass % or less, more preferably 0.5 mass % or less, and even more preferably 0.1 mass % or less, relative to the total mass of the antibacterial portion.
アルコールは、1種を単独で用いても、2種以上を併用してもよい。
抗菌部に含まれるアルコールとしては、例えば、メタノール、エタノール、n-プロパノール、イソプロパール、n-ブタノール、及び、イソブタノール等が挙げられる。
抗菌部がアルコールを含む場合、アルコールの含有量は、抗菌部の全質量に対して、1質量%以下が好ましく、0.5質量%以下がより好ましく、0.1質量%以下が更に好ましい。 The antibacterial portion preferably contains alcohol, since this provides superior disinfecting performance for reducing bacteria and viruses present in the filter portion in which the antibacterial portion is provided.
The alcohols may be used alone or in combination of two or more.
Examples of the alcohol contained in the antibacterial portion include methanol, ethanol, n-propanol, isopropanol, n-butanol, and isobutanol.
When the antibacterial portion contains alcohol, the alcohol content is preferably 1 mass % or less, more preferably 0.5 mass % or less, and even more preferably 0.1 mass % or less, relative to the total mass of the antibacterial portion.
銀系抗菌剤以外の他の抗菌剤としては、銀系抗菌剤以外の無機系抗菌剤、及び、有機系抗菌剤が挙げられる。
無機系抗菌剤としては、例えば、金属を含む抗菌剤が挙げられる。上記金属としては、例えば、銅、亜鉛、水銀、鉄、鉛、ビスマス、チタン、錫、及び、ニッケル等が挙げられる。また、抗菌剤に含まれる金属の態様は特に制限されず、金属粒子、金属イオン、金属酸化物、及び、金属塩(金属錯体を含む)等の形態が挙げられる。
金属を含む抗菌剤としては、担体と、担体上に担持された銀以外の金属を含む金属担持担体が好ましい。担体については、好ましい態様も含めて、既に説明した通りである。
有機系抗菌剤としては、例えば、第4級アンモニウム塩、フェノールエーテル誘導体、イミダゾール誘導体、スルホン誘導体、N-ハロアルキルチオ化合物、アニリド誘導体、ピロール誘導体、ピリジン系化合物、トリアジン系化合物、ベンゾイソチアゾリン系化合物、及び、イソチアゾリン系化合物等が挙げられる。 Examples of antibacterial agents other than silver-based antibacterial agents include inorganic antibacterial agents other than silver-based antibacterial agents and organic antibacterial agents.
Examples of inorganic antibacterial agents include antibacterial agents containing metals. Examples of the metals include copper, zinc, mercury, iron, lead, bismuth, titanium, tin, and nickel. The form of the metal contained in the antibacterial agent is not particularly limited, and examples of the form include metal particles, metal ions, metal oxides, and metal salts (including metal complexes).
The antibacterial agent containing a metal is preferably a metal-supported carrier containing a carrier and a metal other than silver supported on the carrier. The carrier, including preferred embodiments thereof, is as described above.
Examples of organic antibacterial agents include quaternary ammonium salts, phenol ether derivatives, imidazole derivatives, sulfone derivatives, N-haloalkylthio compounds, anilide derivatives, pyrrole derivatives, pyridine compounds, triazine compounds, benzoisothiazoline compounds, and isothiazoline compounds.
無機系抗菌剤としては、例えば、金属を含む抗菌剤が挙げられる。上記金属としては、例えば、銅、亜鉛、水銀、鉄、鉛、ビスマス、チタン、錫、及び、ニッケル等が挙げられる。また、抗菌剤に含まれる金属の態様は特に制限されず、金属粒子、金属イオン、金属酸化物、及び、金属塩(金属錯体を含む)等の形態が挙げられる。
金属を含む抗菌剤としては、担体と、担体上に担持された銀以外の金属を含む金属担持担体が好ましい。担体については、好ましい態様も含めて、既に説明した通りである。
有機系抗菌剤としては、例えば、第4級アンモニウム塩、フェノールエーテル誘導体、イミダゾール誘導体、スルホン誘導体、N-ハロアルキルチオ化合物、アニリド誘導体、ピロール誘導体、ピリジン系化合物、トリアジン系化合物、ベンゾイソチアゾリン系化合物、及び、イソチアゾリン系化合物等が挙げられる。 Examples of antibacterial agents other than silver-based antibacterial agents include inorganic antibacterial agents other than silver-based antibacterial agents and organic antibacterial agents.
Examples of inorganic antibacterial agents include antibacterial agents containing metals. Examples of the metals include copper, zinc, mercury, iron, lead, bismuth, titanium, tin, and nickel. The form of the metal contained in the antibacterial agent is not particularly limited, and examples of the form include metal particles, metal ions, metal oxides, and metal salts (including metal complexes).
The antibacterial agent containing a metal is preferably a metal-supported carrier containing a carrier and a metal other than silver supported on the carrier. The carrier, including preferred embodiments thereof, is as described above.
Examples of organic antibacterial agents include quaternary ammonium salts, phenol ether derivatives, imidazole derivatives, sulfone derivatives, N-haloalkylthio compounds, anilide derivatives, pyrrole derivatives, pyridine compounds, triazine compounds, benzoisothiazoline compounds, and isothiazoline compounds.
銀系抗菌剤以外の他の抗菌剤としては、優れた抗菌性を長期間にわたって維持できる点で、無機系抗菌剤が好ましく、銅系抗菌剤がより好ましい。銅系抗菌剤としては、銅イオン(Cu+又はCu2+)を含む抗菌剤が挙げられる。具体的には、興研株式会社製「イマディーズ」等が挙げられる。
抗菌部が上記他の抗菌剤を含む場合、銀系抗菌剤と他の抗菌剤との合計含有量が、上記銀系抗菌剤の含有量の範囲内にあることが好ましい。 As the antibacterial agent other than the silver-based antibacterial agent, an inorganic antibacterial agent is preferable, and a copper-based antibacterial agent is more preferable, because it can maintain excellent antibacterial properties for a long period of time. An example of the copper-based antibacterial agent is an antibacterial agent containing copper ions (Cu + or Cu 2+ ). Specifically, an example of the antibacterial agent is "Imadies" manufactured by Koken Co., Ltd.
When the antibacterial portion contains the other antibacterial agent, it is preferable that the total content of the silver-based antibacterial agent and the other antibacterial agent is within the range of the content of the silver-based antibacterial agent.
抗菌部が上記他の抗菌剤を含む場合、銀系抗菌剤と他の抗菌剤との合計含有量が、上記銀系抗菌剤の含有量の範囲内にあることが好ましい。 As the antibacterial agent other than the silver-based antibacterial agent, an inorganic antibacterial agent is preferable, and a copper-based antibacterial agent is more preferable, because it can maintain excellent antibacterial properties for a long period of time. An example of the copper-based antibacterial agent is an antibacterial agent containing copper ions (Cu + or Cu 2+ ). Specifically, an example of the antibacterial agent is "Imadies" manufactured by Koken Co., Ltd.
When the antibacterial portion contains the other antibacterial agent, it is preferable that the total content of the silver-based antibacterial agent and the other antibacterial agent is within the range of the content of the silver-based antibacterial agent.
シリケート系化合物前駆体の縮合を促進する触媒の種類は特に制限されないが、アルカリ触媒、及び、有機金属触媒が挙げられる。
アルカリ触媒としては、例えば、水酸化ナトリウム、水酸化カリウム、及び、水酸化テトラメチルアンモニウム等が挙げられる。
有機金属触媒としては、例えば、アルミニウムビス(エチルアセトアセテート)モノ(アセチルアセトネート)、アルミニウムトリス(アセチルアセトネート)、及び、アルミニウムエチルアセトアセテートジイソプロピレート等のアルミキレート化合物、ジルコニウムテトラキス(アセチルアセトネート)、及び、ジルコニウムビス(ブトキシ)ビス(アセチルアセトネート)等のジルコニウムキレート化合物、チタニウムテトラキス(アセチルアセトネート)、及び、チタニウムビス(ブトキシ)ビス(アセチルアセトネート)等のチタンキレート化合物、並びに、ジブチルスズジアセテート、ジブチルスズジラウレート、及び、ジブチルスズジオクチエート等の有機スズ化合物等が挙げられる。
触媒の種類は特に制限されないが、有機金属触媒が好ましく、アルミキレート化合物、又は、ジルコニウムキレート化合物がより好ましく、アルミキレート化合物が更に好ましい。
触媒としては、市販品を使用できる。具体的には、川研ファインケミカル株式会社製のアルミキレートA、アルミキレートD、アルミキレートM、ALCH、及び、ALCH-TR等(いずれも商品名)が挙げられる。 The type of catalyst that promotes the condensation of the silicate-based compound precursor is not particularly limited, but examples thereof include alkali catalysts and organometallic catalysts.
Examples of the alkali catalyst include sodium hydroxide, potassium hydroxide, and tetramethylammonium hydroxide.
Examples of the organometallic catalyst include aluminum chelate compounds such as aluminum bis(ethylacetoacetate)mono(acetylacetonate), aluminum tris(acetylacetonate), and aluminum ethylacetoacetate diisopropylate; zirconium chelate compounds such as zirconium tetrakis(acetylacetonate) and zirconium bis(butoxy)bis(acetylacetonate); titanium chelate compounds such as titanium tetrakis(acetylacetonate) and titanium bis(butoxy)bis(acetylacetonate); and organotin compounds such as dibutyltin diacetate, dibutyltin dilaurate, and dibutyltin dioctiate.
The type of catalyst is not particularly limited, but an organometallic catalyst is preferable, an aluminum chelate compound or a zirconium chelate compound is more preferable, and an aluminum chelate compound is further preferable.
As the catalyst, commercially available products can be used, specifically, Alumichelate A, Alumichelate D, Alumichelate M, ALCH, and ALCH-TR (all trade names) manufactured by Kawaken Fine Chemical Co., Ltd. can be mentioned.
アルカリ触媒としては、例えば、水酸化ナトリウム、水酸化カリウム、及び、水酸化テトラメチルアンモニウム等が挙げられる。
有機金属触媒としては、例えば、アルミニウムビス(エチルアセトアセテート)モノ(アセチルアセトネート)、アルミニウムトリス(アセチルアセトネート)、及び、アルミニウムエチルアセトアセテートジイソプロピレート等のアルミキレート化合物、ジルコニウムテトラキス(アセチルアセトネート)、及び、ジルコニウムビス(ブトキシ)ビス(アセチルアセトネート)等のジルコニウムキレート化合物、チタニウムテトラキス(アセチルアセトネート)、及び、チタニウムビス(ブトキシ)ビス(アセチルアセトネート)等のチタンキレート化合物、並びに、ジブチルスズジアセテート、ジブチルスズジラウレート、及び、ジブチルスズジオクチエート等の有機スズ化合物等が挙げられる。
触媒の種類は特に制限されないが、有機金属触媒が好ましく、アルミキレート化合物、又は、ジルコニウムキレート化合物がより好ましく、アルミキレート化合物が更に好ましい。
触媒としては、市販品を使用できる。具体的には、川研ファインケミカル株式会社製のアルミキレートA、アルミキレートD、アルミキレートM、ALCH、及び、ALCH-TR等(いずれも商品名)が挙げられる。 The type of catalyst that promotes the condensation of the silicate-based compound precursor is not particularly limited, but examples thereof include alkali catalysts and organometallic catalysts.
Examples of the alkali catalyst include sodium hydroxide, potassium hydroxide, and tetramethylammonium hydroxide.
Examples of the organometallic catalyst include aluminum chelate compounds such as aluminum bis(ethylacetoacetate)mono(acetylacetonate), aluminum tris(acetylacetonate), and aluminum ethylacetoacetate diisopropylate; zirconium chelate compounds such as zirconium tetrakis(acetylacetonate) and zirconium bis(butoxy)bis(acetylacetonate); titanium chelate compounds such as titanium tetrakis(acetylacetonate) and titanium bis(butoxy)bis(acetylacetonate); and organotin compounds such as dibutyltin diacetate, dibutyltin dilaurate, and dibutyltin dioctiate.
The type of catalyst is not particularly limited, but an organometallic catalyst is preferable, an aluminum chelate compound or a zirconium chelate compound is more preferable, and an aluminum chelate compound is further preferable.
As the catalyst, commercially available products can be used, specifically, Alumichelate A, Alumichelate D, Alumichelate M, ALCH, and ALCH-TR (all trade names) manufactured by Kawaken Fine Chemical Co., Ltd. can be mentioned.
抗菌部が粒子状の銀系抗菌剤を含む場合、抗菌部は分散剤を含むことが好ましい。
分散剤の種類は特に制限されず、公知の分散剤が使用できる。
分散剤としては、ノニオン系又はアニオン系の分散剤が好ましく、銀系抗菌剤に対する親和性の点で、カルボキシ基、リン酸基、及び、水酸基等のアニオン性の極性基を有する分散剤(アニオン系分散剤)がより好ましい。
アニオン系分散剤としては、市販品を使用できる。その具体例としては、BYK社のDISPERBYK(登録商標)-110、-111、-116、-140、-161、-162、-163、-164、-170、-171、-174、-180、及び、-182等(いずれも商品名)が挙げられる。 When the antibacterial portion contains a particulate silver-based antibacterial agent, the antibacterial portion preferably contains a dispersant.
The type of dispersant is not particularly limited, and any known dispersant can be used.
As the dispersant, a nonionic or anionic dispersant is preferred, and from the viewpoint of affinity for the silver-based antibacterial agent, a dispersant having an anionic polar group such as a carboxy group, a phosphate group, or a hydroxyl group (anionic dispersant) is more preferred.
Commercially available anionic dispersants can be used, specific examples of which include DISPERBYK (registered trademark) -110, -111, -116, -140, -161, -162, -163, -164, -170, -171, -174, -180, and -182 (all trade names) manufactured by BYK Corporation.
分散剤の種類は特に制限されず、公知の分散剤が使用できる。
分散剤としては、ノニオン系又はアニオン系の分散剤が好ましく、銀系抗菌剤に対する親和性の点で、カルボキシ基、リン酸基、及び、水酸基等のアニオン性の極性基を有する分散剤(アニオン系分散剤)がより好ましい。
アニオン系分散剤としては、市販品を使用できる。その具体例としては、BYK社のDISPERBYK(登録商標)-110、-111、-116、-140、-161、-162、-163、-164、-170、-171、-174、-180、及び、-182等(いずれも商品名)が挙げられる。 When the antibacterial portion contains a particulate silver-based antibacterial agent, the antibacterial portion preferably contains a dispersant.
The type of dispersant is not particularly limited, and any known dispersant can be used.
As the dispersant, a nonionic or anionic dispersant is preferred, and from the viewpoint of affinity for the silver-based antibacterial agent, a dispersant having an anionic polar group such as a carboxy group, a phosphate group, or a hydroxyl group (anionic dispersant) is more preferred.
Commercially available anionic dispersants can be used, specific examples of which include DISPERBYK (registered trademark) -110, -111, -116, -140, -161, -162, -163, -164, -170, -171, -174, -180, and -182 (all trade names) manufactured by BYK Corporation.
抗菌部は、界面活性剤を含んでいてもよい。界面活性剤は後述する抗菌部形成用組成物の塗布性を向上する作用を有する。
界面活性剤は特に制限されず、例えば、ノニオン性界面活性剤、並びに、イオン性界面活性剤(例えば、アニオン性界面活性剤、カチオン性界面活性剤、及び、両性型界面活性剤)等が挙げられる。 The antibacterial portion may contain a surfactant, which has the effect of improving the applicability of the antibacterial portion-forming composition described below.
The surfactant is not particularly limited, and examples thereof include nonionic surfactants and ionic surfactants (for example, anionic surfactants, cationic surfactants, and amphoteric surfactants).
界面活性剤は特に制限されず、例えば、ノニオン性界面活性剤、並びに、イオン性界面活性剤(例えば、アニオン性界面活性剤、カチオン性界面活性剤、及び、両性型界面活性剤)等が挙げられる。 The antibacterial portion may contain a surfactant, which has the effect of improving the applicability of the antibacterial portion-forming composition described below.
The surfactant is not particularly limited, and examples thereof include nonionic surfactants and ionic surfactants (for example, anionic surfactants, cationic surfactants, and amphoteric surfactants).
ノニオン性界面活性剤としては、例えば、ポリエチレングリコールモノラウリルエーテル、ポリエチレングリコールモノステアリルエーテル、ポリエチレングリコールモノセチルエーテル、ポリエチレングリコールモノラウリルエステル、及び、ポリエチレングリコールモノステアリルエステル等が挙げられる。
ノニオン性界面活性剤としては、日本エマルジョン株式会社製のエマレックス(登録商標)715が挙げられる。 Examples of nonionic surfactants include polyethylene glycol monolauryl ether, polyethylene glycol monostearyl ether, polyethylene glycol monocetyl ether, polyethylene glycol monolauryl ester, and polyethylene glycol monostearyl ester.
An example of the nonionic surfactant is EMALEX (registered trademark) 715 manufactured by Nippon Emulsion Co., Ltd.
ノニオン性界面活性剤としては、日本エマルジョン株式会社製のエマレックス(登録商標)715が挙げられる。 Examples of nonionic surfactants include polyethylene glycol monolauryl ether, polyethylene glycol monostearyl ether, polyethylene glycol monocetyl ether, polyethylene glycol monolauryl ester, and polyethylene glycol monostearyl ester.
An example of the nonionic surfactant is EMALEX (registered trademark) 715 manufactured by Nippon Emulsion Co., Ltd.
イオン性界面活性剤としては、例えば、アルキル硫酸塩、アルキルベンゼンスルホン酸塩、及び、アルキルリン酸塩等のアニオン性界面活性剤;アルキルトリメチルアンモニウム塩、及び、ジアルキルジメチルアンモニウム塩等のカチオン性界面活性剤;アルキルカルボキシベタイン等の両性型界面活性剤が挙げられる。
アニオン性界面活性剤としては、ジ(2-エチルヘキシル)スルホコハク酸ナトリウムが挙げられる。 Examples of ionic surfactants include anionic surfactants such as alkyl sulfates, alkylbenzenesulfonates, and alkyl phosphates; cationic surfactants such as alkyltrimethylammonium salts and dialkyldimethylammonium salts; and amphoteric surfactants such as alkylcarboxybetaines.
Anionic surfactants include sodium di(2-ethylhexyl)sulfosuccinate.
アニオン性界面活性剤としては、ジ(2-エチルヘキシル)スルホコハク酸ナトリウムが挙げられる。 Examples of ionic surfactants include anionic surfactants such as alkyl sulfates, alkylbenzenesulfonates, and alkyl phosphates; cationic surfactants such as alkyltrimethylammonium salts and dialkyldimethylammonium salts; and amphoteric surfactants such as alkylcarboxybetaines.
Anionic surfactants include sodium di(2-ethylhexyl)sulfosuccinate.
抗菌部は、香料を含んでいてもよい。香料の種類は制限されず、抗菌性等の本発明の効果を損なわない香料を選択することが好ましい。
The antibacterial portion may contain a fragrance. There are no limitations on the type of fragrance, and it is preferable to select a fragrance that does not impair the effects of the present invention, such as antibacterial properties.
抗菌フィルタにおける抗菌部の含有量は、特に制限されないが、抗菌フィルタの総質量に対して、0.05~2.0質量%が好ましく、0.1~0.7質量%がより好ましい。
抗菌部の含有量は、後述する抗菌部形成用組成物が含んでいてもよい溶媒に抗菌フィルタを浸漬することにより抗菌部の除去を行い、除去前後にフィルタの重量を測定することにより、測定結果から算出できる。 The content of the antibacterial portion in the antibacterial filter is not particularly limited, but is preferably 0.05 to 2.0 mass %, more preferably 0.1 to 0.7 mass %, relative to the total mass of the antibacterial filter.
The content of the antibacterial portion can be calculated from the measurement results by removing the antibacterial portion by immersing the antibacterial filter in a solvent that may be contained in the composition for forming the antibacterial portion described below, and measuring the weight of the filter before and after removal.
抗菌部の含有量は、後述する抗菌部形成用組成物が含んでいてもよい溶媒に抗菌フィルタを浸漬することにより抗菌部の除去を行い、除去前後にフィルタの重量を測定することにより、測定結果から算出できる。 The content of the antibacterial portion in the antibacterial filter is not particularly limited, but is preferably 0.05 to 2.0 mass %, more preferably 0.1 to 0.7 mass %, relative to the total mass of the antibacterial filter.
The content of the antibacterial portion can be calculated from the measurement results by removing the antibacterial portion by immersing the antibacterial filter in a solvent that may be contained in the composition for forming the antibacterial portion described below, and measuring the weight of the filter before and after removal.
〔フィルタユニット〕
本発明の抗菌フィルタは、必要に応じて、抗菌フィルタの周縁を囲むように抗菌フィルタを支持する枠体(支持枠)を設けて、フィルタユニットとして用いてもよい。抗菌フィルタを支持する枠体としては、抗菌フィルタの用途等に応じ、金属製又は樹脂製の部材が用いられる。樹脂製の枠体を用いる場合には、射出成形法により枠体を成形すると同時にこの枠体に抗菌フィルタを固定してもよい。
また、フィルタ部と支持枠とを備えるフィルタユニットを作製した後、後述する方法によりフィルタ部上に抗菌部を設けてもよい。 [Filter unit]
The antibacterial filter of the present invention may be used as a filter unit by providing a frame (support frame) that supports the antibacterial filter so as to surround the periphery of the antibacterial filter, if necessary. As the frame that supports the antibacterial filter, a metal or resin member is used depending on the application of the antibacterial filter. When a resin frame is used, the antibacterial filter may be fixed to the frame at the same time as the frame is molded by injection molding.
Furthermore, after a filter unit including a filter portion and a support frame is produced, an antibacterial portion may be provided on the filter portion by the method described below.
本発明の抗菌フィルタは、必要に応じて、抗菌フィルタの周縁を囲むように抗菌フィルタを支持する枠体(支持枠)を設けて、フィルタユニットとして用いてもよい。抗菌フィルタを支持する枠体としては、抗菌フィルタの用途等に応じ、金属製又は樹脂製の部材が用いられる。樹脂製の枠体を用いる場合には、射出成形法により枠体を成形すると同時にこの枠体に抗菌フィルタを固定してもよい。
また、フィルタ部と支持枠とを備えるフィルタユニットを作製した後、後述する方法によりフィルタ部上に抗菌部を設けてもよい。 [Filter unit]
The antibacterial filter of the present invention may be used as a filter unit by providing a frame (support frame) that supports the antibacterial filter so as to surround the periphery of the antibacterial filter, if necessary. As the frame that supports the antibacterial filter, a metal or resin member is used depending on the application of the antibacterial filter. When a resin frame is used, the antibacterial filter may be fixed to the frame at the same time as the frame is molded by injection molding.
Furthermore, after a filter unit including a filter portion and a support frame is produced, an antibacterial portion may be provided on the filter portion by the method described below.
〔抗菌フィルタの性能等〕
本発明の抗菌フィルタは、以下の性能を有することが好ましい。 [Antibacterial filter performance, etc.]
The antibacterial filter of the present invention preferably has the following properties.
本発明の抗菌フィルタは、以下の性能を有することが好ましい。 [Antibacterial filter performance, etc.]
The antibacterial filter of the present invention preferably has the following properties.
<粒子捕集率>
抗菌フィルタは、捕集性能がより優れる点で、JIS B 9927-5:2022附属書Cに規定される手順に従って除電された状態の抗菌フィルタに対して、風速5.3cm/sの条件で粒径が0.3μmである粒子を通過させた際の粒子捕集率が、99.95%以上であることが好ましく、99.97%以上であることがより好ましい。粒子捕集率は、100%であってよい。
抗菌フィルタの粒子捕集率は、上記の試験Aに準じた方法により測定できる。 <Particle collection rate>
The antibacterial filter has a more excellent particle collection performance, and when particles having a particle size of 0.3 μm are passed through the antibacterial filter in a state in which static electricity has been removed according to the procedure specified in JIS B 9927-5:2022, Appendix C, at a wind speed of 5.3 cm/s, the particle collection efficiency is preferably 99.95% or more, and more preferably 99.97% or more. The particle collection efficiency may be 100%.
The particle capture rate of the antibacterial filter can be measured by a method similar to Test A above.
抗菌フィルタは、捕集性能がより優れる点で、JIS B 9927-5:2022附属書Cに規定される手順に従って除電された状態の抗菌フィルタに対して、風速5.3cm/sの条件で粒径が0.3μmである粒子を通過させた際の粒子捕集率が、99.95%以上であることが好ましく、99.97%以上であることがより好ましい。粒子捕集率は、100%であってよい。
抗菌フィルタの粒子捕集率は、上記の試験Aに準じた方法により測定できる。 <Particle collection rate>
The antibacterial filter has a more excellent particle collection performance, and when particles having a particle size of 0.3 μm are passed through the antibacterial filter in a state in which static electricity has been removed according to the procedure specified in JIS B 9927-5:2022, Appendix C, at a wind speed of 5.3 cm/s, the particle collection efficiency is preferably 99.95% or more, and more preferably 99.97% or more. The particle collection efficiency may be 100%.
The particle capture rate of the antibacterial filter can be measured by a method similar to Test A above.
<初期圧力損失>
抗菌フィルタの初期圧力損失は、特に制限されないが、50~150Paが好ましく、60~100Paがより好ましい。
ここで、初期圧力損失とは、未使用の抗菌フィルタに対してJIS B 9927:1999の附属書の「3.2圧力損失試験」に記載されている方法に従って清浄な空気を用いて測定される値である。
抗菌フィルタの初期圧力損失は、例えば、フィルタ部を構成するフィルタろ材の構造及び材料、並びに、フィルタ部のひだ形状等を適宜選択することによって調整できる。 <Initial pressure loss>
The initial pressure loss of the antibacterial filter is not particularly limited, but is preferably 50 to 150 Pa, and more preferably 60 to 100 Pa.
Here, the initial pressure loss is a value measured on an unused antibacterial filter using clean air according to the method described in "3.2 Pressure Loss Test" in the appendix of JIS B 9927:1999.
The initial pressure loss of the antibacterial filter can be adjusted by, for example, appropriately selecting the structure and material of the filter medium constituting the filter portion, and the pleat shape of the filter portion.
抗菌フィルタの初期圧力損失は、特に制限されないが、50~150Paが好ましく、60~100Paがより好ましい。
ここで、初期圧力損失とは、未使用の抗菌フィルタに対してJIS B 9927:1999の附属書の「3.2圧力損失試験」に記載されている方法に従って清浄な空気を用いて測定される値である。
抗菌フィルタの初期圧力損失は、例えば、フィルタ部を構成するフィルタろ材の構造及び材料、並びに、フィルタ部のひだ形状等を適宜選択することによって調整できる。 <Initial pressure loss>
The initial pressure loss of the antibacterial filter is not particularly limited, but is preferably 50 to 150 Pa, and more preferably 60 to 100 Pa.
Here, the initial pressure loss is a value measured on an unused antibacterial filter using clean air according to the method described in "3.2 Pressure Loss Test" in the appendix of JIS B 9927:1999.
The initial pressure loss of the antibacterial filter can be adjusted by, for example, appropriately selecting the structure and material of the filter medium constituting the filter portion, and the pleat shape of the filter portion.
抗菌フィルタの形状及びサイズは特に制限されず、用途及び/又は組み込まれる装置によって適宜調整される。
The shape and size of the antibacterial filter are not particularly limited and may be adjusted as appropriate depending on the application and/or the device in which it is incorporated.
〔抗菌フィルタの製造方法〕
本発明の抗菌フィルタの製造方法としては、例えば、上記フィルタ部に、後述する抗菌部形成用組成物を接触させることにより、フィルタ部上に抗菌部を形成する方法が挙げられる。上記抗菌部形成用組成物をフィルタ部に接触させて抗菌部を形成することにより、抗菌フィルタを通過する空気に存在する菌及びウイルスを捕集して空気を清浄化するだけでなく、捕集した菌及びウイルスを不活化する機能に優れた抗菌フィルタを製造できる。
即ち、本発明は、上記要件Aを満たすフィルタに、銀系抗菌剤と、シリケート系化合物前駆体とを含む抗菌部形成用組成物を接触させる工程を有する、抗菌フィルタの製造方法を含む。
以下、本発明の抗菌フィルタの製造方法について、より詳しく説明する。
なお、本発明の抗菌フィルタの製造方法における要件Aを満たすフィルタについては、好ましい態様も含めて既に説明したフィルタ部と同じである。 [Method of manufacturing antibacterial filter]
An example of a method for producing the antibacterial filter of the present invention is a method in which an antibacterial portion is formed on the filter portion by contacting the filter portion with an antibacterial portion-forming composition described below. By contacting the filter portion with the antibacterial portion-forming composition to form an antibacterial portion, an antibacterial filter can be produced that not only purifies the air by capturing bacteria and viruses present in the air passing through the antibacterial filter, but also has an excellent function of inactivating the captured bacteria and viruses.
That is, the present invention includes a method for producing an antibacterial filter, comprising the step of contacting a filter satisfying the above requirement A with a composition for forming an antibacterial portion, the composition containing a silver-based antibacterial agent and a silicate-based compound precursor.
The method for producing the antibacterial filter of the present invention will be described in more detail below.
The filter that satisfies requirement A in the manufacturing method of the antibacterial filter of the present invention is the same as the filter portion already explained, including the preferred embodiments.
本発明の抗菌フィルタの製造方法としては、例えば、上記フィルタ部に、後述する抗菌部形成用組成物を接触させることにより、フィルタ部上に抗菌部を形成する方法が挙げられる。上記抗菌部形成用組成物をフィルタ部に接触させて抗菌部を形成することにより、抗菌フィルタを通過する空気に存在する菌及びウイルスを捕集して空気を清浄化するだけでなく、捕集した菌及びウイルスを不活化する機能に優れた抗菌フィルタを製造できる。
即ち、本発明は、上記要件Aを満たすフィルタに、銀系抗菌剤と、シリケート系化合物前駆体とを含む抗菌部形成用組成物を接触させる工程を有する、抗菌フィルタの製造方法を含む。
以下、本発明の抗菌フィルタの製造方法について、より詳しく説明する。
なお、本発明の抗菌フィルタの製造方法における要件Aを満たすフィルタについては、好ましい態様も含めて既に説明したフィルタ部と同じである。 [Method of manufacturing antibacterial filter]
An example of a method for producing the antibacterial filter of the present invention is a method in which an antibacterial portion is formed on the filter portion by contacting the filter portion with an antibacterial portion-forming composition described below. By contacting the filter portion with the antibacterial portion-forming composition to form an antibacterial portion, an antibacterial filter can be produced that not only purifies the air by capturing bacteria and viruses present in the air passing through the antibacterial filter, but also has an excellent function of inactivating the captured bacteria and viruses.
That is, the present invention includes a method for producing an antibacterial filter, comprising the step of contacting a filter satisfying the above requirement A with a composition for forming an antibacterial portion, the composition containing a silver-based antibacterial agent and a silicate-based compound precursor.
The method for producing the antibacterial filter of the present invention will be described in more detail below.
The filter that satisfies requirement A in the manufacturing method of the antibacterial filter of the present invention is the same as the filter portion already explained, including the preferred embodiments.
<抗菌部形成用組成物(組成物A)>
まず、抗菌フィルタの製造に用いる抗菌部形成用組成物(以下、「組成物A」ともいう。)について説明する。
組成物Aは、銀系抗菌剤と、シリケート系化合物前駆体とを少なくとも含む。組成物Aに含まれる銀系抗菌剤については、好ましい態様も含めて、既に説明した通りである。 <Composition for forming antibacterial part (composition A)>
First, the antibacterial portion-forming composition (hereinafter, also referred to as "composition A") used in the production of the antibacterial filter will be described.
Composition A contains at least a silver-based antibacterial agent and a silicate-based compound precursor. The silver-based antibacterial agent contained in composition A, including preferred embodiments thereof, is as already described above.
まず、抗菌フィルタの製造に用いる抗菌部形成用組成物(以下、「組成物A」ともいう。)について説明する。
組成物Aは、銀系抗菌剤と、シリケート系化合物前駆体とを少なくとも含む。組成物Aに含まれる銀系抗菌剤については、好ましい態様も含めて、既に説明した通りである。 <Composition for forming antibacterial part (composition A)>
First, the antibacterial portion-forming composition (hereinafter, also referred to as "composition A") used in the production of the antibacterial filter will be described.
Composition A contains at least a silver-based antibacterial agent and a silicate-based compound precursor. The silver-based antibacterial agent contained in composition A, including preferred embodiments thereof, is as already described above.
(シリケート系化合物前駆体)
シリケート系化合物前駆体としては、例えば、加水分解及び加水分解縮合の一方又は両者を経て上記シリケート系化合物となる化合物が挙げられる。即ち、シリケート系化合物は、シリケート系化合物前駆体の加水分解物又は加水分解縮合物であってよい。 (Silicate compound precursor)
Examples of the silicate-based compound precursor include compounds that become the above-mentioned silicate-based compounds through one or both of hydrolysis and hydrolysis condensation. That is, the silicate-based compound may be a hydrolysate or hydrolysis condensate of a silicate-based compound precursor.
シリケート系化合物前駆体としては、例えば、加水分解及び加水分解縮合の一方又は両者を経て上記シリケート系化合物となる化合物が挙げられる。即ち、シリケート系化合物は、シリケート系化合物前駆体の加水分解物又は加水分解縮合物であってよい。 (Silicate compound precursor)
Examples of the silicate-based compound precursor include compounds that become the above-mentioned silicate-based compounds through one or both of hydrolysis and hydrolysis condensation. That is, the silicate-based compound may be a hydrolysate or hydrolysis condensate of a silicate-based compound precursor.
シリケート系化合物前駆体としては、上記式(1)で表される化合物、その加水分解物、及び、その加水分解縮合物からなる群より選ばれる少なくとも1種が挙げられる。
式(1)で表される化合物、その加水分解物、及び、その加水分解縮合物については、それぞれの好ましい態様も含めて、既に説明した通りである。 The silicate compound precursor may be at least one selected from the group consisting of the compound represented by the above formula (1), its hydrolysate, and its hydrolyzed condensate.
The compound represented by formula (1), its hydrolysate, and its hydrolyzed condensate are as already explained, including their respective preferred embodiments.
式(1)で表される化合物、その加水分解物、及び、その加水分解縮合物については、それぞれの好ましい態様も含めて、既に説明した通りである。 The silicate compound precursor may be at least one selected from the group consisting of the compound represented by the above formula (1), its hydrolysate, and its hydrolyzed condensate.
The compound represented by formula (1), its hydrolysate, and its hydrolyzed condensate are as already explained, including their respective preferred embodiments.
組成物Aにおいて、式(1)で表される化合物は、水成分と共に混合されることにより、少なくとも一部が加水分解された状態となる。式(1)で表される化合物の加水分解物は、式(1)で表される化合物を水成分と反応させ、ケイ素に結合したOR基をヒドロキシ基に変化させることにより得られる。加水分解に際しては必ずしも全てのOR基が反応する必要はないが、塗布後に親水性を発揮するためにはなるべく多くのOR基が加水分解されることが好ましい。また、加水分解に際して最低限必要な水成分の量は式(1)で表される化合物のOR基と等しいモル量となるが、反応を円滑に進めるには大過剰の量の水が存在することが好ましい。
上記シリケート系化合物前駆体の加水分解反応及び縮合反応は室温でも進行するが、反応促進のために加温してもよい。また、反応時間は長い方がより反応が進むため好ましい。また、触媒の存在下であれば半日程度でも加水分解物を得ることが可能である。 In composition A, the compound represented by formula (1) is mixed with water to be at least partially hydrolyzed. The hydrolyzate of the compound represented by formula (1) is obtained by reacting the compound represented by formula (1) with water to convert the OR group bonded to silicon to a hydroxy group. It is not necessary for all the OR groups to react during hydrolysis, but it is preferable that as many OR groups as possible are hydrolyzed in order to exhibit hydrophilicity after application. In addition, the minimum amount of water required during hydrolysis is the same molar amount as the OR group of the compound represented by formula (1), but it is preferable that a large excess of water is present in order to smoothly proceed with the reaction.
The hydrolysis and condensation reactions of the silicate compound precursor proceed at room temperature, but may be heated to accelerate the reaction. A longer reaction time is preferable because the reaction proceeds more quickly. In addition, in the presence of a catalyst, it is possible to obtain a hydrolyzate in about half a day.
上記シリケート系化合物前駆体の加水分解反応及び縮合反応は室温でも進行するが、反応促進のために加温してもよい。また、反応時間は長い方がより反応が進むため好ましい。また、触媒の存在下であれば半日程度でも加水分解物を得ることが可能である。 In composition A, the compound represented by formula (1) is mixed with water to be at least partially hydrolyzed. The hydrolyzate of the compound represented by formula (1) is obtained by reacting the compound represented by formula (1) with water to convert the OR group bonded to silicon to a hydroxy group. It is not necessary for all the OR groups to react during hydrolysis, but it is preferable that as many OR groups as possible are hydrolyzed in order to exhibit hydrophilicity after application. In addition, the minimum amount of water required during hydrolysis is the same molar amount as the OR group of the compound represented by formula (1), but it is preferable that a large excess of water is present in order to smoothly proceed with the reaction.
The hydrolysis and condensation reactions of the silicate compound precursor proceed at room temperature, but may be heated to accelerate the reaction. A longer reaction time is preferable because the reaction proceeds more quickly. In addition, in the presence of a catalyst, it is possible to obtain a hydrolyzate in about half a day.
組成物Aにおけるシリケート系化合物前駆体の含有量は、特に制限されないが、組成物全質量に対して、0.10~0.50質量%が好ましく、0.10~0.40質量%がより好ましく、0.20~0.31質量%が更に好ましい。
組成物Aの全固形分に対するシリケート系化合物前駆体の好ましい含有量は、上述した抗菌部に対するシリケート系化合物の好ましい含有量と同じであってよい。
なお、固形分とは、組成物中の溶媒を除いた成分を意図する。なお、溶媒以外の成分の性状が液体状であっても、固形分として計算する。 The content of the silicate compound precursor in composition A is not particularly limited, but is preferably 0.10 to 0.50 mass %, more preferably 0.10 to 0.40 mass %, and even more preferably 0.20 to 0.31 mass %, based on the total mass of the composition.
The preferred content of the silicate-based compound precursor relative to the total solid content of the composition A may be the same as the preferred content of the silicate-based compound relative to the antibacterial portion described above.
The solid content refers to the components in the composition excluding the solvent. Even if the components other than the solvent are in a liquid state, they are counted as solids.
組成物Aの全固形分に対するシリケート系化合物前駆体の好ましい含有量は、上述した抗菌部に対するシリケート系化合物の好ましい含有量と同じであってよい。
なお、固形分とは、組成物中の溶媒を除いた成分を意図する。なお、溶媒以外の成分の性状が液体状であっても、固形分として計算する。 The content of the silicate compound precursor in composition A is not particularly limited, but is preferably 0.10 to 0.50 mass %, more preferably 0.10 to 0.40 mass %, and even more preferably 0.20 to 0.31 mass %, based on the total mass of the composition.
The preferred content of the silicate-based compound precursor relative to the total solid content of the composition A may be the same as the preferred content of the silicate-based compound relative to the antibacterial portion described above.
The solid content refers to the components in the composition excluding the solvent. Even if the components other than the solvent are in a liquid state, they are counted as solids.
(溶媒)
組成物Aは、溶媒を含んでいてもよく、溶媒を含むことが好ましい。
溶媒の種類は特に制限されず、水及び有機溶媒が挙げられる。
水は、精製水であることが好ましく、蒸留水、イオン交換水、RO(Reverse Osmosis)水、純水、又は、超純水であることがより好ましい。なかでも、抗菌剤の安定性の点で、イオン交換水であることが更に好ましい。
水の電気伝導率は、0.1~0.2mS/mであることが好ましい。 (solvent)
Composition A may contain a solvent, and preferably contains a solvent.
The type of the solvent is not particularly limited, and examples thereof include water and organic solvents.
The water is preferably purified water, more preferably distilled water, ion-exchanged water, RO (reverse osmosis) water, pure water, or ultrapure water, and is more preferably ion-exchanged water in terms of the stability of the antibacterial agent.
The electrical conductivity of the water is preferably 0.1 to 0.2 mS/m.
組成物Aは、溶媒を含んでいてもよく、溶媒を含むことが好ましい。
溶媒の種類は特に制限されず、水及び有機溶媒が挙げられる。
水は、精製水であることが好ましく、蒸留水、イオン交換水、RO(Reverse Osmosis)水、純水、又は、超純水であることがより好ましい。なかでも、抗菌剤の安定性の点で、イオン交換水であることが更に好ましい。
水の電気伝導率は、0.1~0.2mS/mであることが好ましい。 (solvent)
Composition A may contain a solvent, and preferably contains a solvent.
The type of the solvent is not particularly limited, and examples thereof include water and organic solvents.
The water is preferably purified water, more preferably distilled water, ion-exchanged water, RO (reverse osmosis) water, pure water, or ultrapure water, and is more preferably ion-exchanged water in terms of the stability of the antibacterial agent.
The electrical conductivity of the water is preferably 0.1 to 0.2 mS/m.
有機溶媒としては、例えば、メタノール、エタノール、n-プロパノール、イソプロパノール、n-ブタノール、イソブタノール、sec-ブタノール、tert-ブタノール、n-ペンタノール、イソペンタノール、フェニルエチルアルコール、カプリルアルコール、ラウリルアルコール、及び、ミリスチルアルコール等のアルコール系溶媒;メチルセロソルブ、エチルセロソルブ、エチレングリコールジメチルエーテル、エチレングリコールジエチルエーテル、プロピレングリコールモノメチルエーテル、プロピレングリコールモノエチルエーテル、プロピレングリコールモノプロピルエーテル、プロピレングリコールジメチルエーテル、プロピレングリコールジエチルエーテル、エチレングリコールモノブチルエーテル、ジエチレングリコールモノブチルエーテル、トリエチレングリコールモノブチルエーテル、テトラエチレングリコールモノブチルエーテル、及び、ジプロピレングリコールモノブチルエーテル等のグリコールエーテル系溶媒;ベンゼン、トルエン、キシレン、及び、エチルベンゼン等の芳香族炭化水素系溶媒;シクロペンタン、シクロヘキサン、メチルシクロヘキサン、及び、エチルシクロヘキサン等の脂環族炭化水素系溶媒;テトラヒドロフラン、ジオキサン、ジイソプロピルエーテル、及び、ジ-n-ブチルエーテル等のエーテル系溶媒;アセトン、メチルエチルケトン、及び、メチルイソブチルケトン等のケトン系溶媒;酢酸メチル、酢酸エチル、酢酸n-プロピル、酢酸イソプロピル、酢酸n-ブチル、酢酸イソブチル、酢酸n-アミル、酢酸イソアミル、酢酸ヘキシル、プロピオン酸エチル、及び、プロピオン酸ブチル等のエステル系溶媒;10質量%安息香酸デナトニウムアルコール溶液、ゲラニオール、八アセチル化ショ糖、ブルシン、リナロール、リナリールアセテート、及び、酢酸等の親水性溶媒;が挙げられる。
Examples of organic solvents include alcohol-based solvents such as methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, sec-butanol, tert-butanol, n-pentanol, isopentanol, phenylethyl alcohol, capryl alcohol, lauryl alcohol, and myristyl alcohol; methyl cellosolve, ethyl cellosolve, ethylene glycol dimethyl ether, ethylene glycol diethyl ether, propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol monopropyl ether, propylene glycol dimethyl ether, propylene glycol diethyl ether, ethylene glycol monobutyl ether, diethylene glycol monobutyl ether, triethylene glycol monobutyl ether, tetraethylene glycol monobutyl ether, and diethylene glycol monobutyl ether. glycol ether solvents such as propylene glycol monobutyl ether; aromatic hydrocarbon solvents such as benzene, toluene, xylene, and ethylbenzene; alicyclic hydrocarbon solvents such as cyclopentane, cyclohexane, methylcyclohexane, and ethylcyclohexane; ether solvents such as tetrahydrofuran, dioxane, diisopropyl ether, and di-n-butyl ether; ketone solvents such as acetone, methyl ethyl ketone, and methyl isobutyl ketone; ester solvents such as methyl acetate, ethyl acetate, n-propyl acetate, isopropyl acetate, n-butyl acetate, isobutyl acetate, n-amyl acetate, isoamyl acetate, hexyl acetate, ethyl propionate, and butyl propionate; hydrophilic solvents such as 10% by mass denatonium benzoate alcohol solution, geraniol, octaacetylated sucrose, brucine, linalool, linalyl acetate, and acetic acid.
組成物Aの固形分量は特に制限されず、塗布性がより優れる点で、組成物全質量に対して、0.001~80質量%が好ましく、0.01~10質量%がより好ましく、0.1~5.0質量%が更に好ましく、0.1~1.0質量%が特に好ましい。上記固形分になるよう、組成物における溶媒の含有量を調整することが好ましい。
溶媒は1種を単独で用いても、2種以上を用いてもよい。 The solid content of the composition A is not particularly limited, and is preferably 0.001 to 80 mass%, more preferably 0.01 to 10 mass%, still more preferably 0.1 to 5.0 mass%, and particularly preferably 0.1 to 1.0 mass%, based on the total mass of the composition, in terms of superior coating properties. It is preferable to adjust the content of the solvent in the composition so as to obtain the above solid content.
The solvent may be used alone or in combination of two or more kinds.
溶媒は1種を単独で用いても、2種以上を用いてもよい。 The solid content of the composition A is not particularly limited, and is preferably 0.001 to 80 mass%, more preferably 0.01 to 10 mass%, still more preferably 0.1 to 5.0 mass%, and particularly preferably 0.1 to 1.0 mass%, based on the total mass of the composition, in terms of superior coating properties. It is preferable to adjust the content of the solvent in the composition so as to obtain the above solid content.
The solvent may be used alone or in combination of two or more kinds.
組成物Aは、病原体等の短期間の消毒性能がより優れる点で、アルコールを含むことが好ましい。アルコールとしては、上記のアルコール系溶媒が挙げられる。
組成物Aがアルコールを含む場合、その含有量は、組成物全質量に対して、82.0質量%以下が好ましい。下限は特に制限されないが、20質量%以上が好ましく、55.0質量%以上がより好ましい。
組成物Aが2種以上のアルコールを含む場合(例えば、エタノール及びイソプロパノールを使用する場合)、その合計量が上記範囲内であることが好ましい。
また、組成物Aがアルコールを含む場合、抗菌剤の凝集安定性がより優れる点で、溶媒として水を更に含むことが好ましい。 Composition A preferably contains alcohol, since it has better short-term disinfecting performance against pathogens, etc. Examples of the alcohol include the above-mentioned alcohol-based solvents.
When composition A contains an alcohol, the content thereof is preferably 82.0% by mass or less based on the total mass of the composition. Although there is no particular lower limit, the content is preferably 20% by mass or more, and more preferably 55.0% by mass or more.
When composition A contains two or more types of alcohol (for example, when ethanol and isopropanol are used), the total amount thereof is preferably within the above range.
In addition, when composition A contains alcohol, it is preferable that composition A further contains water as a solvent in that the aggregation stability of the antibacterial agent is superior.
組成物Aがアルコールを含む場合、その含有量は、組成物全質量に対して、82.0質量%以下が好ましい。下限は特に制限されないが、20質量%以上が好ましく、55.0質量%以上がより好ましい。
組成物Aが2種以上のアルコールを含む場合(例えば、エタノール及びイソプロパノールを使用する場合)、その合計量が上記範囲内であることが好ましい。
また、組成物Aがアルコールを含む場合、抗菌剤の凝集安定性がより優れる点で、溶媒として水を更に含むことが好ましい。 Composition A preferably contains alcohol, since it has better short-term disinfecting performance against pathogens, etc. Examples of the alcohol include the above-mentioned alcohol-based solvents.
When composition A contains an alcohol, the content thereof is preferably 82.0% by mass or less based on the total mass of the composition. Although there is no particular lower limit, the content is preferably 20% by mass or more, and more preferably 55.0% by mass or more.
When composition A contains two or more types of alcohol (for example, when ethanol and isopropanol are used), the total amount thereof is preferably within the above range.
In addition, when composition A contains alcohol, it is preferable that composition A further contains water as a solvent in that the aggregation stability of the antibacterial agent is superior.
(他の成分)
組成物Aは、上述した成分以外の他の成分を含んでいてもよい。
他の成分としては、例えば、シリケート系化合物前駆体の縮合を促進する触媒、分散剤、界面活性剤、重合開始剤、造膜剤、及び、香料が挙げられる。
上記の成分については、既に抗菌部に含まれてもよい他の成分として説明した通りである。 (Other ingredients)
Composition A may contain other components in addition to the components described above.
Examples of other components include a catalyst that promotes condensation of a silicate-based compound precursor, a dispersant, a surfactant, a polymerization initiator, a film-forming agent, and a fragrance.
The above components have already been explained as other components that may be contained in the antibacterial portion.
組成物Aは、上述した成分以外の他の成分を含んでいてもよい。
他の成分としては、例えば、シリケート系化合物前駆体の縮合を促進する触媒、分散剤、界面活性剤、重合開始剤、造膜剤、及び、香料が挙げられる。
上記の成分については、既に抗菌部に含まれてもよい他の成分として説明した通りである。 (Other ingredients)
Composition A may contain other components in addition to the components described above.
Examples of other components include a catalyst that promotes condensation of a silicate-based compound precursor, a dispersant, a surfactant, a polymerization initiator, a film-forming agent, and a fragrance.
The above components have already been explained as other components that may be contained in the antibacterial portion.
組成物Aが上記の他の成分を含む場合、それぞれの含有量は、公知の技術に基づいて、抗菌性等の本発明の効果を損なわない範囲で適宜調整される。
組成物Aが触媒を含む場合の触媒の含有量は、組成物全質量に対して、0.005~0.0025質量%が好ましく、0.011~0.019質量%がより好ましい。
組成物Aが粒子状の銀系抗菌剤を含む場合、組成物Aは分散剤を含むことが好ましい。組成物Aが分散剤を含む場合の分散剤の含有量は、組成物の全固形分に対して、40質量%以下が好ましく、20質量%以下がより好ましく、10質量%以下が更に好ましい。下限値は特に制限されず、例えば組成物の全固形分に対して0.01質量%以上であってよい。 When composition A contains the other components described above, the content of each component is appropriately adjusted based on known techniques within a range that does not impair the effects of the present invention, such as antibacterial properties.
When composition A contains a catalyst, the content of the catalyst is preferably from 0.005 to 0.0025% by mass, and more preferably from 0.011 to 0.019% by mass, based on the total mass of the composition.
When composition A contains a particulate silver-based antibacterial agent, composition A preferably contains a dispersant. When composition A contains a dispersant, the content of the dispersant is preferably 40% by mass or less, more preferably 20% by mass or less, and even more preferably 10% by mass or less, based on the total solid content of the composition. The lower limit is not particularly limited, and may be, for example, 0.01% by mass or more based on the total solid content of the composition.
組成物Aが触媒を含む場合の触媒の含有量は、組成物全質量に対して、0.005~0.0025質量%が好ましく、0.011~0.019質量%がより好ましい。
組成物Aが粒子状の銀系抗菌剤を含む場合、組成物Aは分散剤を含むことが好ましい。組成物Aが分散剤を含む場合の分散剤の含有量は、組成物の全固形分に対して、40質量%以下が好ましく、20質量%以下がより好ましく、10質量%以下が更に好ましい。下限値は特に制限されず、例えば組成物の全固形分に対して0.01質量%以上であってよい。 When composition A contains the other components described above, the content of each component is appropriately adjusted based on known techniques within a range that does not impair the effects of the present invention, such as antibacterial properties.
When composition A contains a catalyst, the content of the catalyst is preferably from 0.005 to 0.0025% by mass, and more preferably from 0.011 to 0.019% by mass, based on the total mass of the composition.
When composition A contains a particulate silver-based antibacterial agent, composition A preferably contains a dispersant. When composition A contains a dispersant, the content of the dispersant is preferably 40% by mass or less, more preferably 20% by mass or less, and even more preferably 10% by mass or less, based on the total solid content of the composition. The lower limit is not particularly limited, and may be, for example, 0.01% by mass or more based on the total solid content of the composition.
組成物Aの塗布性が向上する作用を有することから、組成物Aは、界面活性剤を含むことが好ましい。組成物Aが界面活性剤を含む場合の界面活性剤の含有量は特に制限されないが、組成物の全固形分に対して、0.01質量%以上が好ましい。界面活性剤の含有量の上限値は特に制限されないが、組成物の全固形分に対して、10質量%以下が好ましく、7質量%以下がより好ましい。
界面活性剤は1種を単独で用いても、2種以上を用いてもよい。界面活性剤を2種以上用いる場合は、銀系抗菌剤の凝集安定性の点で、ノニオン系界面活性剤とアニオン系界面活性剤との組み合わせが好ましい。 Composition A preferably contains a surfactant because it has the effect of improving the coatability of composition A. When composition A contains a surfactant, the content of the surfactant is not particularly limited, but is preferably 0.01 mass% or more based on the total solid content of the composition. The upper limit of the content of the surfactant is not particularly limited, but is preferably 10 mass% or less, more preferably 7 mass% or less, based on the total solid content of the composition.
The surfactant may be used alone or in combination of two or more. When two or more surfactants are used, a combination of a nonionic surfactant and an anionic surfactant is preferred from the viewpoint of the aggregation stability of the silver-based antibacterial agent.
界面活性剤は1種を単独で用いても、2種以上を用いてもよい。界面活性剤を2種以上用いる場合は、銀系抗菌剤の凝集安定性の点で、ノニオン系界面活性剤とアニオン系界面活性剤との組み合わせが好ましい。 Composition A preferably contains a surfactant because it has the effect of improving the coatability of composition A. When composition A contains a surfactant, the content of the surfactant is not particularly limited, but is preferably 0.01 mass% or more based on the total solid content of the composition. The upper limit of the content of the surfactant is not particularly limited, but is preferably 10 mass% or less, more preferably 7 mass% or less, based on the total solid content of the composition.
The surfactant may be used alone or in combination of two or more. When two or more surfactants are used, a combination of a nonionic surfactant and an anionic surfactant is preferred from the viewpoint of the aggregation stability of the silver-based antibacterial agent.
組成物Aの調製方法は特に制限されず、上述した成分を適宜混合することによって調製できる。上記成分の混合の順番は特に制限されない。
The method for preparing composition A is not particularly limited, and it can be prepared by appropriately mixing the above-mentioned components. The order in which the above-mentioned components are mixed is not particularly limited.
<フィルタと組成物Aとの接触工程>
本発明の抗菌フィルタの製造方法では、要件Aを満たすフィルタに組成物Aを接触させる。この接触工程によって、フィルタを構成するろ材の表面(細孔表面を含む)に、銀系抗菌剤及びシリケート系化合物前駆体等が付着される。その後、フィルタに浸潤した溶媒が気化することによって、銀系抗菌剤及びシリケート系化合物を含み、フィルタ上に配置される抗菌部が形成される。 <Contacting the filter with composition A>
In the method for producing an antibacterial filter of the present invention, composition A is brought into contact with a filter that satisfies requirement A. This contact step causes the silver-based antibacterial agent and silicate-based compound precursor, etc., to adhere to the surface (including the pore surface) of the filter medium that constitutes the filter. Thereafter, the solvent that has infiltrated the filter is evaporated to form an antibacterial portion that contains the silver-based antibacterial agent and the silicate-based compound and is disposed on the filter.
本発明の抗菌フィルタの製造方法では、要件Aを満たすフィルタに組成物Aを接触させる。この接触工程によって、フィルタを構成するろ材の表面(細孔表面を含む)に、銀系抗菌剤及びシリケート系化合物前駆体等が付着される。その後、フィルタに浸潤した溶媒が気化することによって、銀系抗菌剤及びシリケート系化合物を含み、フィルタ上に配置される抗菌部が形成される。 <Contacting the filter with composition A>
In the method for producing an antibacterial filter of the present invention, composition A is brought into contact with a filter that satisfies requirement A. This contact step causes the silver-based antibacterial agent and silicate-based compound precursor, etc., to adhere to the surface (including the pore surface) of the filter medium that constitutes the filter. Thereafter, the solvent that has infiltrated the filter is evaporated to form an antibacterial portion that contains the silver-based antibacterial agent and the silicate-based compound and is disposed on the filter.
フィルタに組成物Aを接触させる工程としては、例えば、フィルタに組成物Aを塗布する工程、及び、フィルタを組成物Aに浸漬する工程が挙げられ、フィルタに組成物Aを塗布する塗布工程が好ましい。
上記塗布工程においてフィルタに組成物Aを塗布する方法としては、例えば、スプレー法、ロールコータ法、グラビアコータ法、スクリーン法、スピンコータ法、フローコータ法、インクジェット法、及び、ワイプ法が挙げられ、スプレー法が好ましい。中でも、エアガン(エアスプレーガン)を用いてフィルタに組成物Aを塗布することがより好ましい。 Examples of the step of contacting the filter with composition A include a step of applying composition A to the filter and a step of immersing the filter in composition A, and a step of applying composition A to the filter is preferred.
In the above-mentioned coating step, the method of coating the composition A on the filter includes, for example, a spray method, a roll coater method, a gravure coater method, a screen method, a spin coater method, a flow coater method, an inkjet method, and a wipe method, and the spray method is preferred. Among these, it is more preferred to coat the composition A on the filter using an air gun (air spray gun).
上記塗布工程においてフィルタに組成物Aを塗布する方法としては、例えば、スプレー法、ロールコータ法、グラビアコータ法、スクリーン法、スピンコータ法、フローコータ法、インクジェット法、及び、ワイプ法が挙げられ、スプレー法が好ましい。中でも、エアガン(エアスプレーガン)を用いてフィルタに組成物Aを塗布することがより好ましい。 Examples of the step of contacting the filter with composition A include a step of applying composition A to the filter and a step of immersing the filter in composition A, and a step of applying composition A to the filter is preferred.
In the above-mentioned coating step, the method of coating the composition A on the filter includes, for example, a spray method, a roll coater method, a gravure coater method, a screen method, a spin coater method, a flow coater method, an inkjet method, and a wipe method, and the spray method is preferred. Among these, it is more preferred to coat the composition A on the filter using an air gun (air spray gun).
上記塗布工程を実施する場合、フィルタへの組成物Aの塗布は1回のみであってもよいが、複数回行うことが好ましい。
より具体的には、フィルタに組成物Aを塗布し、乾燥して抗菌部を形成した後、再度、組成物Aを塗布し、乾燥して抗菌部を形成する処理を繰り返し実施することが好ましい。また、より均一な抗菌部が形成できる点で、フィルタが有する双方の主面に対して組成物Aの塗布を1回以上実施することが好ましい。
即ち、塗布工程において、一方の主面に対して組成物Aの塗布による抗菌部の形成を2回以上繰り返し実施するとともに、他方の主面に対して組成物Aの塗布による抗菌部の形成を2回以上繰り返し実施して、合計4回以上の塗布を実施することが好ましい。
上記の塗布工程においては、フィルタのそれぞれの主面に対する塗布の回数が、1~4回であることが好ましく、2~4回がより好ましく、2又は3回が更に好ましい。 When carrying out the above-mentioned coating step, the composition A may be applied to the filter only once, but it is preferable to carry out the coating a plurality of times.
More specifically, it is preferable to repeatedly apply composition A to the filter, dry it to form an antibacterial portion, and then apply composition A again and dry it to form the antibacterial portion. In addition, it is preferable to apply composition A to both main surfaces of the filter at least once in order to form a more uniform antibacterial portion.
That is, in the coating process, it is preferable to repeatedly apply composition A to one main surface to form an antibacterial portion at least two times, and to repeatedly apply composition A to the other main surface to form an antibacterial portion at least two times, for a total of four or more applications.
In the above coating step, the number of coatings on each main surface of the filter is preferably 1 to 4 times, more preferably 2 to 4 times, and even more preferably 2 or 3 times.
より具体的には、フィルタに組成物Aを塗布し、乾燥して抗菌部を形成した後、再度、組成物Aを塗布し、乾燥して抗菌部を形成する処理を繰り返し実施することが好ましい。また、より均一な抗菌部が形成できる点で、フィルタが有する双方の主面に対して組成物Aの塗布を1回以上実施することが好ましい。
即ち、塗布工程において、一方の主面に対して組成物Aの塗布による抗菌部の形成を2回以上繰り返し実施するとともに、他方の主面に対して組成物Aの塗布による抗菌部の形成を2回以上繰り返し実施して、合計4回以上の塗布を実施することが好ましい。
上記の塗布工程においては、フィルタのそれぞれの主面に対する塗布の回数が、1~4回であることが好ましく、2~4回がより好ましく、2又は3回が更に好ましい。 When carrying out the above-mentioned coating step, the composition A may be applied to the filter only once, but it is preferable to carry out the coating a plurality of times.
More specifically, it is preferable to repeatedly apply composition A to the filter, dry it to form an antibacterial portion, and then apply composition A again and dry it to form the antibacterial portion. In addition, it is preferable to apply composition A to both main surfaces of the filter at least once in order to form a more uniform antibacterial portion.
That is, in the coating process, it is preferable to repeatedly apply composition A to one main surface to form an antibacterial portion at least two times, and to repeatedly apply composition A to the other main surface to form an antibacterial portion at least two times, for a total of four or more applications.
In the above coating step, the number of coatings on each main surface of the filter is preferably 1 to 4 times, more preferably 2 to 4 times, and even more preferably 2 or 3 times.
塗布工程においてフィルタに塗布される組成物Aの塗布量は、フィルタの主面の面積に対して、50~1000mL/m2が好ましく、100~500mL/m2がより好ましく、150~300mL/m2が更に好ましい。なお、フィルタへの組成物Aの塗布を複数回行う場合、上記塗布量は、複数回の合計塗布量である。また、「フィルタの主面の面積」とは、フィルタの外形寸法から算出される面積を意味する。
The amount of composition A applied to the filter in the application step is preferably 50 to 1000 mL/ m2 , more preferably 100 to 500 mL/ m2 , and even more preferably 150 to 300 mL/ m2 , relative to the area of the main surface of the filter. When composition A is applied to the filter multiple times, the above-mentioned application amount is the total application amount of the multiple times. Moreover, the "area of the main surface of the filter" means the area calculated from the outer dimensions of the filter.
フィルタに組成物Aを接触させた後、溶媒の除去を促進するために加熱処理(乾燥処理)を行ってもよい。
加熱処理の条件は特に制限されず、例えば、加熱温度としては、50~200℃が好ましく、加熱時間としては、15~600秒間が好ましい。 After contacting the filter with Composition A, a heat treatment (drying treatment) may be carried out to promote removal of the solvent.
The conditions for the heat treatment are not particularly limited. For example, the heating temperature is preferably 50 to 200° C., and the heating time is preferably 15 to 600 seconds.
加熱処理の条件は特に制限されず、例えば、加熱温度としては、50~200℃が好ましく、加熱時間としては、15~600秒間が好ましい。 After contacting the filter with Composition A, a heat treatment (drying treatment) may be carried out to promote removal of the solvent.
The conditions for the heat treatment are not particularly limited. For example, the heating temperature is preferably 50 to 200° C., and the heating time is preferably 15 to 600 seconds.
〔用途〕
本発明の抗菌フィルタは、例えば、空気清浄機、エアコンディショナー、ビル用ファンコイルユニット、及び、クリーンルームの空調設備等に使用できる。特に、本発明の抗菌フィルタは、室内又は車内等の換気が困難な空間内において、病原体等の有害物質を除去し、空気を清浄化する機能を有する空気清浄機に用いられることにより、本発明の効果がより有効に発揮される。
また、本発明の抗菌フィルタは、人体に装着するマスクにも使用できる。 [Application]
The antibacterial filter of the present invention can be used, for example, in air purifiers, air conditioners, fan coil units for buildings, and air conditioning equipment for clean rooms, etc. In particular, the effects of the present invention can be more effectively exhibited by using the antibacterial filter of the present invention in an air purifier that has the function of removing harmful substances such as pathogens and purifying the air in spaces where ventilation is difficult, such as the inside of a room or a vehicle.
The antibacterial filter of the present invention can also be used in a mask that is worn on the human body.
本発明の抗菌フィルタは、例えば、空気清浄機、エアコンディショナー、ビル用ファンコイルユニット、及び、クリーンルームの空調設備等に使用できる。特に、本発明の抗菌フィルタは、室内又は車内等の換気が困難な空間内において、病原体等の有害物質を除去し、空気を清浄化する機能を有する空気清浄機に用いられることにより、本発明の効果がより有効に発揮される。
また、本発明の抗菌フィルタは、人体に装着するマスクにも使用できる。 [Application]
The antibacterial filter of the present invention can be used, for example, in air purifiers, air conditioners, fan coil units for buildings, and air conditioning equipment for clean rooms, etc. In particular, the effects of the present invention can be more effectively exhibited by using the antibacterial filter of the present invention in an air purifier that has the function of removing harmful substances such as pathogens and purifying the air in spaces where ventilation is difficult, such as the inside of a room or a vehicle.
The antibacterial filter of the present invention can also be used in a mask that is worn on the human body.
[空気清浄機]
本発明の抗菌フィルタの好ましい使用態様としては、本発明の抗菌フィルタを備える空気清浄機が挙げられる。
空気清浄機は、例えば、ケーシングと、ケーシングに設けられた吸気口及び排気口と、本発明の抗菌フィルタと、送風手段と、を備える。
ケーシング内では、吸気口から吸い込まれた空気が抗菌フィルタを通過した後、排気口から排出されるように流通路が設けられている。送風手段(例えばターボファン等)は、抗菌フィルタに対して、吸気口側(上流側)又は排気口側(下流側)に配置される。吸気口側に配置される送風手段は、ケーシング外の空気を吸気口を通過してケーシング内に吸い込む。排気口側に配置される送風手段により、ケーシング内の空気をケーシング外に吹き出す。送風手段は、吸気口側及び排気口側のそれぞれに配置されていてもよい。
このような空気清浄機において送風手段を稼動すると、ケーシング外の空気が吸気口を介してケーシング内に導入され、導入された空気が抗菌フィルタを通過することで清浄化し、次いで、清浄化された空気が排気口を介してケーシング外へと排出される。これにより、機外の空気を抗菌フィルタにより清浄化した後、再度機外に送り出す空気清浄機の機能が発揮される。 [Air cleaner]
A preferred embodiment of the antibacterial filter of the present invention is an air purifier equipped with the antibacterial filter of the present invention.
The air purifier comprises, for example, a casing, an air inlet and an air outlet provided in the casing, the antibacterial filter of the present invention, and air blowing means.
A flow passage is provided in the casing so that air drawn in from the intake port passes through the antibacterial filter and is then discharged from the exhaust port. The blowing means (e.g., turbo fan, etc.) is disposed on the intake port side (upstream side) or the exhaust port side (downstream side) with respect to the antibacterial filter. The blowing means disposed on the intake port side draws air outside the casing through the intake port into the casing. The blowing means disposed on the exhaust port side blows air inside the casing out of the casing. The blowing means may be disposed on both the intake port side and the exhaust port side.
When the blowing means of such an air purifier is operated, air outside the casing is introduced into the casing through the intake port, the introduced air is purified by passing through the antibacterial filter, and then the purified air is exhausted outside the casing through the exhaust port. This achieves the function of the air purifier, which purifies the air outside the machine through the antibacterial filter and then sends it out of the machine again.
本発明の抗菌フィルタの好ましい使用態様としては、本発明の抗菌フィルタを備える空気清浄機が挙げられる。
空気清浄機は、例えば、ケーシングと、ケーシングに設けられた吸気口及び排気口と、本発明の抗菌フィルタと、送風手段と、を備える。
ケーシング内では、吸気口から吸い込まれた空気が抗菌フィルタを通過した後、排気口から排出されるように流通路が設けられている。送風手段(例えばターボファン等)は、抗菌フィルタに対して、吸気口側(上流側)又は排気口側(下流側)に配置される。吸気口側に配置される送風手段は、ケーシング外の空気を吸気口を通過してケーシング内に吸い込む。排気口側に配置される送風手段により、ケーシング内の空気をケーシング外に吹き出す。送風手段は、吸気口側及び排気口側のそれぞれに配置されていてもよい。
このような空気清浄機において送風手段を稼動すると、ケーシング外の空気が吸気口を介してケーシング内に導入され、導入された空気が抗菌フィルタを通過することで清浄化し、次いで、清浄化された空気が排気口を介してケーシング外へと排出される。これにより、機外の空気を抗菌フィルタにより清浄化した後、再度機外に送り出す空気清浄機の機能が発揮される。 [Air cleaner]
A preferred embodiment of the antibacterial filter of the present invention is an air purifier equipped with the antibacterial filter of the present invention.
The air purifier comprises, for example, a casing, an air inlet and an air outlet provided in the casing, the antibacterial filter of the present invention, and air blowing means.
A flow passage is provided in the casing so that air drawn in from the intake port passes through the antibacterial filter and is then discharged from the exhaust port. The blowing means (e.g., turbo fan, etc.) is disposed on the intake port side (upstream side) or the exhaust port side (downstream side) with respect to the antibacterial filter. The blowing means disposed on the intake port side draws air outside the casing through the intake port into the casing. The blowing means disposed on the exhaust port side blows air inside the casing out of the casing. The blowing means may be disposed on both the intake port side and the exhaust port side.
When the blowing means of such an air purifier is operated, air outside the casing is introduced into the casing through the intake port, the introduced air is purified by passing through the antibacterial filter, and then the purified air is exhausted outside the casing through the exhaust port. This achieves the function of the air purifier, which purifies the air outside the machine through the antibacterial filter and then sends it out of the machine again.
本発明の抗菌フィルタは、綿埃等の塵を除くためのプレフィルタ、消臭性能を有する光触媒フィルタ等の脱臭フィルタ、及び、VOC吸着フィルタ等の公知のフィルタと組み合わせて用いてもよい。即ち、本発明の抗菌フィルタを備える空気清浄機は、少なくとも1つの上記フィルタを更に備えていてもよい。空気清浄機が上記フィルタを備える場合、抗菌フィルタに対して吸気口側に上記フィルタ(特にプレフィルタ)が配置されていることが好ましい。
The antibacterial filter of the present invention may be used in combination with a prefilter for removing dust such as cotton dust, a deodorizing filter such as a photocatalyst filter having deodorizing properties, and a known filter such as a VOC adsorption filter. That is, an air purifier equipped with the antibacterial filter of the present invention may further include at least one of the above filters. When the air purifier includes the above filter, it is preferable that the above filter (particularly the prefilter) is disposed on the air intake side relative to the antibacterial filter.
以下に実施例に基づいて本発明を更に詳細に説明する。以下の実施例に示す材料、使用量、割合、処理内容、及び、処理手順は、本発明の趣旨を逸脱しない限り適宜変更することができる。したがって、本発明の範囲は以下に示す実施例により制限的に解釈されるべきものではない。
The present invention will be described in more detail below based on examples. The materials, amounts used, ratios, processing contents, and processing procedures shown in the following examples can be changed as appropriate without departing from the spirit of the present invention. Therefore, the scope of the present invention should not be interpreted as being limited by the examples shown below.
[実施例1]
<組成物A1の調製>
容器内でエタノール(760g)を撹拌しながら、シロキサン化合物(三菱化学株式会社製「MKC(登録商標)シリケートMS-51」、式(X)で表される化合物に該当。n=2~100)(2.9g)、アルミキレートD(川研ファインケミカル株式会社製、アルミニウムビス(エチルアセトアセテート)モノ(アセチルアセトネート)、エタノール希釈:固形分濃度76質量%)(0.23g)、イソプロピルアルコール(IPA)(38.5g)、ノニオン性界面活性剤(日本エマルジョン株式会社製「エマレックス715」、イオン交換水希釈:固形分濃度0.5質量%)(47.3g)、アニオン性界面活性剤(ジ(2-エチルヘキシル)スルホコハク酸ナトリウム、イオン交換水希釈:固形分濃度1.0質量%)(2.36g)、イオン交換水(128g)を順次加えた後、事前に調製した抗菌剤粒子溶液21.01gを加えて、30分間撹拌して、組成物A1を得た。
抗菌剤粒子溶液は、容器内でエタノール(19.6g)を撹拌しながら、分散剤(BYK社製「DISPERBYK-180」)(0.61g)を添加後、15分間撹拌し、続いて、銀担持ガラス分散液(富士ケミカル株式会社製「バクテライトMP-103DV」)(0.80g)を加えて、15分間撹拌して調製した。上記銀担持ガラス分散液は、リン酸塩ガラスからなる無機酸化物担体に銀が担持してなる銀担持無機酸化物を含む分散液であり、分散液の固形分濃度は25質量%であり、銀担持担体の全質量に対する銀の含有量は2質量%であった。 [Example 1]
<Preparation of Composition A1>
In a container, while stirring ethanol (760 g), a siloxane compound ("MKC (registered trademark) Silicate MS-51" manufactured by Mitsubishi Chemical Corporation, which corresponds to a compound represented by formula (X); n = 2 to 100) (2.9 g), aluminum chelate D (aluminum bis(ethylacetoacetate) mono(acetylacetonate) manufactured by Kawaken Fine Chemical Co., Ltd., diluted with ethanol: solid content concentration 76% by mass) (0.23 g), isopropyl alcohol (IPA) ( 38.5 g), a nonionic surfactant ("EMALEX 715" manufactured by Nippon Emulsion Co., Ltd., diluted with ion-exchanged water: solids concentration 0.5% by mass) (47.3 g), an anionic surfactant (sodium di(2-ethylhexyl)sulfosuccinate, diluted with ion-exchanged water: solids concentration 1.0% by mass) (2.36 g), and ion-exchanged water (128 g) were added in that order, and then 21.01 g of the antibacterial particle solution prepared in advance was added and stirred for 30 minutes, thereby obtaining composition A1.
The antibacterial particle solution was prepared by adding a dispersant (BYK Corporation's "DISPERBYK-180") (0.61 g) while stirring ethanol (19.6 g) in a container, followed by stirring for 15 minutes, and then adding a silver-loaded glass dispersion (Fuji Chemical Co., Ltd.'s "Bacterite MP-103DV") (0.80 g) and stirring for 15 minutes. The silver-loaded glass dispersion was a dispersion containing a silver-loaded inorganic oxide in which silver was loaded on an inorganic oxide carrier made of phosphate glass, the solids concentration of the dispersion was 25 mass%, and the silver content relative to the total mass of the silver-loaded carrier was 2 mass%.
<組成物A1の調製>
容器内でエタノール(760g)を撹拌しながら、シロキサン化合物(三菱化学株式会社製「MKC(登録商標)シリケートMS-51」、式(X)で表される化合物に該当。n=2~100)(2.9g)、アルミキレートD(川研ファインケミカル株式会社製、アルミニウムビス(エチルアセトアセテート)モノ(アセチルアセトネート)、エタノール希釈:固形分濃度76質量%)(0.23g)、イソプロピルアルコール(IPA)(38.5g)、ノニオン性界面活性剤(日本エマルジョン株式会社製「エマレックス715」、イオン交換水希釈:固形分濃度0.5質量%)(47.3g)、アニオン性界面活性剤(ジ(2-エチルヘキシル)スルホコハク酸ナトリウム、イオン交換水希釈:固形分濃度1.0質量%)(2.36g)、イオン交換水(128g)を順次加えた後、事前に調製した抗菌剤粒子溶液21.01gを加えて、30分間撹拌して、組成物A1を得た。
抗菌剤粒子溶液は、容器内でエタノール(19.6g)を撹拌しながら、分散剤(BYK社製「DISPERBYK-180」)(0.61g)を添加後、15分間撹拌し、続いて、銀担持ガラス分散液(富士ケミカル株式会社製「バクテライトMP-103DV」)(0.80g)を加えて、15分間撹拌して調製した。上記銀担持ガラス分散液は、リン酸塩ガラスからなる無機酸化物担体に銀が担持してなる銀担持無機酸化物を含む分散液であり、分散液の固形分濃度は25質量%であり、銀担持担体の全質量に対する銀の含有量は2質量%であった。 [Example 1]
<Preparation of Composition A1>
In a container, while stirring ethanol (760 g), a siloxane compound ("MKC (registered trademark) Silicate MS-51" manufactured by Mitsubishi Chemical Corporation, which corresponds to a compound represented by formula (X); n = 2 to 100) (2.9 g), aluminum chelate D (aluminum bis(ethylacetoacetate) mono(acetylacetonate) manufactured by Kawaken Fine Chemical Co., Ltd., diluted with ethanol: solid content concentration 76% by mass) (0.23 g), isopropyl alcohol (IPA) ( 38.5 g), a nonionic surfactant ("EMALEX 715" manufactured by Nippon Emulsion Co., Ltd., diluted with ion-exchanged water: solids concentration 0.5% by mass) (47.3 g), an anionic surfactant (sodium di(2-ethylhexyl)sulfosuccinate, diluted with ion-exchanged water: solids concentration 1.0% by mass) (2.36 g), and ion-exchanged water (128 g) were added in that order, and then 21.01 g of the antibacterial particle solution prepared in advance was added and stirred for 30 minutes, thereby obtaining composition A1.
The antibacterial particle solution was prepared by adding a dispersant (BYK Corporation's "DISPERBYK-180") (0.61 g) while stirring ethanol (19.6 g) in a container, followed by stirring for 15 minutes, and then adding a silver-loaded glass dispersion (Fuji Chemical Co., Ltd.'s "Bacterite MP-103DV") (0.80 g) and stirring for 15 minutes. The silver-loaded glass dispersion was a dispersion containing a silver-loaded inorganic oxide in which silver was loaded on an inorganic oxide carrier made of phosphate glass, the solids concentration of the dispersion was 25 mass%, and the silver content relative to the total mass of the silver-loaded carrier was 2 mass%.
<抗菌フィルタの製造>
抗菌フィルタの製造に用いるフィルタろ材として、PTFE多孔質膜と、PTFE多孔質膜を挟む2枚の不織布とが積層されてなるシート状のフィルタろ材(日東電工株式会社製「TEMISH(登録商標)NTF-9307-L03」)を準備した。
上記フィルタろ材にプリーツ加工を施し、幅240mm、長さ417mm、厚み51mmの外形寸法を有し、ピッチが約3.5mmであり、山部及び谷部をそれぞれ120個有するひだ形状が形成されてなるフィルタ(フィルタパック)を製造した。
上記製造されたフィルタについて、試験Aとして既に説明した方法に従って、除電した後、風速5.3cm/sの条件で粒径0.3μmの粒子の粒子捕集率を測定した結果、上記粒子捕集率が9.97%以上であり、要件Aを満たすことが確認された。 <Manufacture of antibacterial filters>
As a filter medium used in the manufacture of the antibacterial filter, a sheet-like filter medium ("TEMISH (registered trademark) NTF-9307-L03" manufactured by Nitto Denko Corporation) was prepared, which was made by laminating a PTFE porous membrane and two sheets of nonwoven fabric sandwiching the PTFE porous membrane.
The above filter medium was pleated to produce a filter (filter pack) having outer dimensions of 240 mm in width, 417 mm in length, and 51 mm in thickness, with a pitch of approximately 3.5 mm and pleated shapes having 120 peaks and 120 valleys.
The produced filter was subjected to static electricity removal in accordance with the method already explained as Test A, and then the particle collection efficiency of particles having a particle diameter of 0.3 μm was measured under a wind speed of 5.3 cm/s. As a result, it was confirmed that the particle collection efficiency was 9.97% or more and satisfied requirement A.
抗菌フィルタの製造に用いるフィルタろ材として、PTFE多孔質膜と、PTFE多孔質膜を挟む2枚の不織布とが積層されてなるシート状のフィルタろ材(日東電工株式会社製「TEMISH(登録商標)NTF-9307-L03」)を準備した。
上記フィルタろ材にプリーツ加工を施し、幅240mm、長さ417mm、厚み51mmの外形寸法を有し、ピッチが約3.5mmであり、山部及び谷部をそれぞれ120個有するひだ形状が形成されてなるフィルタ(フィルタパック)を製造した。
上記製造されたフィルタについて、試験Aとして既に説明した方法に従って、除電した後、風速5.3cm/sの条件で粒径0.3μmの粒子の粒子捕集率を測定した結果、上記粒子捕集率が9.97%以上であり、要件Aを満たすことが確認された。 <Manufacture of antibacterial filters>
As a filter medium used in the manufacture of the antibacterial filter, a sheet-like filter medium ("TEMISH (registered trademark) NTF-9307-L03" manufactured by Nitto Denko Corporation) was prepared, which was made by laminating a PTFE porous membrane and two sheets of nonwoven fabric sandwiching the PTFE porous membrane.
The above filter medium was pleated to produce a filter (filter pack) having outer dimensions of 240 mm in width, 417 mm in length, and 51 mm in thickness, with a pitch of approximately 3.5 mm and pleated shapes having 120 peaks and 120 valleys.
The produced filter was subjected to static electricity removal in accordance with the method already explained as Test A, and then the particle collection efficiency of particles having a particle diameter of 0.3 μm was measured under a wind speed of 5.3 cm/s. As a result, it was confirmed that the particle collection efficiency was 9.97% or more and satisfied requirement A.
上記で調製された組成物A1を、エアガン(アネスト岩田株式会社製、製品名「WIDER」)の容器に充填した。このエアガンを用いて、上記製造されたフィルタの一方の主面(第1面)の全面に組成物A1を塗布した後、組成物A1の塗布膜が形成されたフィルタを、20~35℃の環境下で1時間放置する自然乾燥により乾燥した。次いで、上記エアガンを用いて、上記フィルタの第1面に対向する他方の主面(第2面)の全面に組成物A1を塗布し、同じ条件で乾燥処理を行った。1回の塗布工程における組成物A1の塗布量はフィルタの主面の面積に対して150mL/m2であり、フィルタに塗布された組成物A1の合計塗布量はフィルタの主面の面積に対して300mL/m2であった。
これにより、フィルタ部と抗菌部とを有する本発明の抗菌フィルタを製造した。 The composition A1 prepared above was filled into the container of an air gun (manufactured by Anest Iwata Corporation, product name "WIDER"). Using this air gun, the composition A1 was applied to the entire surface of one of the main surfaces (first surface) of the filter manufactured above, and then the filter on which the coating film of the composition A1 was formed was left in an environment of 20 to 35 ° C. for 1 hour to dry by natural drying. Next, using the air gun, the composition A1 was applied to the entire surface of the other main surface (second surface) opposite to the first surface of the filter, and a drying process was performed under the same conditions. The coating amount of the composition A1 in one coating step was 150 mL/m 2 relative to the area of the main surface of the filter, and the total coating amount of the composition A1 applied to the filter was 300 mL/m 2 relative to the area of the main surface of the filter.
In this way, an antibacterial filter of the present invention having a filter portion and an antibacterial portion was produced.
これにより、フィルタ部と抗菌部とを有する本発明の抗菌フィルタを製造した。 The composition A1 prepared above was filled into the container of an air gun (manufactured by Anest Iwata Corporation, product name "WIDER"). Using this air gun, the composition A1 was applied to the entire surface of one of the main surfaces (first surface) of the filter manufactured above, and then the filter on which the coating film of the composition A1 was formed was left in an environment of 20 to 35 ° C. for 1 hour to dry by natural drying. Next, using the air gun, the composition A1 was applied to the entire surface of the other main surface (second surface) opposite to the first surface of the filter, and a drying process was performed under the same conditions. The coating amount of the composition A1 in one coating step was 150 mL/m 2 relative to the area of the main surface of the filter, and the total coating amount of the composition A1 applied to the filter was 300 mL/m 2 relative to the area of the main surface of the filter.
In this way, an antibacterial filter of the present invention having a filter portion and an antibacterial portion was produced.
[実施例2]
実施例1に記載の方法に従って、第1面からの組成物A1の塗布、乾燥処理、第2面からの組成物A1の塗布、及び、乾燥処理からなる一連の処理を実施した後、抗菌部が形成されたフィルタに対して、再度、第1面からの組成物A1の塗布、乾燥処理、第2面からの組成物A1の塗布、及び、乾燥処理からなる一連の処理を実施した。1回の塗布工程における組成物A1の塗布量はフィルタの主面の面積に対して150mL/m2であり、フィルタに塗布された組成物A1の合計塗布量はフィルタの主面の面積に対して600mL/m2であった。 [Example 2]
According to the method described in Example 1, a series of treatments consisting of application of composition A1 from the first surface, drying treatment, application of composition A1 from the second surface, and drying treatment were performed, and then a series of treatments consisting of application of composition A1 from the first surface, drying treatment, application of composition A1 from the second surface, and drying treatment were performed again on the filter on which the antibacterial portion was formed. The application amount of composition A1 in one application step was 150 mL/ m2 relative to the area of the main surface of the filter, and the total application amount of composition A1 applied to the filter was 600 mL/ m2 relative to the area of the main surface of the filter.
実施例1に記載の方法に従って、第1面からの組成物A1の塗布、乾燥処理、第2面からの組成物A1の塗布、及び、乾燥処理からなる一連の処理を実施した後、抗菌部が形成されたフィルタに対して、再度、第1面からの組成物A1の塗布、乾燥処理、第2面からの組成物A1の塗布、及び、乾燥処理からなる一連の処理を実施した。1回の塗布工程における組成物A1の塗布量はフィルタの主面の面積に対して150mL/m2であり、フィルタに塗布された組成物A1の合計塗布量はフィルタの主面の面積に対して600mL/m2であった。 [Example 2]
According to the method described in Example 1, a series of treatments consisting of application of composition A1 from the first surface, drying treatment, application of composition A1 from the second surface, and drying treatment were performed, and then a series of treatments consisting of application of composition A1 from the first surface, drying treatment, application of composition A1 from the second surface, and drying treatment were performed again on the filter on which the antibacterial portion was formed. The application amount of composition A1 in one application step was 150 mL/ m2 relative to the area of the main surface of the filter, and the total application amount of composition A1 applied to the filter was 600 mL/ m2 relative to the area of the main surface of the filter.
[実施例3]
実施例2に記載の方法に従って、第1面からの組成物A1の塗布、乾燥処理、第2面からの組成物A1の塗布、及び、乾燥処理からなる一連の処理を2回繰り返し実施した後、抗菌部が形成されたフィルタに対して、再度、第1面からの組成物A1の塗布、乾燥処理、第2面からの組成物A1の塗布、及び、乾燥処理からなる一連の処理を実施した。1回の塗布工程における組成物A1の塗布量はフィルタの主面の面積に対して150mL/m2であり、フィルタに塗布された組成物A1の合計塗布量はフィルタの主面の面積に対して900mL/m2であった。 [Example 3]
According to the method described in Example 2, a series of processes consisting of applying composition A1 from the first surface, drying treatment, applying composition A1 from the second surface, and drying treatment were repeated twice, and then a series of processes consisting of applying composition A1 from the first surface, drying treatment, applying composition A1 from the second surface, and drying treatment were again performed on the filter on which the antibacterial portion was formed. The amount of composition A1 applied in one application step was 150 mL/ m2 relative to the area of the main surface of the filter, and the total amount of composition A1 applied to the filter was 900 mL/ m2 relative to the area of the main surface of the filter.
実施例2に記載の方法に従って、第1面からの組成物A1の塗布、乾燥処理、第2面からの組成物A1の塗布、及び、乾燥処理からなる一連の処理を2回繰り返し実施した後、抗菌部が形成されたフィルタに対して、再度、第1面からの組成物A1の塗布、乾燥処理、第2面からの組成物A1の塗布、及び、乾燥処理からなる一連の処理を実施した。1回の塗布工程における組成物A1の塗布量はフィルタの主面の面積に対して150mL/m2であり、フィルタに塗布された組成物A1の合計塗布量はフィルタの主面の面積に対して900mL/m2であった。 [Example 3]
According to the method described in Example 2, a series of processes consisting of applying composition A1 from the first surface, drying treatment, applying composition A1 from the second surface, and drying treatment were repeated twice, and then a series of processes consisting of applying composition A1 from the first surface, drying treatment, applying composition A1 from the second surface, and drying treatment were again performed on the filter on which the antibacterial portion was formed. The amount of composition A1 applied in one application step was 150 mL/ m2 relative to the area of the main surface of the filter, and the total amount of composition A1 applied to the filter was 900 mL/ m2 relative to the area of the main surface of the filter.
実施例1~3の各抗菌フィルタについて抗菌性能試験を実施した結果、実施例1~3の抗菌フィルタは優れた抗菌性を示しており、本発明が所望の効果を有することが確認された。
Antibacterial performance tests were conducted on each of the antibacterial filters of Examples 1 to 3, and the results confirmed that the antibacterial filters of Examples 1 to 3 exhibited excellent antibacterial properties and that the present invention has the desired effects.
[フィルタ性能試験]
実施例2の抗菌フィルタ、及び、下記参照用フィルタについて、下記条件でフィルタ性能試験を実施した。
・評価装置:JIS B 9908に準拠したフィルタ性能評価機。
・試験粉体:SAP試験用粉体3の3種(STP3-3)(焼成関東ローム)日本粉体工業技術協会製。
・参照用フィルタ:帯電HEPAフィルタ(シャープ株式会社製「FZ-14EXSF(商品名)」)
・試験風量:420m3/h
各フィルタサンプルを上記評価装置に設置した。次いで、評価装置が備える送風機により空気を送り込むとともに、装置内のフィルタサンプルの上流側に設けた粉体投入口から上記試験粉体を徐々に投入することにより、上記試験粉体が混合してなる混合ガスをフィルタサンプルに通過させた。試験粉体の投入を開始する初期において、装置内のフィルタサンプルの下流側に設けたオリフィスにより、フィルタサンプルを通過する混合ガスの流量が上記試験風量の値になるように調整し、その後は試験終了まで風量の調整は行わなかった。
試験粉体を100g投入した時点で試験を終了とした。試験終了後のフィルタサンプルの重量を測定し、予め測定された試験開始前のフィルタサンプルの重量との差分(フィルタ重量増加分)を算出した。また、試験終了後の評価装置内においてフィルタサンプルよりも上流側に残留した試験粉体を集めて、その総重量(未到達粉体重量)を測定した。評価装置に投入した試験粉体の重量(100g)から、上記で測定された未到達粉体重量を差し引くことにより、試験中にフィルタサンプルに到達した試験粉体の重量(到達粉体重量)を求めた。得られた到達粉体重量に対するフィルタ重量増加分の比率の百分率((フィルタ重量増加分/到達粉体重量)×100)を、粉体捕捉率(%)として算出し、フィルタサンプルの粉体捕捉性能を評価した。 [Filter performance test]
The antibacterial filter of Example 2 and the reference filter described below were subjected to a filter performance test under the following conditions.
Evaluation device: A filter performance evaluation device conforming to JIS B 9908.
Test powder: SAP test powder 3 type 3 (STP3-3) (calcined Kanto loam) manufactured by the Japan Powder Industry and Technology Association.
Reference filter: Charged HEPA filter ("FZ-14EXSF (product name)" manufactured by Sharp Corporation)
Test air volume: 420 m3 /h
Each filter sample was placed in the evaluation device. Then, air was sent in by a blower provided in the evaluation device, and the test powder was gradually introduced from a powder introduction port provided on the upstream side of the filter sample in the device, so that a mixed gas containing the test powder was passed through the filter sample. At the beginning of the introduction of the test powder, the flow rate of the mixed gas passing through the filter sample was adjusted by an orifice provided on the downstream side of the filter sample in the device so that it was equal to the test air volume, and thereafter, the air volume was not adjusted until the end of the test.
The test was terminated when 100 g of the test powder was added. The weight of the filter sample after the test was measured, and the difference (filter weight increase) between the weight of the filter sample before the test, which was measured in advance, was calculated. In addition, the test powder remaining upstream of the filter sample in the evaluation device after the test was completed was collected, and the total weight (unreached powder weight) was measured. The weight of the test powder that reached the filter sample during the test (reached powder weight) was obtained by subtracting the unreached powder weight measured above from the weight (100 g) of the test powder charged into the evaluation device. The percentage of the ratio of the filter weight increase to the obtained reached powder weight ((filter weight increase/reached powder weight) x 100) was calculated as the powder capture rate (%), and the powder capture performance of the filter sample was evaluated.
実施例2の抗菌フィルタ、及び、下記参照用フィルタについて、下記条件でフィルタ性能試験を実施した。
・評価装置:JIS B 9908に準拠したフィルタ性能評価機。
・試験粉体:SAP試験用粉体3の3種(STP3-3)(焼成関東ローム)日本粉体工業技術協会製。
・参照用フィルタ:帯電HEPAフィルタ(シャープ株式会社製「FZ-14EXSF(商品名)」)
・試験風量:420m3/h
各フィルタサンプルを上記評価装置に設置した。次いで、評価装置が備える送風機により空気を送り込むとともに、装置内のフィルタサンプルの上流側に設けた粉体投入口から上記試験粉体を徐々に投入することにより、上記試験粉体が混合してなる混合ガスをフィルタサンプルに通過させた。試験粉体の投入を開始する初期において、装置内のフィルタサンプルの下流側に設けたオリフィスにより、フィルタサンプルを通過する混合ガスの流量が上記試験風量の値になるように調整し、その後は試験終了まで風量の調整は行わなかった。
試験粉体を100g投入した時点で試験を終了とした。試験終了後のフィルタサンプルの重量を測定し、予め測定された試験開始前のフィルタサンプルの重量との差分(フィルタ重量増加分)を算出した。また、試験終了後の評価装置内においてフィルタサンプルよりも上流側に残留した試験粉体を集めて、その総重量(未到達粉体重量)を測定した。評価装置に投入した試験粉体の重量(100g)から、上記で測定された未到達粉体重量を差し引くことにより、試験中にフィルタサンプルに到達した試験粉体の重量(到達粉体重量)を求めた。得られた到達粉体重量に対するフィルタ重量増加分の比率の百分率((フィルタ重量増加分/到達粉体重量)×100)を、粉体捕捉率(%)として算出し、フィルタサンプルの粉体捕捉性能を評価した。 [Filter performance test]
The antibacterial filter of Example 2 and the reference filter described below were subjected to a filter performance test under the following conditions.
Evaluation device: A filter performance evaluation device conforming to JIS B 9908.
Test powder: SAP test powder 3 type 3 (STP3-3) (calcined Kanto loam) manufactured by the Japan Powder Industry and Technology Association.
Reference filter: Charged HEPA filter ("FZ-14EXSF (product name)" manufactured by Sharp Corporation)
Test air volume: 420 m3 /h
Each filter sample was placed in the evaluation device. Then, air was sent in by a blower provided in the evaluation device, and the test powder was gradually introduced from a powder introduction port provided on the upstream side of the filter sample in the device, so that a mixed gas containing the test powder was passed through the filter sample. At the beginning of the introduction of the test powder, the flow rate of the mixed gas passing through the filter sample was adjusted by an orifice provided on the downstream side of the filter sample in the device so that it was equal to the test air volume, and thereafter, the air volume was not adjusted until the end of the test.
The test was terminated when 100 g of the test powder was added. The weight of the filter sample after the test was measured, and the difference (filter weight increase) between the weight of the filter sample before the test, which was measured in advance, was calculated. In addition, the test powder remaining upstream of the filter sample in the evaluation device after the test was completed was collected, and the total weight (unreached powder weight) was measured. The weight of the test powder that reached the filter sample during the test (reached powder weight) was obtained by subtracting the unreached powder weight measured above from the weight (100 g) of the test powder charged into the evaluation device. The percentage of the ratio of the filter weight increase to the obtained reached powder weight ((filter weight increase/reached powder weight) x 100) was calculated as the powder capture rate (%), and the powder capture performance of the filter sample was evaluated.
また、上記フィルタ性能試験において、試験粉体を投入する直前及び試験終了直後のそれぞれの時点での各フィルタサンプルの圧力損失を測定した。また、試験粉体を投入する直前及び試験終了直後のそれぞれの時点での、混合ガスの流量を測定した。
In addition, in the above filter performance test, the pressure loss of each filter sample was measured immediately before the test powder was added and immediately after the test was completed. The flow rate of the mixed gas was also measured immediately before the test powder was added and immediately after the test was completed.
表1に、上記試験結果を示す。
表中、「圧力損失」欄の上段には、上記の試験終了直後に測定された各フィルタサンプルの圧力損失を示し、下段の括弧内には、試験開始前の圧力損失の測定値に対する試験終了直後の圧力損失の測定値の比率を百分率で示す。
表中、「風量」欄の上段には、上記の試験終了直後に測定されたフィルタサンプルを通過する空気の流量を示し、下段の括弧内には、試験開始前に測定された上記流量に対する試験終了直後に測定された上記流量の比率を百分率で示す。
表中、「実施例」は、上記実施例2の抗菌フィルタの測定結果であることを意味し、「参照例」は、上記参照用フィルタの測定結果であることを意味する。また、それぞれのフィルタについて2回の測定を行っており、「実施例」及び「参照例」の「(1)」及び「(2)」にそれぞれの測定結果を記載する。 Table 1 shows the test results.
In the table, the upper row of the "Pressure Loss" column shows the pressure loss of each filter sample measured immediately after the completion of the above-mentioned test, and the lower row in parentheses shows the ratio, expressed as a percentage, of the pressure loss measured immediately after the completion of the test to the pressure loss measured before the start of the test.
In the table, the upper row of the "Air Volume" column shows the flow rate of air passing through the filter sample measured immediately after the completion of the above test, and the lower row in parentheses shows the ratio, expressed as a percentage, of the flow rate measured immediately after the completion of the test to the flow rate measured before the start of the test.
In the table, "Example" means the measurement result of the antibacterial filter of Example 2, and "Reference Example" means the measurement result of the reference filter. In addition, two measurements were taken for each filter, and the respective measurement results are shown in "(1)" and "(2)" of "Example" and "Reference Example".
表中、「圧力損失」欄の上段には、上記の試験終了直後に測定された各フィルタサンプルの圧力損失を示し、下段の括弧内には、試験開始前の圧力損失の測定値に対する試験終了直後の圧力損失の測定値の比率を百分率で示す。
表中、「風量」欄の上段には、上記の試験終了直後に測定されたフィルタサンプルを通過する空気の流量を示し、下段の括弧内には、試験開始前に測定された上記流量に対する試験終了直後に測定された上記流量の比率を百分率で示す。
表中、「実施例」は、上記実施例2の抗菌フィルタの測定結果であることを意味し、「参照例」は、上記参照用フィルタの測定結果であることを意味する。また、それぞれのフィルタについて2回の測定を行っており、「実施例」及び「参照例」の「(1)」及び「(2)」にそれぞれの測定結果を記載する。 Table 1 shows the test results.
In the table, the upper row of the "Pressure Loss" column shows the pressure loss of each filter sample measured immediately after the completion of the above-mentioned test, and the lower row in parentheses shows the ratio, expressed as a percentage, of the pressure loss measured immediately after the completion of the test to the pressure loss measured before the start of the test.
In the table, the upper row of the "Air Volume" column shows the flow rate of air passing through the filter sample measured immediately after the completion of the above test, and the lower row in parentheses shows the ratio, expressed as a percentage, of the flow rate measured immediately after the completion of the test to the flow rate measured before the start of the test.
In the table, "Example" means the measurement result of the antibacterial filter of Example 2, and "Reference Example" means the measurement result of the reference filter. In addition, two measurements were taken for each filter, and the respective measurement results are shown in "(1)" and "(2)" of "Example" and "Reference Example".
上記表に示す通り、実施例2の抗菌フィルタは、到達した粉体の捕捉率がほぼ100%であり、優れた粉体捕捉性能を有することがわかった。
また、実施例2の抗菌フィルタは、粉体捕集後の圧力損失及び風量の低下も抑制されており、従来の帯電フィルタの実績から鑑みても十分な実用性を有するレベルにあると判断できる。 As shown in the above table, the antibacterial filter of Example 2 achieved a powder capture rate of nearly 100%, and was found to have excellent powder capture performance.
Moreover, the antibacterial filter of Example 2 also suppresses the pressure loss and reduction in air volume after powder capture, and can be judged to be at a level that has sufficient practicality even in light of the track record of conventional electrically charged filters.
また、実施例2の抗菌フィルタは、粉体捕集後の圧力損失及び風量の低下も抑制されており、従来の帯電フィルタの実績から鑑みても十分な実用性を有するレベルにあると判断できる。 As shown in the above table, the antibacterial filter of Example 2 achieved a powder capture rate of nearly 100%, and was found to have excellent powder capture performance.
Moreover, the antibacterial filter of Example 2 also suppresses the pressure loss and reduction in air volume after powder capture, and can be judged to be at a level that has sufficient practicality even in light of the track record of conventional electrically charged filters.
Claims (11)
- 以下の要件Aを満たすフィルタ部と、
前記フィルタ部上に配置されている抗菌部とを有し、
前記抗菌部は、銀系抗菌剤及びシリケート系化合物を含む、抗菌フィルタ。
要件A:JIS B 9927-5:2022附属書Cに規定される手順に従って除電した状態のフィルタ部に対して、風速5.3cm/sの条件で粒径が0.3μmである粒子を通過させた際の粒子捕集率が、99.95%以上である。 A filter unit that satisfies the following requirement A;
an antibacterial portion disposed on the filter portion,
The antibacterial filter, wherein the antibacterial portion contains a silver-based antibacterial agent and a silicate-based compound.
Requirement A: When particles with a particle size of 0.3 μm are allowed to pass through a filter part that has been destaticized in accordance with the procedure specified in JIS B 9927-5:2022, Annex C, at a wind speed of 5.3 cm/s, the particle collection efficiency is 99.95% or more. - 前記銀系抗菌剤が、銀担持無機酸化物である、請求項1に記載の抗菌フィルタ。 The antibacterial filter according to claim 1, wherein the silver-based antibacterial agent is a silver-supported inorganic oxide.
- 前記抗菌部がアルコールを含む、請求項1に記載の抗菌フィルタ。 The antibacterial filter according to claim 1, wherein the antibacterial portion contains alcohol.
- 空気清浄機用である、請求項1に記載の抗菌フィルタ。 The antibacterial filter according to claim 1, which is for use in an air purifier.
- 以下の要件Aを満たすフィルタに抗菌部形成用組成物を接触させる工程を有し、
前記抗菌部形成用組成物が、銀系抗菌剤と、シリケート系化合物前駆体とを含む、抗菌フィルタの製造方法。
要件A:JIS B 9927-5:2022附属書Cに規定される手順に従って除電された状態のフィルタに対して、風速5.3cm/sの条件で粒径が0.3μmである粒子を通過させた際の粒子捕集率が、99.95%以上である。 The method includes a step of contacting a filter that satisfies the following requirement A with a composition for forming an antibacterial portion,
The method for producing an antibacterial filter, wherein the composition for forming an antibacterial portion contains a silver-based antibacterial agent and a silicate-based compound precursor.
Requirement A: The particle capture efficiency when particles with a diameter of 0.3 μm are passed through a filter in a state where static electricity has been removed in accordance with the procedure specified in JIS B 9927-5:2022, Appendix C, at a wind speed of 5.3 cm/s is 99.95% or more. - 前記工程が、前記フィルタに前記抗菌部形成用組成物を塗布する塗布工程を有する、請求項5に記載の抗菌フィルタの製造方法。 The method for manufacturing an antibacterial filter according to claim 5, wherein the process includes a coating process of coating the antibacterial portion-forming composition on the filter.
- 前記塗布工程において前記フィルタに塗布される前記抗菌部形成用組成物の塗布量が、50~1000mL/m2である、請求項5又は6に記載の抗菌フィルタの製造方法。 The method for manufacturing an antibacterial filter according to claim 5 or 6, wherein the amount of the antibacterial portion-forming composition applied to the filter in the application step is 50 to 1000 mL/ m2 .
- 前記銀系抗菌剤が、銀担持無機酸化物である、請求項5又は6に記載の抗菌フィルタの製造方法。 The method for manufacturing an antibacterial filter according to claim 5 or 6, wherein the silver-based antibacterial agent is a silver-supported inorganic oxide.
- 前記抗菌部形成用組成物がアルコールを含む、請求項5又は6に記載の抗菌フィルタの製造方法。 The method for manufacturing an antibacterial filter according to claim 5 or 6, wherein the composition for forming the antibacterial portion contains alcohol.
- 前記抗菌フィルタが空気清浄機用である、請求項5又は6に記載の抗菌フィルタの製造方法。 The method for manufacturing an antibacterial filter according to claim 5 or 6, wherein the antibacterial filter is for an air purifier.
- 請求項1~4のいずれか1項に記載の抗菌フィルタを備える空気清浄機。 An air purifier equipped with an antibacterial filter according to any one of claims 1 to 4.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2023-010476 | 2023-01-26 | ||
JP2023010476 | 2023-01-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024157756A1 true WO2024157756A1 (en) | 2024-08-02 |
Family
ID=91970343
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2024/000225 WO2024157756A1 (en) | 2023-01-26 | 2024-01-10 | Antibacterial filter, method for manufacturing antibacterial filter, and air purifier |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2024157756A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0731812A (en) * | 1993-07-19 | 1995-02-03 | Matsushita Electric Ind Co Ltd | Antibacterial filter |
JP2001246208A (en) * | 2000-03-06 | 2001-09-11 | Toray Ind Inc | Filter |
JP2002058925A (en) * | 2000-08-21 | 2002-02-26 | Kansai Paint Co Ltd | Air cleaning filter and producing method thereof |
JP2021142505A (en) * | 2020-03-13 | 2021-09-24 | 三菱製紙株式会社 | Air filter medium |
-
2024
- 2024-01-10 WO PCT/JP2024/000225 patent/WO2024157756A1/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0731812A (en) * | 1993-07-19 | 1995-02-03 | Matsushita Electric Ind Co Ltd | Antibacterial filter |
JP2001246208A (en) * | 2000-03-06 | 2001-09-11 | Toray Ind Inc | Filter |
JP2002058925A (en) * | 2000-08-21 | 2002-02-26 | Kansai Paint Co Ltd | Air cleaning filter and producing method thereof |
JP2021142505A (en) * | 2020-03-13 | 2021-09-24 | 三菱製紙株式会社 | Air filter medium |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6726313B2 (en) | Photocatalytic functional filter | |
EP2546290A1 (en) | Patient interface with coating | |
US20200362179A1 (en) | Ionic liquid-based coating and method of making articles coated with the same | |
CN101362035B (en) | Expanded polytetrafluoroethylene bacteriostatic coated filter material and production method thereof | |
Kim et al. | Application of 2D materials for adsorptive removal of air pollutants | |
CN110809405A (en) | Composition, film-attached substrate, method for producing film-attached substrate, and modified substrate | |
WO2024157756A1 (en) | Antibacterial filter, method for manufacturing antibacterial filter, and air purifier | |
CN106268041A (en) | A kind of for composite purifying air and its preparation method and application | |
DE102005042181B4 (en) | Shaped body and method for producing a shaped body | |
EP3885032A1 (en) | Smart filters with improved properties in filtration and antibacterial efficiency applicable in fluids | |
JP6967086B2 (en) | Method for manufacturing composition, wet wiper, spray, surface treatment base material | |
JPH11128632A (en) | Filter and air cleaning device | |
WO2022009776A1 (en) | Composition, wet wiper, spray, mask with antimicrobial agent, faceguard with antimicrobial agent, and antimicrobial liquid material | |
JP4889035B2 (en) | Cleaner | |
JP5699546B2 (en) | Composite base material and method for producing the composite base material | |
CN113774657A (en) | Antibacterial and antiviral fiber cloth composite material and preparation method and application thereof | |
KR102453620B1 (en) | Dust filter structure having antimicrobia property, and fabricating of the same | |
Oproescu et al. | Trends and Advantages in Using Nanomaterials for Air Filtration | |
KR102383557B1 (en) | Composite material and manufacturing tmethod for the same | |
KR102262258B1 (en) | Chemical-chemi adsorption filter for removal of odor and hazardous dust | |
WO2023166841A1 (en) | Filter material, air filter, air conditioner, water filter, and water cleaner | |
WO2020045404A1 (en) | Composition, spray, wiper, membrane, substrate with membrane, and resin molded body | |
WO2020045416A1 (en) | Deodorant composition, spray, wiper, membrane, substrate with membrane, and resin molded body | |
Aamer et al. | ZnO-Impregnated Polyacrylonitrile Nanofiber Filters against Various Phases of Air Pollutants. Nanomaterials 2021, 11, 2313 | |
WO2023183430A1 (en) | Hybrid nanoporous membrane assembled from 3d nanospiky particles for environmental and biological applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 24747087 Country of ref document: EP Kind code of ref document: A1 |